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ABSTRACT 
Andres Ruben Henriquez Coria: Ozone-induced lung injury and inflammation are modulated by 
circulating stress hormones  
(Under the direction of Urmila P. Kodavanti) 
 
 
 
 
Air pollution has been associated with a wide-range of health effects. Pulmonary effects 
of acute ozone inhalation have been widely characterized in humans and animals. These 
include decrements in lung function, neutrophilic inflammation, and increased epithelial 
permeability. Ozone has also been shown to induce cardiovascular, neurological, metabolic and 
immune effects. It is believed that the “spillover” of bioactive lung-derived molecules to the 
circulation is responsible for extra-pulmonary effects of ozone. Our lab has recently shown that 
ozone, in addition to pulmonary effects, induces widespread systemic metabolic and immune 
effects in rats and humans. Importantly, these systemic changes are associated with increased 
circulating stress hormones, such as corticosterone and epinephrine, which are known to be 
involved in the “fight-or-flight” response.  In our intervention study, we noted that extra-
pulmonary but also pulmonary effects of ozone were dramatically reduced in adrenalectomized 
rats, indicating that circulating stress hormones contributed to all ozone effects. 
Since neuroendocrine stress response targets two essential survival processes, 
metabolic and immune, in this project we characterized in detail how pulmonary immune 
response and injury are influenced by the enhanced release of circulating stress hormones after 
ozone inhalation. In the first study, we demonstrated that the circulating stress hormones act at 
a transcriptional level to change gene expression after ozone exposure since global pulmonary 
gene changes induced by ozone exposure were attenuated in adrenalectomized rats. These 
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ozone-induced expression changes depicted similarity to those predicted by glucocorticoid and 
adrenergic receptor activation, suggesting the contribution of stress hormones in mediating 
transcriptional effects. In our second round of studies, we demonstrated that by blocking 
endogenous stress hormone signaling adrenergic and glucocorticoid receptor antagonists, 
ozone-induced lung injury and inflammation were reduced in a receptor-specific manner (i.e. β 
adrenergic blocker inhibited lung neutrophilia while glucocorticoid receptor blocker caused 
lymphopenia). These results validated the role of stress hormones as bona fide circulating 
mediators acting directly on the lungs, and provided insights on the role of corticosterone versus 
epinephrine as individual modulators of ozone effects. In the third study, we combined surgical 
and pharmacological approaches, and demonstrated that the ozone-injury and inflammation 
phenotypes can be restored in adrenalectomized rats by providing exogenous glucocorticoid 
and β-adrenergic receptor agonists. These findings demonstrated unequivocally that stress 
hormones are the key systemic mediators of ozone-induced lung injury and innate immune 
effects. Thus, we show that circulating stress hormones, released from adrenal glands in 
response to ozone exposure, through their effects on β-adrenergic and glucocorticoid receptors, 
mediate most known pulmonary injury and innate immune effects. Our studies highlight the role 
of neuroendocrine stress response as a potential key regulator of air pollution health effects.  
Any perturbations in this neuroendocrine pathway and/or β-adrenergic and glucocorticoid 
receptor signaling through disease processes or the use of adrenergic or steroidal therapies, 
are likely to play a central role in susceptibility to air pollution health effects. 
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CHAPTER 1: GENERAL INTRODUCTION 
1.1 Air Pollution and Health  
Air pollution has been described as the single largest environmental health risk by the 
World Health Organization (WHO) (“Burden of disease”, 2017). Human morbidity and mortality 
are increased after acute and chronic exposure to air pollution (Pope and Dockery, 2006; 
Gotschi et al., 2008; Bell et al., 2013) with outdoor and indoor air pollutants accounting for 7 
million premature deaths, or one in eight deaths globally, during 2012 (“7 million premature 
deaths”, 2017). In addition, life expectancy reduction is associated with air pollution levels 
(Correia et al., 2013), and global disease burden attributable to air pollution has increased 
during the last 25 years because of recent demographic changes (Cohen et al., 2017).  
Historically, air pollution health effects have been reported from antiquity. There is 
evidence of pneumoconiosis induced by dust exposures in Ancient Egypt (Cockburn et al., 
1975) and old texts indicating the dissatisfaction produced by sources of odor or pestilence in 
Greece and Rome (Sundell, 2004). Transitioning to modernity, the development of technologies, 
escalation of energy production and consumption exploiting sources such as wood, coal and 
fossil fuels, the exponential increase in population size, and the growth of urban centers have 
resulted in the occurrence of extensive episodes of air pollution. “Fogs” described in Meuse 
Valley, Belgium (1930), Donora, US (1948), Pozo Rico, Mexico (1950), and London, England 
(1952) are among the most severe episodes reported during the 19th century causing excess 
human mortality (Holgate et al., [Chapter 2], 1999)  
Currently, in the US, a country with relatively low levels of air pollutants (“WHO Global 
Urban”, 2017; Friedrich, 2016), both ambient particulate matter (PM) and ozone pollution are in 
the top 20 risk factors of death among the population (Murray et al., 2013). In spite of massive 
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improvements in the air quality and an attempt for compliance with the current national 
standards (“Air Quality – National Summary”, 2017), air pollutants are still associated with 
excess mortality (Di et al., 2017) bringing attention on the lack of “safe levels” or a threshold 
below which air pollution effects are likely to be absent (WHO, 2013).     
1.1.1 Air Pollutants: Types, Sources and Policies 
The term “air pollution” is a wide categorical description to account for the “presence of 
substances in the air that are harmful to human health or toxic”. Physically, gases and particles 
can be distinguished in the atmosphere. Particles are microscopic solid or liquid matter forming 
an aerosol in the air, while compressible toxic gases are mixed in the atmosphere. The 
interaction and transition between particles and gases is determined by variables such as 
temperature, pressure, concentration and volume, which altogether determine the occurrence of 
physical changes and chemical reactions (Seinfeld and Pandis, 2006). Air pollutants are defined 
as primary when they are directly emitted into the atmosphere or secondary when they are 
formed in the atmosphere from reactive precursors. The source of the pollutant can be 
anthropogenic when humans are directly involved in their formation/release or natural such as 
volcanoes or marine sea salts. Multiple additional classifications have been developed to 
establish distinctions among pollutants such as point sources or non-point sources, stationary or 
mobile sources, indoor or outdoor air pollutants, etc. For particles, size becomes a key feature 
because it determines the penetrability to the respiratory system after inhalation, thus 
determining the area where these particles are deposited and react. Generally, particles with an 
aerodynamic diameter larger than 10 μm are retained in the extra-thoracic region such as nasal 
passages and larynx; particles with an aerodynamic diameter between 2.5 and 10 μm are 
defined as the “coarse fraction” and are retained in the tracheobronchial region; while particles 
with an aerodynamic diameter between 2.5 μm to 100 nm (fine fraction) and those less than 100 
nm (ultrafine fraction) are retained in the alveolar region (Lippmann, 2010). From the public 
health perspective, extensive research and regulation has focused on the coarse (PM10) and 
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fine (PM2.5) fractions. Gases — unlike particles which are classified purely by a physical 
property (size) for policy purposes — are diverse, and their availability, reactivity and 
concentration can determine their chemical nature and toxicological potential.        
Government regulations of air pollutants were established initially in developed countries 
to minimize the noxious effects on the population. The Clean Air Act (CAA) of 1963 was the first 
piece of major legislation in the US implemented with the intent to monitor and control air 
pollution levels.  After the establishment of the Environmental Protection Agency (EPA) in 1970 
and several additional laws, including major revisions to the CAA, the National Ambient Air 
Quality Standards (NAAQS) were developed to limit the outdoor concentrations of six key 
ubiquitous pollutants referred to as “criteria pollutants”. Sulfur dioxide (SO2), PM, carbon 
monoxide (CO), nitrogen dioxides (NO2), lead (Pb) and ozone (O3) primary and secondary 
standards were developed to protect human health and public welfare (Bachmann et al., 2007). 
NAAQS have been regularly revised based on continued research findings during the past few 
decades (Owens et al., 2017; Mervis, 2015). Air quality standards have also been established in 
Europe for benzene, arsenic (As), cadmium (Cd), nickel (Ni) and polycyclic aromatic 
hydrocarbons (PAHs) (Air Quality Standards, 2017). Air pollution regulations established in the 
US and Europe are also currently being adopted and implemented in developing countries 
(Giannadakci et al., 2016). In addition, other institutions (i.e. WHO), scientific associations (i.e.  
American Thoracic Society (ATS)) and advocacy groups (i.e. Coalition for Clean Air (CCAIR)) 
have developed air quality guidelines, recommendations, and educational reports on the 
impacts of air pollution on human health. Recently, the Green Heart Initiative was established by 
the EPA to educate the general public about the adverse cardiovascular health effects of 
inhaled pollutants.   
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1.1.2 Ozone, a criteria pollutant resurfaced 
Ozone, at ground level, is a secondary pollutant primarily formed by the reaction of 
volatile organic compounds (VOCs), nitrogen oxides (NOx) and CO in the presence of sunlight 
(Haagen-Smit, 1963). These precursors are directly emitted by anthropogenic sources such as 
automobiles, motor engines, and industrial sources. Therefore, urban settings with hot tropical 
climates are especially prone to exhibit high ozone concentrations. Cities such as Los Angeles, 
CA and Houston, TX are known for photochemical smog that is enriched in secondary pollutants 
such as fine particles and ozone (Haagen-Smit, 1970; Couzo et al., 2013, Berlin et al., 2013). 
The current NAAQS for ozone is 0.07 ppm, or 140 μg/m3, averaged over an 8-hr period (“Table 
of Historical Ozone National Ambient Air Quality Standards (NAAQS)”, 2017).  As the EPA 
ozone 8-hr standard has been reduced several times over the years (1997: from 0.12 to 0.08 
ppm; 2008: from 0.08 to 0.075 ppm; and 2015: from 0.075 to 0.07 ppm), many areas within the 
US remain under nonattainment (“Ozone National Ambient Air Quality Standards”, 2017). The 
standards set by the current European Union are even lower than that of the US (0.06 ppm).  As 
such, ATS has recommended that the US follow similar stringent standards for this gaseous 
pollutant (“Air Pollution Standards”, 2016). The air quality guidelines recommended by the WHO 
in 2005 calls for even lower standards of ozone to 0.05 ppm (WHO, 2005); however, these 
levels are difficult to attain in many areas falling within certain zones of the equator. 
Based on the 2008 ozone standard, approximately 110 million people live in non-
attainment areas in the US (“8-Hour Ozone (2008) Nonattainment Area Summary”, 2017) and 
almost 20 million live in areas classified as extreme (>0.175 ppm) for ozone pollution including 
Los Angeles- South Coast Air Basin, CA and Son Joaquin Valley, CA (“Ozone Designation and 
Classification Information”, 2017), making ozone the number 1 criteria air pollutant for non-
attainment Figure 1.1A. In the international scenario, megacities such as Lagos, Beijing, Paris, 
Karachi, Delhi and Mumbai exhibit a similar percent of ozone episodes above 0.07 ppm to that 
of Los Angeles (Kornei, 2017) Figure 1.1B. 
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Due to their secondary nature, ozone levels exhibit high variability, both temporally and 
geographically. In urban settings, ozone levels generally peak in the summer and a precise daily 
cycle shows the occurrence of the peak in the afternoons (Wang et al., 2017; Anderson and 
Bell, 2010 Figure 1.1C). Although tropospheric ozone levels, and its precursors NOx and VOCs, 
have been decreasing during over past few years in the US (Simon et al., 2015; “Ozone trends”, 
2017), climate change could significantly alter the formation of ground level ozone (Hoag, 2014; 
Horton et al., 2014) due to increased sunlight to react with anthropogenic and wild-fire 
precursors (Zhang and Wang, 2016) leading to worsening of ozone episodes (Schnell and 
Prather, 2016).    
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Figure 1.1 
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Figure 1.1 Levels of ozone in the US and around the world. A) Categorized three-year 
average of the 4th highest 8-hour daily maximum ozone concentration in US urban areas (2012-
2014), source: https://www3.epa.gov/airquality/greenbook/hnsum.html. B) Worldwide levels of 
ozone in urban centers as percent of observations above 70 ppb threshold; source: 
http://www.sciencemag.org/news/2017/03/here-are-some-world-s-worst-cities-air-quality 
c) Trends of ozone levels in US from 1980 to 2016; source: https://www.epa.gov/air-
trends/ozone-trends. 
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1.2 Ozone. Health effects and toxicology  
1.2.1 Epidemiological and clinical studies involving ozone exposure  
Ozone health effects have been extensively investigated at epidemiological and 
toxicological levels. Epidemiological studies have shown that short- and long-term ozone 
exposures have been associated with increased cardiopulmonary morbidity and mortality. 
Short-term effects of ozone exposure have demonstrated that an increase of 10 ppb ozone 
concentration in the preceding week is associated with a 0.52% increase in daily mortality (Bell 
et al., 2004). In a database of Medicare recipients (people over 65 years old), Di et al., 2017 
found that a 10 ppb increase in ozone was associated with a 1.1% increase in total mortality.  
Gent et al., 2003 showed that ozone, but not PM2.5, concentrations below current NAAQS levels 
(0.07 ppm) significantly worsened respiratory symptoms in asthmatic children using 
maintenance medication. Lam et al., 2016 reported that high temperature, humidity and ozone 
were associated with increased summer-time hospitalizations for asthma while Byers et al., 
2016 found associations between ozone exposure and asthma-related emergency department 
visits in Indianapolis. Similarly, Malig et al., 2016 demonstrated that in California, ozone was 
associated with increases in emergency department visits for asthma, pneumonia, chronic 
obstructive pulmonary disease (COPD) and upper respiratory tract infection (URTI). In addition, 
due to its irritant nature, ozone exposure is associated with increased dry eye disease 
prevalence in humans (Hwang et al., 2016). Collectively, these studies demonstrate that acute 
ozone exposure increases the risk of mortality, worsens asthma symptoms, and exerts 
pulmonary and extra-pulmonary physiological changes.  
Controlled human exposures are limited to short-term due to technical and ethical 
reasons. Humans exposed to ozone at 0.06 ppm, a concentration below the current NAAQS, for 
6.6 hr in chambers under controlled conditions demonstrated pulmonary neutrophilic 
inflammation and significant decrements in forced expiratory volume (Kim et al., 2011). Ozone 
at 0.08 ppm concentration for 6.6 hr also induced the recruitment of neutrophils, monocytes and 
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dendritic cells in bronchoalveolar lavage (BAL) fluid 18 hr after exposure (Alexis et al., 2010), 
while under similar settings, 0.07 ppm levels induced significant decrements in FEV1 in healthy 
young adults (Schelegle et al., 2009). Ozone exposure at 0.1 and 0.2 ppm for 4 hr significantly 
changed the expression of oxidative stress response genes in BAL cells from both healthy and 
asthmatic volunteers (Leroy et al., 2015), and induced systemic inflammation as evidenced by 
increases in C-reactive protein (CRP) along with cardiac autonomic changes (Arjomandi et al., 
2015). Women exposed to 0.4 ppm exhibited increased airway hyperresponsiveness, sputum 
neutrophils, and plasma IL-6 levels (Bennet et al., 2016). In a review by Bromberg, 2016, acute 
ozone exposure in humans was found to decrease vital capacity, exacerbate bronchial 
reactivity, increase airway permeability, induce neutrophilic inflammation, and cause a modest 
degree of bronchoconstriction, which are reversed completely after hours of exposure without 
causing chronic edema or lung disease development. These effects of ozone on humans 
exposed to realistic ambient levels under controlled conditions highlight the importance of 
further research and support the need for more stringent standards to protect human health. 
Frampton, 2011 summarized this concept as “this may be the time to reconsider the way we 
regulate criteria pollutants, and rewrite the Clean Air Act”. 
The impact of long-term exposure to ozone on human health has also been studied. 
Jerret et al., (2009) through the analysis of 18 years follow-up data found that risk of death 
associated with ozone exposure was significant for respiratory (10 ppb increases the risk of 
death by 1.040%) but not for cardiovascular causes. A meta-analysis of multiple studies 
concluded that during the warm season, hazard ratios for cardiovascular and respiratory causes 
of death increased to 1.01 and 1.03, respectively, with 10 ppb increase in ozone concentration 
(Atkinson et al., 2016). Conversely, Prueitt et al., (2014) performed a weight of evidence 
analysis and concluded that “there is no convincing case for a causal relationship between long-
term exposure to ambient ozone and adverse effect on the cardiovascular system on humans”. 
Although epidemiological studies have not been consistent in establishing the role of ozone as a 
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causal factor of pulmonary and extra-pulmonary effects after long-term exposure, short-term 
exposures have revealed multiple pulmonary, cardiovascular, cerebrovascular, and systemic 
effects. 
1.2.2 Ozone inhalation, distribution, and absorption   
Ozone penetrates to the alveoli upon inhalation and therefore, is considered a deep lung 
irritant. This results in exposure of all encountered sections of the respiratory tract to ozone 
upon inhalation. Thus, the cellular effects of ozone inhalation are likely influenced by its 
distribution and deposition in different parts of the respiratory system. Overall, the fate and 
uptake of ozone after entrance to the respiratory system is dependent on the transport 
(convection and diffusion), chemical processes (dissolution and reaction) and physical 
properties (solubility and partition coefficient) (Schlosser et al., 2010). Ozone is relatively 
insoluble in water and extremely reactive. Several mathematical models have been employed to 
determine ozone longitudinal distribution in the respiratory tract and realistic simulations have 
shown that a significant proportion of inhaled ozone reaches the lower respiratory tract (≈60%, 
Miller, 1995), the conducting lower airways (~65%), and distal areas (≈25%, Hu et al., 1992, 
1994). The distribution and absorption of ozone is also changed by anatomical differences in 
specific subjects and sex (Bush et al., 1996).     
Since rodents are obligate nose-breathers and their nasal passages are complex, once 
inhaled ozone and similar gases are significantly scrubbed off within the nose, their deposition 
in the lower respiratory tract can be reduced. However, in humans, oral respiration facilitates the 
direct entrance of ozone to the upper and lower respiratory tract (Kabel et al., 1985). Also, 
exercise favors the distal distribution of ozone to the respiratory airspaces (Ultman et al., 1994), 
a critical point to consider since most clinical studies with ozone are conducted during 
intermittent exercise. 
Interspecies comparisons to elucidate the similarities of ozone internal dose among 
humans and rats demonstrate that resting humans and rats have similar alveolar ozone doses 
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(Hatch et al., 2013). Also, different publications have asserted that humans are more 
susceptible to ozone than rats (Gerrity and Wiester, 1987). Hatch et al., 1994 showed that 0.4 
ppm of ozone induced higher levels of internal dose and injury endpoints in exercising humans 
when compared to resting rats. McCant et al., (2017) clarified this often made comparison by 
demonstrating that intermittent exercise during human exposure results in respiratory rates 4-5 
times greater than a resting rat leading to differential activity states between humans and 
rodents and thus, the tissue dose of ozone. Also, a comparison of ozone-induced pulmonary 
toxicity between mice, guinea pigs and rats showed that rats were the least responsive of these 
three species (Dormans et al., 1999). However, often the inter-strain variations within a given 
laboratory animal species are remarkable, causing a spectrum of effects among all strains 
within a species (Kodavanti et al., 2015).  
    Absorption of ozone at the mucosa layer has also been studied. In Sprague-Dawley 
rats, total ozone uptake was around 40% of total inspired regardless of ozone concentration 
(Wiester et al., 1987). The penetration of ozone in the lung lining fluid layer (LLFL) is restricted 
due to its reactivity and limited solubility/diffusivity. Calculations have shown that this “reactive 
absorption” of ozone might reach the apical side of epithelial cells in the lower airways where 
patches of relatively thin LLFL are present (Pryor et al., 1992). LLFL presence of phospholipids, 
cholesterol, and proteins such as mucins will determine the formation of intermediate reactive 
metabolites, which will mediate the first steps of ozone-induced effects at the pulmonary level 
(Langford et al., 1995; Pryor et al., 1995).   
1.2.3 Ozone-induced lung injury and inflammation: mechanisms 
Mechanisms of ozone-induced lung injury at the cellular level have been reviewed in 
detail (Bromberg, 2016; Lippmann, 1993; Mudway and Kelly, 2000; Bhalla, 1999). Ozone 
exposure generates secondary reactive metabolites or bioactive products by interacting with 
lung lining components (signal), which are detected or recognized by cells (sensors) in the lung 
resulting in the changed oxidative status of the cell. This along with stimulated cell signaling 
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mechanisms involving MAP kinases and NRF2 results in translocation of these factors to the 
nucleus, DNA binding, and stimulation of pro-inflammatory and phase II metabolism gene 
transcription (i.e. Inflammatory cytokines and genes involved in antioxidant defense). The 
inflammatory cytokines and increased expression of cell surface molecules stimulate the rolling 
of innate immune cells in pulmonary microvasculature and their extravasation into the interstitial 
and airspaces. Also, it is likely that these reactive byproducts can directly damage tissues by 
chemical interaction, which might not depend on the recognition of signals by cell surface 
receptors. 
The general ozone-induced lung injury paradigm involves a rapid reaction of ozone with 
biomolecules in the airway mucosa and alveolar surfactant. LLFL covering the apical side of 
epithelial cells in the respiratory system is the first substance contacting the inhaled ozone. 
LLFL contains water, lipids (i.e. phospholipids and cholesterol), surfactant proteins, high 
molecular weight glycosylated proteins (i.e. mucins), high molecular weight hyaluronic acid 
(HMW-HA), non-protein antioxidants (i.e. ascorbate and glutathione), iron binding proteins (i.e. 
transferrin and ferritin), and resident macrophages patrolling the airways and alveoli (George 
and Hook, 1984; Han and Mallampalli, 2015). The relative proportion and distribution of these 
components change throughout the respiratory tract. For example, mucus producing cells and 
surfactant contribute differently to mucosal architecture in the lower respiratory system and 
alveoli respectively, and the distribution of antioxidant molecules changes through the different 
stages of the respiratory tract.  Also, the presence of hydrophobic surfactant proteins is 
restricted to alveoli (Parent et al., [Chapter 22-23], 2015) 
Ozone interaction with lipids generates ozonation byproducts, which are more 
soluble/hydrophilic and are proposed to be involved in mediating ozone-induced lung effects. 
The lipid ozonation products (LOP) could directly contact cell membranes, damage 
phospholipids, and react with other biomolecules (Pryor et al., 1995). Oxidized lipid molecules 
can act as bioactive pro-inflammatory molecules. Oxidized phospholipids derived from 
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arachidonic acid by enzymatic and non-enzymatic reactions have also been proposed as 
mediators of ozone-induced oxidative stress (Alexis et al., 2000; Schulz et al., 2012). LOP 
increases the activity of phospholipase C, which catalyzes the conversion of phospholipids to 
arachidonic acid (Kafoury et al., 1998). In addition, pro-inflammatory lipids such as 
prostaglandins and leukotrienes are increased after ozone exposure (Hazbun et al., 1993, 
Alfaro et al., 2007). Leukotriene B4 antagonists were shown to protect against ozone-induced 
airway hyperresponsiveness (Stevens et al., 1995). Cholesterol oxidation products, known as 
oxysterols, have also been investigated as a mediator of ozone effects (Speen et al., 2016). 
Upon exposure, ozone can degrade the surfactant lipids 
(dipalmitoylphosphatidylcholine [DPPC]) in vitro (Qiao et al., 2015). Other ozone-induced lipid 
peroxidation products are aldehydes, such as 4-hydroxynonenal (HNE), which generates 
protein adducts (Kirichenko et al., 1996) and can mediate ozone-induced effects (Hamilton et 
al., 1998). HNE has been used as a surrogate of ozone-exposure in some studies (Hamilton et 
al., 1996). Ozone oxidation of surfactant proteins may reduce their activity (Hemming et al., 
2015; Haque et al., 2009) and oxidized mucin proteins could generate inter- and intramolecular 
disulfide bonds and the formation of mucin polymers with altered viscoelastic properties (Thai et 
al., 2008). 
Consequently, the biomolecules modified by ozone and the secondary reactive 
compounds generated from ozone-induced cell injury are detected as damage associated 
molecular patterns (DAMPs). Reactive compounds and DAMPS can activate membrane 
receptors such as TLR4 (Connor et al., 2012; Williams et al., 2007), TRPA1 (Taylor-Clark and 
Undem, 2010), and EGFR (Wu et al., 2014). Subsequent activation of intracellular signaling 
pathways up-regulate the transcription of pro-inflammatory cytokines with the concomitant 
release of proteins such as cytokines and recruitment of inflammatory cells such as neutrophils 
(Alexis et al., 2009; Johnston et al., 2005; Kirsten et al., 2013; Williams et al., 2007). Production 
of reactive oxygen species (Valavanidis et al., 2013; Wiegman et al., 2014) results in the loss of 
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epithelial layer integrity with the concomitant vascular leakage (Kadiiska et al., 2011; Kleeberger 
et al., 2001; Koren et al., 1989). The activation of neutrophils and other leukocytes in the lungs 
also damages the surrounding tissue inducing a positive feedback loop of pro-inflammatory 
activation (Auerbach and Hernandez, 2012). The process of inflammatory response once 
initiated after ozone exposure continues for several hours, which also triggers repair 
mechanisms and the injury response is fully reversed with reestablishment of normal 
homeostasis.   
Cell-mediated effects of ozone have also been studied at the lung level. For instance, a 
mast cell stabilizer reduced ozone-induced lung inflammation in mice (Kleeberger et al., 1993, 
1999), newly divided eosinophils limited ozone-induced airway hyperreactivity in guinea pigs 
(Wicher et al., 2017) and macrophage inhibition with gadolinium chloride treatment decreased 
ozone induced pulmonary injury and inflammation in rats (Pendino et al., 1995). A summary of 
selected mechanisms involved in ozone-induced injury in the respiratory tract is presented in  
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Figure 1.2 
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Figure 1.2 Known mechanisms of ozone-induced lung injury and inflammation. Adapted 
from Auerbach and Hernandez, 2012. AEC: Airway epithelial cell, IL: Interleukin, PGE2: 
Prostaglandin 2, ATP: Adenosine triphosphate, LDH: Lactate Dehydrogenase, H/LMW HA: 
High/Low Molecular Weight Hyaluronic Acid, DAMPs: Damage Associated Molecular Patterns, 
TNF-α: Tumor Necrosis Factor alpha, LRT: Lower Respiratory Tract, LLFL Lung Lining Fluid 
layer, TLR4: Toll-like receptor 4, P2X7: P2X purinoceptor 7. 
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1.2.4 Ozone-induced pulmonary vascular leakage 
Airway permeability is increased after ozone exposure causing protein and albumin to 
leak from the pulmonary vasculature into the lung and ultimately the BALF, thus allowing 
researchers to measure the magnitude of epithelial permeability (Reinhart et al., 1998; 
Kleeberger et al., 2001; Gupta [Chapter 12], 2014). In contrast, specific Clara cell protein CC16 
can translocate from lungs to the circulation (Broeckaert et al., 2000; Blomberg et al., 2003), 
demonstrating that ozone-induced vascular leakage facilitates the bidirectional translocation of 
biomolecules. A number of mechanisms might be involved in increasing vascular protein 
leakage to the Lung. Ozone exposure is known to cause epithelial injury as indicated in the 
earlier discussion. Especially in the alveolar region this injury to type 1 cells can lead to leakage 
of protein in the alveoli (Banks et al., 1990). Moreover, vascular leakage also can occur through 
increased activity of sympathetic nerves which may lead baroreflex-induced bradycardia. The 
increase in the blood flow to the lung can cause vascular congestion, and increase pressure 
and thus damage to the capillary walls and protein leakage into the alveoli (Šedý et al., 2015). 
Increased catecholamines have also been postulated to increase pulmonary edema 
(Krishnamoorthy et al., 2012). Ozone is known to induce bradycardia in rodents (Gordon et al., 
2014), decrease blood pressure (Uchiyama et al., 1986) and produce cardiac depression 
(Wagner et al., 2014). These changes can increase pulmonary vascular pressure and contribute 
to lung protein leakage.  
1.2.5 Systemic effects of ozone: inflammation 
Extra-pulmonary effects of ozone inhalation have been long recognized (Goldstein, 
1978). The range of ozone-induced extra-pulmonary effects reported in laboratory animals 
englobe virtually all systems. Hepatic dysregulation (Laskin et al., 1994, Theis et al., 2014), 
metabolomic changes (Miller et al., 2015, Mathews et al., 2017), atherogenic progression 
(Chuang et al., 2009, Tham et al., 2017), nervous system disruption (Chen et al., 2003, 
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Chounlamountry et al., 2015) and cardiovascular depression (Wagner et al., 2014, Farraj et al., 
2012) represent some of the extra-pulmonary responses occurring after acute ozone-inhalation. 
Thomson et al., (2013) found that ozone inhalation was sufficient to change the expression of a 
wide variety of genes in the lung, heart, liver, kidney, spleen, and pituitary tissues. For example, 
ozone exposure has shown to increase the circulating levels of serum amyloid A in mice 
(Erickson et al., 2017), while some studies have found increases in circulating IL-8, IL-1β and 
decreased levels of PAI-1 in healthy volunteers exposed to 0.3 ppm of ozone during 2 hr of 
intermittent exercise (Devlin et al., 2012). In addition, Bhalla et al., (2002) found that 
intraperitoneal injection of anti-TNF-α antibody reduced ozone-induced lung injury. Based on 
ozone and other air pollutant studies it has been believed that the spillover of bioactive 
compounds from the lungs to the periphery is involved in mediating extra-pulmonary effects. 
Systemic Inflammation and vascular impacts have been reported after ozone exposure 
in humans. Li et al., (2017) found a positive association between ozone exposure and blood 
levels of tumor necrosis factor receptor 2 (TNFR2) in a Boston area cohort. In a longitudinal 
study analyzing ozone exposure in controlled scenarios, it was found that short-term exposure 
was associated with increased blood pressure and platelet activation (Day et al., 2017). Acute 
ozone exposure has also been associated with increases in relative risk for myocardial 
infarction (Chiu et al., 2017) and hypertension (Coogan et al., 2017). On the other hand, there 
are a few negative studies showing no changes in circulating cytokines after ozone exposure in 
humans and in animals (Erickson et al., 2017; Urch et al., 2010; Bass et al., 2013; Miller et al., 
2015).  
1.2.6 Ozone effects on the central nervous system (CNS) 
 Ozone exposure has been recently linked to increased neurological disorders such as 
dementia, Alzheimer’s and Parkinson’s disease (Jung et al., 2015; Kirrane et al., 2015; Wu et 
al., 2015). It has been shown that in rats ozone inhalation promotes hippocampal 
neurodegeneration and reduced repair (Rivas-Arancibia et al., 2010; Solleiro-Villavicencio and 
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Rivas-Arancibia, 2010), as well as oxidative stress in the hippocampus mimicking molecular 
events exhibited in Alzheimer’s disease such as amyloid overproduction and mitochondrial 
abnormalities (Hernandez-Zimbron and Rivas-Arancibia, 2015). Similarly, apoptosis, cell cycle 
and antioxidant pathways were dysregulated in the hippocampus of rats exposed to ozone 
(Gomez-Crisostomo et al., 2014). Gonzalez-Guevara et al., (2014) postulated that ozone-
induced systemic inflammatory response was accountable for neurological inflammation 
characterized by high TNF-α and IL-6 levels in the brains of rats. Ozone exposure in rats was 
also shown to induce cell death in the substantia nigra involved in Parkinson’s disease (Rivas-
Arancibia et al., 2015). In the same study, the authors found increased levels of oxidized 
proteins and neuroinflammation associated with increased levels of NF-kB and COX-2, as well 
as activated astrocytes and microglia. Similarly, Mumaw et al., (2016) demonstrated that serum 
samples obtained from ozone-exposed rats promoted microglial activation by cytokine-
independent factors. These responses were exacerbated in aged glial cells, which highlights the 
role of the lung-brain axis as an important communication system involved in the development 
of extra-pulmonary effects of ozone inhalation. Serum amyloid A, a protein capable of crossing 
the blood-brain-barrier, has been implicated in these ozone effects on the CNS. Martinez-
Lazcano et al., (2013) reviewed the basic mechanisms by which ozone exposure may damage 
the CNS by highlighting the role of neuroinflammation and oxidative stress. Collectively, these 
studies support the conclusion that ozone exposure is associated with neurological effects 
although the causal mechanisms still remain speculative. 
1.2.7 Ozone-induced autonomic effects 
Ozone inhalation has been demonstrated to alter autonomic tone. Autonomic control of 
breathing patterns is mainly regulated by trigeminal nerve afferents, which send signals to the 
brainstem where breathing centers are located (Sozansky and Houser, 2014). Ozone exposure 
induces a rapid, shallow breathing (Lee et al., 1979; Alfaro et al., 2007), which results in a 
reduction in ozone deposition (Alfaro et al., 2004). In agreement with this, trigeminal nerve 
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irritation has been proposed as a sensory mechanism mediating ozone-induced dysregulation of 
breathing patterns (Kulle et al., 1975; Shusterman, 2007).  
Parasympathetic tone has also been shown to increase after ozone exposure, which is 
associated with cardiac electrophysiological changes including bradycardia and a decrease in 
blood pressure in rats (Farraj et al., 2012). Along the same line, several studies have shown 
decreased heart rate, cardiac depression and bradycardia as a consequence of ozone exposure 
in animals (Gordon et al., 2014; Arito et al., 1990, 1992; Uchiyama et al., 1986) and humans 
(Hampel et al., 2012; Jia et al., 2011; Devlin et al., 2012). Epidemiological studies have also 
found lower blood pressure in ozone exposed populations (Hoffmann et al., 2012), although 
contradicting effects of ozone increasing blood pressure have also been reported (Coogan et 
al., 2017, Day et al., 2017).  Parasympathetically-mediated pulmonary changes have also been 
examined after ozone inhalation (Jones et al., 1987). Ozone enhances bronchial reactivity to 
muscarinic agonists (Roum and Mourlas, 1984), and promotes a loss of M2 muscarinic receptor 
function (Schultheis et al., 1994; Yost et al., 1999). These studies support the role of autonomic, 
especially parasympathetic tone, in mediating cardiac electrophysiological changes after ozone 
exposure. 
Ozone-induced stimulation of pulmonary sympathetic tone was postulated to protect 
from ozone-induced vascular leakage (Delaunois et al., 1997). Graham et al. (2001), using 
transgenic murine models exhibiting sympathetic hyper- and hypo-innervation, demonstrated 
that ozone-induced neutrophilia was directly correlated with the magnitude of the innervation. 
Similarly, the overexpression of β2AR in airway epithelial cells decreased ozone-induced 
vasoconstriction in mice (McGraw et al., 2000). However, another study showed that 
sympathetic nerve traffic was not changed by acute ozone-induced airway inflammation in 
humans (Tank et al., 2011), which might be due to the lack of dynamic assessment. 
Nevertheless, the above studies emphasize the likely involvement of the autonomic system in 
mediating ozone-induced cardiovascular, and, perhaps also, pulmonary effects.  
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Another major centrally-mediated mechanism altered during ozone exposure is 
hypothermia. The hypothalamus plays an important role in thermoregulation (Morrison and 
Nakamura, 2011). Acute ozone exposure stimulation of hypothermia in rodents (Mautz and 
Bufalino, 1989) and reptiles (Mautz and Dohm, 2004) is absent in humans (Watkinson and 
Gordon, 1993). It has been hypothesized that the decrease in core body temperature might 
serve as an adaptive mechanism to reduce metabolic rate, and thus, the adversity of ozone-
induced changes (Gordon et al., 2014).  
Finally, behavioral effects of ozone exposure have also been reported (Weiss et al., 
1981). Animal experiments have shown dysregulation of sleep patterns (Alfaro-Rodriguez and 
Gonzalez-Pina, 2005), motor activity (Gordon et al., 2013), decrease exploratory and increased 
freezing behaviors (Rivas-Arancibia, et al., 2003), as well as overall performance in mice 
(Sorace et al., 2001) after ozone exposure. Epidemiological studies have shown adverse 
neurobehavioral effects of ambient air pollutants including ozone (Chen and Schwartz, 2009), 
and an association between ozone levels and suicides (Biermann et al., 2009).  These studies 
support the involvement of autonomic and other neuronal effects following acute ozone 
inhalation. 
1.2.7.1 The role of vagal C fibers and peripheral neurons in ozone-induced cardiopulmonary 
changes 
Pulmonary vagus innervation involving afferent sensory and efferent neurons 
encompassing both parasympathetic and sympathetic nerves might play an important role in the 
mediation of ozone-induced responses. Changes in vagal reflex tone are linked to ozone-
induced responses in rabbits (Freed et al., 1996). Bilateral vagotomy enhanced peripheral lung 
reactivity in ozone-exposed rats, suggesting a protective role of vagal reflex stimulation (Ho et 
al., 1998). In a different strategy, Schelegle et al., (1993) demonstrated that blocking canine 
vagal C fibers in the lower airways by cooling them abolished ozone-induced effects such as 
shallow breathing and bronchoconstriction. Autonomic control of blood pressure has also been 
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studied in relation with ozone exposures. These studies in general support the involvement of 
autonomic regulation in the cardiophysiological effects of ozone. 
Because of its chemical reactivity, ozone is able to activate nerve endings in the airways. 
Peripheral C fibers located in the respiratory tract are activated by ozone (Jimba et al., 1995; 
Coleridge et al., 1993; Joad et al., 1996). The depletion of C fibers by capsaicin administration 
prevented ozone-induced changes in breathing patterns and epithelial injury (Vesely et al., 
1999). Ozone-induced chest pain has been correlated with its effect on C fibers causing 
neuropathic pain (McDonnell et al., 1983) and throat and eye irritation (Tepper and Wood, 1985; 
Hoppe et al., 1995). C fibers contain ion channels such as TRPA1, which are selectively 
activated by ozone inhalation (Taylor-Clark and Undem, 2010). TRPA1 knock-out mice were 
protected against the effects of acrolein, a gas irritant (Kurhanewicz et al., 2017). Neural reflex 
activation has been proposed as a plausible mode of action determining ozone-induced lung 
function decrements (Prueitt and Goodman, 2016). Ozone interacts with sensory nerves in 
bronchial mucosa (Krishna et al., 1997) and triggers the secretion of bioactive neuropeptides 
such as substance P (Nishiyama et al., 1998; Schierhorn et al., 2002), nerve growth factor 
(Verhein et al., 2011; Barker et al., 2015), calcitonin gene-related peptide (Oslund et al., 2009; 
Wu et al., 2007), neurokinin A (Oslund et al., 2008), and tachykinins (Takebayashi et al., 1985). 
Thus, the experimental evidence shows that ozone is capable of generating sensory signals 
through the activation of C fibers and the local release of neurokinins and tachykinins, which 
often have been linked to pulmonary effects of ozone and the generation of reflex 
cardiopulmonary physiological changes. 
1.2.7.2 Consequences of ozone activation of stress responsive regions in CNS  
The most convincing evidence of an ozone impact on brain regions responsive to stress 
comes from a number of earlier studies. Neural disturbances associated with catecholaminergic 
changes in brain areas such as locus coeruleus, striatum and nucleus tractus solitarius (NTS) 
involved in chemosensory, arousal and motor control were observed after short- and long-term 
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exposure to ozone (Cottet-Emard et al., 1997; Soulage et al., 2004). Ozone was able to 
increase catecholamine turnover in sympathetic and central neurons located in the cervical 
ganglia, NTS and cortex (Soulage et al., 2004). In infant primates, episodic ozone exposure 
triggered neuroplasticity in the NTS neurons (Chen et al., 2003). Gackière et al., (2011) 
demonstrated that ozone inhalation caused a time and dose dependent neuronal activation in 
stress-responsive regions of the brain, specifically the paraventricular hypothalamic nucleus and 
dorsolateral regions of the NTS overlapping terminal fields of lung vagal afferent nerves, thus 
providing a possible mechanism by which ozone-induced lung responses are communicated to 
the brain (i.e. through the vagus nerve). Chounlamountry et al., (2015) described how ozone 
promotes remodeling of glial coverage and glutamatergic synapses in rat NTS and concluded 
that “O3 -induced pulmonary inflammation results in a specific activation of vagal lung afferents 
rather than non-specific overall brain alterations mediated by blood-borne agents”. These 
studies support the evidence that neural mechanisms rather than circulating mediators might be 
involved in ozone-induced cardiovascular and pulmonary changes. 
These stress responsive regions stimulated by ozone inhalation can activate the 
sympathetic-adrenal-medullary (SAM) and hypothalamus-pituitary-adrenal (HPA) axes. HPA 
and SAM activation culminate with the release of catecholamines and glucocorticoids , 
respectively, into the bloodstream. Generally, epinephrine and corticosterone synthesized and 
released from adrenal medulla and cortex, respectively, are considered stress hormones in 
addition to norepinephrine which is mainly synthesized in postganglionic sympathetic neurons. 
We and others have recently observed that ozone inhalation activates HPA and SAM axes 
resulting in increased levels of adrenocorticotropic hormone (ACTH), corticosterone and 
epinephrine in rodents, and cortisol and corticosterone in humans (Gunnison et al., 1997; 
Martrette et al., 2011; Thomson et al., 2013; Bass et al., 2013; Miller et al., 2016a, 2016b). In 
addition, other irritant gases such as acrolein, which primarily induces nasal irritation, has been 
shown to induce similar responses in rats (Snow et al., 2017). Interestingly, ACTH also has 
24 
 
steroid-independent immunomodulatory properties by binding to melanocortin receptors in 
leukocytes (Catania et al., 2004). Our studies with ozone and acrolein demonstrate that 
increases in stress hormones are associated with a variety of metabolic and immune effects in 
animals (Miller et al., 2015; 2016a, Snow et al., 2017). 
1.2.7.3 Neuroendocrine fight-or-flight stress response is similar to the response induced by 
ozone exposure 
The physiological changes associated with the fight-or-flight stress response are well 
characterized. There is a concerted effort of different organs of the body to channel metabolic 
energy and immune cells to the site of injury or stress such that the stressed portion of the body 
has resources needed to assure repair and survival, and reestablish homeostasis to a normal 
level. Stress has been defined as the “nonspecific response of the body to any demand on it” 
such as injury or fear (Szabo et al., 2017). Taking into account that different fields of 
biomedicine such as psychology and behavioral sciences also employ “stress” to denote bodily 
responses, stress has been mechanistically linked to neuroendocrine activation. Eugene Yates 
defined stress as “any stimulus that will provoke the release of ACTH and adrenal 
glucocorticoids” and Walter Cannon enriched this definition to include “sympathetic markers of 
stress” (Fink, 2010 [Chapter 1).  Initial observations of stress hallmarks often referred to as 
“general adaptation system” or a “stress triad” is characterized by hyperemia (enlargement of 
adrenals), thymus atrophy and hemorrhagic gastric ulcers (Fink, 2010 [Chapter 1).  During 
psychosocial stress, different cues can trigger different responses depending on the ability of 
the subject to interpret the stress signals coming from the environment. Biogenic or physical 
stress bypasses the interpretative mechanisms and promotes the neuroendocrine changes 
(Everly and Lating, 2012). 
Stress response, the ultimate survival mechanism, is regulated by the neuroendocrine 
system of the body. Neuroendocrine responses activated after stressful stimuli are conserved 
from an evolutionary point of view and are present in all living organisms starting from uni- and 
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multicellular organisms to humans (Fink, 2010 [Chapter 1]). “Fight or flight” or “acute stress 
response” has been defined as a rapid reaction to any perceived threat. In this scenario, rapid 
changes increase the blood concentration of stress hormones such as catecholamines 
(epinephrine and norepinephrine) and glucocorticoids. These circulating hormones prepare the 
subject to an eventual danger by mobilizing energy sources from their depots to escape or face 
the threat, redirecting blood flow to muscles, promoting tunnel vision, increasing blood clotting 
function, among others. This neural and endocrine activation response initiates changes in 
virtually all organ systems of the body and based on the type of stress being encountered, these 
changes vary between organs (Everly and Lating, 2012). 
Acute stress is characterized by the activation of both HPA and SAM axes. HPA axis 
activation starts with the release of corticotropic release hormone (CRH) from the 
hypothalamus, which activates the pituitary gland to release ACTH which in turn activates 
melanocortin receptor type 2 located in the adrenal cortex. ACTH promotes the release of 
glucocorticoids from the adrenal cortex, in humans this is primarily cortisol while in rodents it is 
corticosterone (Koren et al., 2012). SAM axis activation precedes HPA activation as a rapid 
response and is controlled by the direct sympathetic innervation of the adrenal medulla which 
causes the release of epinephrine and norepinephrine into the bloodstream (Ranabir and Reetu, 
2011).  While epinephrine is primarily made in adrenal medulla, only a small portion of 
circulating norepinephrine is derived from the adrenal medulla (~10-20%). Sympathetic nerve 
endings distributed in all organs of the body produce norepinephrine locally, which in a 
paracrine manner induce rapid local responses upon stimulation of the sympathetic system.   
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1.2.8 Ozone and stress response 
1.2.8.1 Ozone exposure induces a neuroendocrine stress response 
Although ozone exposure has been previously linked to stimulation of catecholaminergic 
neural mechanisms, it is only recently that our lab in a series of studies characterized this 
response as the same neuroendocrine stress response described above and linked it to a 
variety of systemic metabolic and immune changes that are often observed after an air pollution 
exposure. Our lab demonstrated that ozone acts as a stressor and, upon inhalation, consistently 
activates processes like fight-or-flight response not only in animals but also in humans (Bass et 
al., 2013; Miller et al., 2015, 2016a; Snow et al., 2017). For example, ozone-induced HPA axis 
activation characterized by increasing levels of circulating glucocorticoids (Miller et al., 2016a); 
SAM axis activation characterized by high levels of circulating epinephrine, hyperglycemia, and 
glucose intolerance (Bass et al., 2013; Miller et al., 2015), degradation of rich energy sources 
through catabolic reactions such as adipose lipolysis and muscle protein breakdown (Miller et 
al., 2015), acute phase response (Bass et al., 2015; Miller et al., 2015), and lung innate immune 
response (Miller et al., 2016b, 2016c).  
1.2.8.2 Neuroendocrine stress response and immunomodulation by ozone exposure  
Lymphoid organs are essential for leukocyte maturation. Spleen, thymus and bone 
marrow have been studied in relation with the regulation of ozone-induced inflammation.  
Thymus atrophy as a consequence of ozone exposure has been reported (Dziedzic and White, 
1986). Li and Richters, (1991) have shown that short-term ozone inhalation reduced thymocytes 
and spleen T-lymphocytes. Chronic exposure to ozone has also been shown to induce 
splenomegaly (Hassett et al., 1985) and altered maturation of myelopoietic progenitors in the 
spleen (Goodman et al., 1989). Holz et al., (2010) hypothesized that a CXCR2 antagonist 
inhibited ozone-induced neutrophilia by blocking the egress of neutrophils from the bone 
marrow, while Kenyon et al., (2006) demonstrated that bone marrow-derived neutrophils are 
recruited into the lungs after ozone inhalation. Francis et al., (2017) showed that the spleen is a 
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source of lung inflammatory macrophages after ozone exposure and splenectomized rats 
exhibited decreased levels of ozone-induced pulmonary vascular leakage and cellular 
infiltration.  The mobilization of immune cells has been observed after ozone exposure. 
Peripheral blood neutrophilia (Bosson et al., 2013), lymphopenia (Miller et al., 2016b), and an 
increase in CD11b+ circulating leukocytes (Alexis et al., 2004) have been associated with ozone 
inhalation in vivo.   Although ozone-induced innate immune responses are fairly well 
characterized, no studies have addressed the mechanisms by which these responses are 
induced and especially the role of neuroendocrine stress axes activation in immune responses 
induced by air pollution exposure. 
Dhabhar et al., (2012) using a rat model of restraint-induced stress characterized 
dynamic immune responses occurring minutes and hours after the encounter of stressful stimuli. 
Immediately after stress, the levels of circulating stress hormones were increased as expected. 
These increases were first associated with the mobilization of lymphocytes, monocytes and 
neutrophils from “barracks” (marginated pools such as bone marrow, spleen, or lymph nodes) to 
the circulation. This change was attributed to the rapid increase of epinephrine and 
norepinephrine peak minutes after the stimulus. After this period, a reduction of circulating 
leukocytes is observed due to their egress; this time from the circulation to peripheral organs. 
Dhabhar explained that neutrophils mobilize to the “battlefields” where injury or infection is 
occurring while lymphocytes and monocytes mobilize to areas of surveillance, such as skin or 
digestive tract, or return to the “barracks”. This delayed effect is attributed to corticosterone and 
epinephrine (Figure 1.3). These studies were followed with examining the effects of stress 
hormones directly by injecting these hormones in rats (Dhabhar et al., 2012; Dhabhar, 2014). 
Based on this evidence, we postulated that ozone-induced innate immune response might 
involve dynamic changes in circulating stress hormones. The changes observed after ozone 
exposure seem to mimic the changes induced by a stress response in these Dhabhar studies.   
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Figure 1.3 
 
 
Figure 1.3 Stress induced leukocyte distribution.  NE: Norepinephrine, EPI: Epinephrine, 
CORT: Cortisol. Source: Adapted and simplified from Dhabhar et al., 2012 
EXTRAVASCULAR / 
BLOOD VESSELS
B
lo
o
d
 i
m
m
u
n
e
 c
e
ll
 n
u
m
b
e
r
Time during stress
minutes hours
EPI,CORT
NE,EPI
BARRACKS
Marginated Pools
(spleen, lung, 
bone marrow, 
lymph nodes)
MOBILIZATION
(Leukocytes ↑ 
[Blood])
2ND
MOBILIZATION
TRAFFICKING & 
SURVEILLANCE
(Lymphocytes↓
Monocytes↓
[in blood]
(Neutrophils)
STRESSOR
BATTLEFIELDS
(Site of wounding, 
inflammation)
IMMUNE 
FUNCTION
Resting state
29 
 
1.2.9 Air pollution, psychosocial stress and therapeutic manipulation of stress hormone 
receptors 
Psychosocial stress potentiates air pollution induced health effects in controlled in vivo 
and epidemiological studies (Cloughery et al., 2010; Fuller et al., 2017), and it is postulated that 
this interaction involves activation of neuroendocrine system involving the SAM and HPA axes. 
Therefore, psychosocial and physical stressors could worsen health outcomes. Alternatively, it 
is also possible that neuroendocrine stress responses triggered by the inhalation of air 
pollutants can additively or synergistically lower the threshold for psychosocial or physical 
stressors to induce deleterious health effects. Interestingly, Gent et al., (2003) found that the 
reported respiratory symptoms in asthmatic children were exacerbated by ozone at levels under 
NAAQS only in those using maintenance medication. This maintenance therapy is vastly based 
on the activation of GR to minimize chronic inflammation and bronchodilators such as long 
acting β2AR agonists. Because β2AR agonists relax constricted airways, they are widely used 
for bronchoconstriction occurring in asthma and COPD, often in conjunction with anti-
inflammatory glucocorticoids (Cazzola et al., 2012).  
Since adrenergic and glucocorticoid agonists mimic the activity of stress hormones and 
air pollution exposure is associated with increases in stress hormones, it is possible that air 
pollution effects are exacerbated in those receiving bronchodilators and steroids. Adrenergic 
receptor (AR) subtypes are selectively located in different tissues. Smooth muscle cells in the 
airways primarily express β2 adrenergic receptors (β2AR), whereas vascular smooth muscle 
cells express alpha receptors, each of which likely having different affinities for epinephrine and 
norepinephrine. Glucocorticoids activate glucocorticoid receptors (GR) which are located 
virtually in all cells and are generally used to diminish inflammation in a wide range of pro-
inflammatory conditions (Barnes, 1995), and insensitivity to their anti-inflammatory properties 
has been widely reported (Barnes and Adcock, 2009). Psychosocial stress has shown to induce 
low grade inflammation (Rohleder, 2014), which is linked to glucocorticoid insensitivity (Li et al., 
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2014). In addition, research linking psychosocial stress with exacerbation of asthma episodes, 
increase in asthma morbidity, deteriorating asthma severity, and development of pediatric 
asthma in children are being widely explored (Yonas et al., 2012, Booster et al., 2016).    
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1.3 Dissertation goals: Linking ozone-induced lung injury and inflammation to activation 
of neuroendocrine stress axes (SAM and HPA). 
Our laboratory has studied ozone for over a decade in the context of host disease 
susceptibility where ozone is used as a prototypic oxidant air pollutant with the understanding 
that any inhaled pollutant that will cause lung injury and inflammation will be comparable to the 
response induced by ozone (Dye et al., 2015a). While trying to understand how an inhalant 
encountered by the lung might increase the susceptibility of those having underlying diseases of 
non-pulmonary origin (i.e. diabetes, cardiovascular, neurobehavioral, reproductive) and 
influence developmental processes, we observed that ozone exposure induces a myriad of 
extra-pulmonary effects in healthy animals. More recently, we have identified a putative link 
involving the activation of neuroendocrine stress axes that allow us to connect air pollutant-
induced lung injury and inflammation to a mechanism common to many types of stressors - 
physical or psychosocial – and link those to multi-organ metabolic and immune effects as 
discussed above.     
Generally, it is believed that extra-pulmonary effects induced by the inhalation of air 
pollutants involve the spillover of bioactive mediators from the lung to the circulation. Pro-
inflammatory molecules such as cytokines, bioactive lipids, or oxidation byproducts originated in 
the lungs have been proposed to migrate to extra-pulmonary organs and act in the periphery to 
promote local effects as explained earlier. A large research effort is invested in identifying 
circulating mediators that induce extra-pulmonary effects after air pollution exposure. Often 
these unknown circulating mediators have been referred to as “molecular shrapnel”, without 
having identity of any specific mediator of group of mediators. Our studies, using the prototypic 
air pollutant ozone, identified this “molecular shrapnel” as hundreds of metabolites, acute phase 
proteins and more importantly stress hormones, and provided mechanistic understanding that 
these molecules did not originate from the lung (Kodavanti, 2016). Our studies, thus, offered an 
alternative mechanistic explanation as to how inhaled pollutants might induce extra-pulmonary 
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effects by activating neuroendocrine axes in rodents and humans and what circulating factors 
might be playing a role. Based on the studies from our laboratory, we believe that the activation 
of neuroendocrine stress axes (SAM and HPA) after air pollution exposure regulates two 
fundamental survival processes, namely metabolism and immune response, and in doing so, 
this activation affects virtually all organs in the body. Since air pollution-induced SAM and HPA 
activation is linked to lung injury and inflammation, the goal of this project was to understand 
how stress hormones regulate lung injury and inflammation induced by ozone exposure. Based 
on a series of publications from our lab which supports the involvement of neuroendocrine 
stress axes (Bass et al., 2013; Miller et al., 2015; 2016a; 2016b; 2016c; Kodavanti, 2016; Snow 
et al., 2017), we propose a model in which stress hormones are critical circulating players 
modulating both pulmonary and extra-pulmonary effects observed after ozone inhalation. We 
sought to provide an alternative mechanistic explanation that circulating mediators released in 
response to neuroendocrine activation (stress hormones) play a critical role in mediating local 
pulmonary effects of ozone.  
We hypothesized that the CNS-mediated release of stress hormones, epinephrine and 
corticosterone, through their action on AR and GR, respectively, modulate ozone-induced 
vascular leakage and inflammation. We addressed this hypothesis by doing a series of 
experiments that are divided in three specific aims:  
1.3.1 Examine if depletion of circulating stress hormones (epinephrine and corticosterone) 
inhibit ozone-induced lung injury and inflammation through their effects on lung transcriptome 
and cytokine expression profile 
In a previous publication, we demonstrated that adrenal demedullation (the source of 
epinephrine) and total bilateral adrenalectomy (the source of both epinephrine and 
corticosterone) diminished ozone-induced lung injury and neutrophil inflammation in rats (Miller 
et al., 2016b). Based on this observation, we hypothesized that the lack of epinephrine and 
corticosterone will result in reduction of pulmonary transcriptome changes induced by ozone, 
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and thus, chemotactic factors involved in neutrophilic inflammation, while changing the balance 
of specific cytokine pools involved in the innate immune response. In the second chapter, we 
examined the lung transcriptome and the role of cytokines and chemotactic factors in ozone-
induced lung inflammation in control, demedullated and adrenalectomized rats. By assessment 
of global mRNA sequencing and specific cytokine characterization of archived lung and lavage 
fluid samples, we examined functional processes differentially impacted by ozone in rats that 
have depleted circulating epinephrine or epinephrine plus corticosterone. 
1.3.2 Assess the role of AR and GR in mediating ozone-induced lung injury and inflammation 
using a pharmacological approach 
Epinephrine and corticosterone induce their effects on different organs by binding to 
their respective receptors. A number of AR subtypes exist and display tissue-specific receptor 
distribution while the affinity of each receptor for epinephrine varies. This variability is essential 
for mediating tissue-specific effects during stress to assure homeostasis. Airway smooth 
muscles express β2AR while αAR are distributed in the vasculature. In the third chapter, we 
focused on understanding the role of βAR and GR blockers in mediating ozone-induced lung 
injury and inflammation in vivo. We hypothesized that blocking these receptors will inhibit 
ozone-induced lung injury and inflammation.  
1.3.3 Examine if agonists of epinephrine and corticosterone will rescue ozone-induced lung 
injury and inflammation in AD rats, while exacerbating effects in control rats  
In the fourth chapter, we examined if βAR and GR agonists can rescue ozone-induced 
injury and inflammation in adrenalectomized (AD) rats, and exacerbate effects in normal rats 
that have undergone sham surgery (SH). Although βAR and GR agonists are widely used in 
chronic inflammatory conditions, their contribution to the effects produced by endogenously 
stress hormones during acute stress has not been delineated. It is not known if ozone-induced 
lung injury/inflammation and mobilization/extravasation of inflammatory cells from the bone 
marrow to the lung involve circulating stress hormones. No prior studies have used the 
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combination of surgical interventions involving adrenalectomy and pharmacological agonists to 
understand how innate immune response is generated after air pollution exposure. We 
hypothesized that treatment of AD rats with βAR and GR agonists will reverse the protective 
effect of adrenalectomy on ozone-induced lung injury and inflammation. Pharmacological 
agonists, Clenbuterol and dexamethasone, widely used in research were employed to address 
this hypothesis in conjunction with surgical intervention of AD and SH in rats. 
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CHAPTER 2: ADRENAL-DERIVED STRESS HORMONES MODULATE OZONE-INDUCED 
LUNG INJURY AND INFLAMMATION 
 
2.1 Introduction 
Ozone is a ubiquitous gaseous air pollutant and one of the major components of smog in 
urban areas (Cooper et al., 2014; Haagen-Smit, 1952). Due to its reactive nature, acute ozone 
inhalation causes oxidation of biomolecules such as proteins (Hemming et al., 2015; Kim et al., 
2010) and lipids (Kadiiska et al., 2013; Thompson et al., 2013) in lung lining fluid and epithelial 
cells. An imbalance in the lung oxidant/antioxidant ratio has been widely reported after ozone 
exposure (Bromberg, 2016; Wiegman et al., 2014). Subsequent activation of pro-inflammatory 
signaling cascades involving mitogen-activated protein kinases (MAPK), phosphoinositide 3-
kinase- protein kinase B (PI3K-AKT), and nuclear factor erythroid 2-related factor 2 (NRF2) 
(Yan et al., 2016) have been shown in vitro and in vivo, to increase transcription of cell adhesion 
molecules and pro-inflammatory cytokines (Bromberg and Koren, 1995; Chen et al., 2007; 
Montuschi et al., 2002). This activation results in the extravasation of innate immune cells, 
including neutrophils, to the lungs within hours after ozone exposure (Kim et al., 2011; Kirsten et 
al., 2013; Cabello et al., 2015; Williams et al., 2007; Auerbach and Hernandez, 2012). Ozone 
exposure has been shown to alter the balance between Th1 and Th2 phenotypes (Steerenberg 
et al., 1996). Th1-type cytokines are involved in immunity against intracellular pathogens where 
the effector cytokine IFNγ plays a pivotal role. Th2-type cytokines are involved in the immunity 
against extracellular parasites as well as development of type 1 hypersensitivity response seen 
in allergic asthma and1 are driven mainly by IL4 and IL13 (Berger, 2000). In mice, an ozone- 
                                                          
1 This chapter previously appeared as Henriquez, A. et al. October 2017. Adrenal-derived stress 
hormones modulate ozone-induced lung injury and inflammation. Toxicol. Appl. Pharmacol. 329, 
249-258. 
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induced Th2 phenotype shift was shown to depend on innate lymphoid cells (Kumagai et al., 
2016).  
Adverse ozone effects are not restricted to the lungs and multiple extra-pulmonary 
alterations have also been reported (Watkinson et al., 2001; Thomson et al., 2013). Ozone 
inhalation activates stress-responsive regions of the brain, including the nucleus tractus 
solitaries (NTS) where terminal fields of the lung vagal afferents overlap (Gackière et al., 2011). 
Ozone exposure also induces reflexively-mediated cardiovascular alterations, such as 
bradycardia and hypothermia, and decreases blood pressure (Akcılar et al., 2015; Uchiyama 
and Yokoyama, 1989; Gordon et al., 2014), indicating activation of the autonomic nervous 
system (Watkinson et al., 1996). It is postulated that nociceptive bronchial C-fibers stimulated by 
ozone inhalation transmit sensory information to the CNS and mediate systemic responses. 
These C-fibers modulate ozone-induced airway hyperresponsiveness but not hypothermia or 
bradycardia in rats (Jimba et al., 1995; Taylor-Clark and Undem, 2011). 
Acute ozone inhalation induces systemic metabolic alterations including hyperglycemia, 
glucose intolerance, release of free fatty acids, activation of acute phase response, and muscle 
protein catabolism associated with a rise in circulating epinephrine and corticosterone levels 
(Bass et al., 2013; Miller et al., 2015, 2016a, 2016b). Further, performing an adrenal 
demedullation (DEMED) or adrenalectomy (ADREX) in rats, which diminishes the source of 
circulating catecholamines (synthesized in adrenal medulla upon sympathetic stimulation) and 
catecholamines plus steroid hormones (later synthesized in the adrenal cortex upon stimulation 
of HPA-axis), respectively, inhibits ozone-induced systemic metabolic impairment (Miller et al., 
2016c). Importantly, pulmonary injury and inflammation induced by ozone exposure in rats that 
have undergone sham surgery (SHAM) are also diminished by ADREX (Miller et al., 2016c), 
highlighting a potential role of stress hormones in mediating ozone-induced pulmonary injury 
and inflammation. Although the mechanisms by which ozone induces local lung injury and 
inflammation are fairly well characterized, the role of circulating factors, such as stress 
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hormones, in modulating pulmonary vascular leakage and extravasation of circulating immune 
cells has not been studied. We hypothesized that analysis of the expressed lung transcriptome 
in SHAM, DEMED, and ADREX rats exposed to ozone would elucidate potential mechanisms 
by which these hormones contribute to inflammation and injury in the lung following ozone 
exposure. Further, that decreased circulating levels of epinephrine and corticosterone in 
ADREX and DEMED rats would transcriptionally inhibit inflammatory modulators involved in 
ozone-induced neutrophilic inflammation while altering the balance of specific cytokine pools 
involved in immune function. 
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2.2 Materials and Methods 
2.2.1 Animals, surgeries and exposure 
Lung tissue samples from healthy, male Wistar Kyoto (WKY) rats aged 12–13 weeks 
(Charles River Laboratories Inc., Raleigh, NC) were used from Miller et al., 2016c. SHAM, 
DEMED and ADREX surgeries were performed using aseptic sterile technique. Briefly, 
ketamine plus xylazine (50 mg plus 4 mg/kg body weight, i.p.) were used for anesthesia. Prior to 
surgery, rats received buprenorphine (0.02mg/kg, subcutaneous) as an analgesic. Charles 
River Surgeons performed three types of sterile surgeries: control sham surgeries where all 
procedures were identical to the ADREX surgery except for the removal of adrenal gland 
(SHAM), bilateral adrenal demedullation where only the medulla portion of the adrenal glands 
was removed while the cortex was kept in place (DEMED), or bilateral total adrenalectomy 
where whole adrenal glands were removed (ADREX). Following 4 days of recovery, rats were 
exposed to either air or 1 ppm ozone, 4 h/day for 1 day or 2 consecutive days (1-D or 2-D) in 
whole body chambers under controlled flow, temperature and relative humidity. Ozone was 
generated by a silent arc discharge generator (OREC, Phoenix, Arizona). The chambers 
(Rochester style “Hinners”) flow was controlled by mass flow controllers (Coastal Instruments 
Inc., Burgaw, North Carolina) and the ozone concentrations were recorded using photometric 
ozone analyzers (API model 400, Teledyne Instruments; San Diego, California). Within 1 h of 
the final exposure, animals were euthanized via an overdose of pentobarbital (>200 mg/kg, i.p.). 
Bronchoalveolar lavage (BAL) was performed on the right lungs and left lung tissues were snap 
frozen in liquid nitrogen for storage at−80 °C for later analysis. Cell free BALF aliquots were 
stored at −80 °C for further analysis. 
2.2.2 RNA sequencing 
mRNAwas isolated from total RNA (500 ng each) using prepX polyA mRNA Isolation Kit 
(Wafergen Biosystems, Fremont, CA). Samples were run using manufacturer's protocol on the 
Apollo324 automated sample processing system for mRNA selection and continued on RNA-
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Seq library prep with Wafergen's PrepX mRNA 48 Protocol. The resulting cDNA libraries were 
PCR amplified for 15 cycleswith indexing primers according to Wafergen's protocol. One 
microliter was taken from each library for quantitation by Qubit dsDNA HS Assay kit (Molecular 
Probes, Eugene, Oregon). The quality of libraries was checked by Agilent Bioanalyzer (Agilent 
Technologies, Santa Clara, CA) and the molar concentration of each library was estimated by 
using average molecular sizes fromBioanalyzer data and the concentration fromQubit 
measurement, and each library was diluted to 4 nM accordingly. The diluted libraries were again 
checked by Qubit to confirm the working concentrations and pooled to make the sample for 
sequencing run. The pooled libraries were denatured and diluted according to Illumina NextSeq 
500 protocols (Illumina Inc., San Diego, CA). The final concentration for sequencing was 1.8 pM 
+ 5% PhiX from Illumina. The sequencing data were stored in Illumina's BaseSpace-cloud. 
2.2.3 Real-time reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) 
For qPCR, each RNA sample was diluted to 10 ng/μL and kept at −80 °C until the day of 
the experiment. One-step qPCR (SuperScript III, Invitrogen, Grand Island, NY) was run on an 
ABI Prism 7900 HT sequence detection system (Applied Biosystems, Foster City, CA) using 50 
ng of RNA. Primers containing a 6-carboxy-fluorescein (FAM dye) label at the 5′ end were 
purchased from Applied Biosystems (Foster City, CA) for the following genes: β-actin 
(Rn00667869_m1), tumor necrosis factor alpha (Tnfα, Rn99999017_m1), interleukin 6 (IL-6, 
Rn01410330_m1), interleukin 1 beta (IL-1β, Rn00580432_m1), interleukin 4 (IL-4, 
Rn01456866_m1), interferon gamma (Ifnγ, Rn00594078_m1), interleukin 5 (IL-5, 
Rn01459975_m1), and interleukin 13 (IL-13, Rn00587615_m1). Data were analyzed using ABI 
sequence detection software, version 2.2 using β-actin as an endogenous control. Expression of 
each sample was calculated as relative fold change over air-SHAM group at each time point (1-
D or 2-D) using the 2−ΔΔCT method. 
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2.2.4 Cytokine protein quantification 
BALF levels of cytokine proteins (IL-1β, IL-4, IL-5, IL-6, IL-10, IFN-γ, KC-GRO, TNF-α) 
were quantified using the V-PLEX proinflammatory panel 2 (rat) kit per manufacturer's protocol 
(Meso Scale Discovery, Gaithersburg, MD). The resulting electrochemiluminescence signals for 
each target protein in sample wells were detected using Meso Scale Discovery® 
electrochemiluminescence (MSD-ECL) platform (Mesoscale Discovery Inc., Rockville, MD). The 
values below the limit of detection were substituted with the lowest quantified value for each 
cytokine. Measurement of BALF inflammatory mediator proteins was restricted to 2-D only since 
ozone-induced inflammation peaks at this time point (Ward et al., 2015). 
2.2.5 Statistics 
2.2.5.1 Analysis of lung mRNA sequencing data  
For mRNA sequencing, sequenced reads were mapped to the rat genome (rn6) using 
ensemble release 83 in the Partek® Flow suite. R version 3.2.3 (2015-12-10) was used for 
subsequent analyses of gene expression changes. The count matrix was rounded to the 
nearest integer and assessed for differential gene expression using DESeq2 (v. 1.10.1) (Love et 
al., 2014). Gene expression was considered different when fold change (FC) was >1.5 
(upregulation) or <0.667 (downregulation) and the adjusted p value was ≤0.05. Pathway 
analysis was conducted using the log2 (fold change) and adjusted p-values from DESeq2 with 
Ingenuity Pathways Analysis® (IPA®, QIAGEN Redwood City, www.qiagen.com/ingenuity) 
using an adjusted p-value cut-off of 0.10 (Krämer et al., 2014). Pathway heat maps of 
normalized counts from DESeq2 were generated with the heatmap.2 function of the g-plots 
package (Warnes et al., 2015). For glucocorticoid responsive genes, fold changes in ozone-
exposed rats relative to air control are reported for each surgery group. To validate qPCR and 
RNAseq data, correlations between selected genes analyzed using qPCR are shown in 
Appendix, Supp Fig. 2.1  
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2.2.5.2 Analysis of RT-qPCR and BALF cytokine protein data  
Relative gene expression and BALF cytokine data were analyzed using a two-way 
analysis of variance (ANOVA) with the 1-D and 2-D exposure groups treated as independent 
experiments. The two independent variables were exposure (air or 1 ppm ozone) and surgery 
(SHAM, DEMED or ADREX). The Holm-Sidak's test was used to correct for all multiple 
comparisons and significant differences were considered when a p-value of 
≤0.05 was achieved. All data (n = 4–6 animals/group; 4 for SHAM air and ozone groups and 5–
6 for ADREX and DEMED groups) are expressed as mean ± SEM. GraphPad prism 6.07 
software was used for statistical analysis. 
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2.3 Results 
2.3.1 Ozone-induced transcriptome changes in SHAM rats are diminished in DEMED and 
ADREX rats 
To determine the impact of DEMED and ADREX-induced depletion of stress hormones 
on ozone-induced global transcriptional changes, total RNA from lung tissue was assessed with 
RNA sequencing (RNAseq). For 1-D time point, air and ozone-exposed SHAM, DEMED and 
ADREX groups were analyzed, while for 2-D time point only air and ozone-exposed SHAM and 
ADREX groups were analyzed. DEMED groups for 2-D were not analyzed due to constraints in 
the number of wells in the plate design. Ozone exposure at 1-D time point induced significant 
changes (p ≤ 0.05) in the expression of 2337 genes in SHAM rats (Fig. 2.1A). The number of 
genes changed by ozone were dropped by over 5-fold in DEMED (461 genes) and ADREX (463 
genes) rats exposed for 1 day (1-D). Of 1452 genes uniquely changed by ozone in SHAM rats 
at 2-D time point, 716 were upregulated and 736 were downregulated. Ozone exposure in 
ADREX rats at 2-D time point resulted in 74 unique significantly changed genes (36 upregulated 
and 38 downregulated). The number of genes changed by ozone were dropped by over 15- fold 
ADREX rats exposed for 2 days (2-D). Only 26 genes were commonly changed by ozone 
between SHAM and ADREX rats at 2-D time point (Fig. 2.1B). Changes in lung gene expression 
of SHAM rats after ozone exposure were reflective of changes in inflammatory, oxidative stress, 
steroid metabolism and cell cycle control processes known to be altered after ozone exposure 
(Ward and Kodavanti, 2015). Ozone-induced expression changes were greatly diminished in 
DEMED and ADREX rats (Appendix, Supp Tables 2.1 and 2.2). Genes that were induced after 
ozone exposure in SHAM rats were either not induced or only moderately induced in DEMED 
and ADREX rats, whereas those that were inhibited in SHAM rats were not inhibited or 
moderately inhibited in DEMED and ADREX rats. The relative fold change in expression of forty 
most induced and forty most inhibited genes in SHAM rats exposed to ozone, and their relative 
expression changes in DEMED and ADREX rats are shown in Appendix, Supp Tables 2.1A and 
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2.1B. These genes are reflective of cellular changes related to oxidative stress, acute phase 
response, inflammatory cell signaling and metabolism processes in SHAM rats. 
To assess ozone-induced gene changes not affected by DEMED and ADREX, we 
examined unique and shared genes (Appendix, Supp Table 2.2 A–D) within the Venn diagram 
(Fig. 2.1). At 1-D, there were 235 genes uniquely changed by ozone in DEMED rats (145 
upregulated and 90 down regulated) and 250 genes in ADREX rats (53 upregulated and 197 
down regulated). Genes upregulated in DEMED by ozone included those involved in DNA 
replication processes while genes downregulated in ADREX by ozone were related to 
processes involved in acquired immunity (Appendix, Supp Table 2.2). There were 193 genes 
changed by ozone in common between SHAM and DEMED rats, and 180 genes were shared 
between SHAM and ADREX rats. Those in common with SHAM and DEMED included genes 
increased in expression related to IL-1 signaling and those involved in temperature and hypoxia 
or mechanical stimulation response. Whereas, those in common between SHAM and ADREX 
included genes with increased expression of those involved in protein metabolic processes and 
decreased expression of those in immune processes (Appendix, Supp Table 2.2). Only 86 
genes changed by ozone were shared between, DEMED and ADREX rats whereas 53 
significant ozone -induced gene changes were shared by all; SHAM, DEMED and ADREX rats. 
Using IPA software, canonical pathways differentially regulated by ozone in SHAM, 
DEMED and ADREX rats (Tables 2.1 and 2.2; Appendix, Supp Table 2.3 and 2.4) were 
identified. The top 20 significantly upregulated (activation score > 0) and down-regulated 
(activation score < 0) canonical pathways after ozone exposure in SHAM rats and their relative 
changes in DEMED and ADREX rats are presented in Tables 2.1A and 2.1B. Notable pathways 
activated by ozone in SHAM rats on 1-D and/or 2-D included ERK5 signaling, acute phase 
response, cell cycle, ceramide signaling, p38 MAPK signaling and Notch signaling while those 
inhibited include interferon signaling, mTOR signaling, aryl hydrocarbon receptor signaling, 
iNOS signaling, JAK/Stat signaling, and IL-2 signaling (Tables 2.1A and 2.1B; Appendix, Supp 
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Table 2.3 and 2.4). In most cases pathway alterations induced by ozone in SHAM rats were 
abolished or mitigated by both DEMED and ADREX surgeries at 1-D (Table 2.1) or at 2-D time 
points (Table 2.1B). Gene specific responses in the selected pathways known to be upregulated 
by ozone such as acute phase response, NRF-2 mediated oxidative stress and PI3K/AKT 
pathways are displayed as heat maps in Fig. 2.2A–C to get insights into how adrenergic and 
steroidal hormones regulate expression of specific genes within a given pathway. The individual 
changes in SHAM rats for specific genes in these pathways are in agreement with our 
previously published data on ozone effects determined using Affymetrix platform (Ward et al., 
2015). Visual display of expression changes for each animal in genes related to specific 
functional category indicates that the pattern of genes changed by ozone exposure in SHAM 
rats are lost in DEMED and ADREX rats (Fig. 2.2A–C). 
Using the IPA comparison of gene expression signatures with previously known 
xenobiotics in its database, xenobiotics known to cause similar expression changes were 
compared to our experiment. Changes in gene expression determined in 1-D ozone exposure in 
SHAM rats were similar to those induced, among others, by methylprednisolone, 
dexamethasone, forskolin, and CREB-1 (Table 2.2), suggesting the significant contribution of 
glucocorticoids and adrenergic mechanisms in ozone-induced changes in lung tissue gene 
expression. The predicted activation scores in 1-D ozone vs. air exposed SHAM rats for these 
compounds were attenuated in animals that underwent either DEMED and ADREX surgeries 
(Table 2.2). 
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Figure 2.1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1 Venn diagrams showing the number of significantly changed genes in lungs of 
SHAM, DEMED and ADREX rats after ozone exposure. Gene expression differences were 
considered significant when the log2 Fold Change (FC) was ≥0.585 or ≤−0.585 [if FC was 
higher than 1.5 (upregulation) or lesser than 0.667 (downregulation)] and the adjusted p value 
was ≤0.05. A) SHAM, DEMED and ADREX rats were assessed for 1-D time point while B) only 
SHAM and ADREX were assessed at 2-D time point. 
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Table 2.1 
 
 
 
Table 2.1 Up and down – regulated canonical pathways A) Left: Twenty most up-regulated 
and twenty most down-regulated canonical pathways after ozone exposure in SHAM, DEMED 
and ADREX rats (1-D time point). B) Right:  Twenty most up-regulated and twenty most down-
regulated canonical pathways after ozone exposure in SHAM and ADREX rats (2-D time point). 
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Figure 2.2 
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Figure 2.2 Heatmaps showing hierarchical clustering of selected genes within given 
signaling pathways after 1-D air or ozone exposure in SHAM, DEMED or ADREX rats. 
Pathway heat maps of row scalled counts from DESeq2 were generated with the heatmap.2 
function of the g-plots package. Increased and decreased expression of genes are shown by 
orange and purple color combination, respectively. Heatmaps were for A) Acute phase 
response genes, B) NRF2-mediated oxidative stress response genes and C) PI3K-AKT 
pathways genes. (For interpretation of the references to color in this figure legend, the reader is 
referred to the web version of this article.) 
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Table 2.2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.2 Identification of 10 most predictive targets changed by ozone exposure (1-D) in 
SHAM, DEMED and ADREX rats using ingenuity upstream regulator analysis. 
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2.3.2 Ozone exposure increased expression of glucocorticoid responsive genes in SHAM but 
not ADREX rats 
RNA sequencing results were useful in determining if glucocorticoid responsive genes 
were changed after ozone exposure. A list of 8 genes upregulated by glucocorticoid receptor 
activation were selected (Bhlhe40, Tsc22d3, Thbd, Sdpr, Slc19a2, Gem, Plk2 and Srgn) (Wang 
et al., 2004) to determine if the lungs were an active target of the increased glucocorticoid 
activity driven by ozone-induced increases in circulating corticosterone (Miller et al., 2016a, 
2016c). SHAM rats exposed to ozone (1-D) compared with air exposed animals displayed 
significantly increased lung expression (in all but Thbd (Table 2.3)). These ozone-induced 
increases were not apparent in ADREX rats demonstrating that ozone activates the expression 
of glucocorticoid responsive genes in SHAM but not in ADREX rats. As expected, ADREX in air-
exposed rats did not change the expression of these genes. On day 2 of exposure, although the 
induction of glucocorticoid responsive genes in SHAM rats was reduced when compared to day 
1 changes, the increases in some of these genes still persisted in ozone-exposed SHAM rats 
and these effects were diminished in ADREX rats (Table 2.3). 
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Table 2.3 
 
 
 
 
 
 
Table 2.3 Ozone-induced fold change in the expression of glucocorticoid responsive 
genes in SHAM, DEMED and ADREX rats. 
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2.3.3 Modulation of lung innate immune response genes (qPCR) and BALF proteins by ozone in 
SHAM, DEMED and ADREX rats 
In order to validate the results obtained using RNAseq, we performed qPCR for innate 
immune genes known to be induced by ozone exposure. Inflammatory gene expression 
changes in the lung were determined at both time points, 1-D and 2-D. Scatter plots of relative 
expression by qPCR and RNAseq in all samples in general, showed significant correlation 
(Appendix, Supp Fig 2.1), indicating that the expression levels obtained using RNAseq are 
reflective of the actual changes in the gene expression. In general, the qPCR of key 
inflammatory genes in ozone-exposed SHAM rats was reflective of changes noted previously in 
other publications (Ward et al., 2015) (Fig. 2.3). There was a trend for increased expression of 
Tnfα after ozone exposure in SHAM rats (p = 0.21) at 2-D time point (Fig. 2.3A). Il-6 was 
markedly induced by ozone exposure in SHAM rats at both time points (Fig. 2.3B) and for Il1-β 
at the 2-D time point (Fig. 2.3C). These ozone-induced changes were maintained for Tnfα (2-D) 
in DEMED rats, while for Il-6 and Il-1β the changes were not observed in DEMED or ADREX 
rats. 
Expression of Tnfα, Ifnγ and Il-5 (Fig. 2.3A, E, F) as determined using qPCR were 
increased at 2-D time point, while the expression of Il-13 was increased at both time points in 
ADREX rats exposed to air (Fig. 2.3G). The expression of Il4, Ifnγ, Il-5 and Il-13 (Fig. 2.3D, E, F, 
G) was increased in ADREX rats exposed to ozone (2-D only). DEMED did not have significant 
effect on the expression of any of these genes in air and 
ozone-exposed rats. 
BALF proteins were analyzed only for 2-D time point since ozone induced inflammation 
peaks at this time. While neither ozone nor ADREX or DEMED changed the levels of IL-1β and 
IFN-γ (Fig. 2.4C, E), compared to air, ozone exposure resulted in increased levels of IL-6, IL-4, 
IL-5 and IL-13 proteins in BALF of SHAM rats (Fig. 2.4B, D, F, G). Significant ozone-induced 
increases of IL-6, IL-4, and IL-13 proteins were not observed in ADREX or DEMED rats (Fig. 
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2.4B, D, G). Ozone-induced IL-5 increase was not affected by DEMED. In ADREX rats 
increases in IL-5 were noted in both air and ozone groups (Fig. 2.4F). ADREX also increased 
BALF protein levels of TNFα (Fig. 2.4A, F). 
To explore changes in Th1 and Th2modulation after ozone exposure in SHAM, DEMED 
and ADREX rats, BALF protein levels of IFNγ and IL4 and their ratio were examined. Increased 
expression of IFNγ preferentially drives a Th1 response while increased IL4 drives a Th2 
response (Serrano et al., 1997). Although IFNγ protein levels were not significantly changed 
after ozone exposure in SHAM rats, the BALF IL-4/IFNγ ratio was increased (Fig. 2.4H) 
suggesting that ozone appears to preferentially drive a Th2 response over Th1. This effect was 
not observed in DEMED and ADREX rats. 
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Figure 2.3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3 The expression of selected inflammatory cytokine genes in lungs of SHAM, 
DEMED, and ADREX rats after exposure to air or ozone as determined using qPCR. 
Values represent mean ± SE of relative fold change from each day SHAM-air control (n= 3–4 
animals for SHAM air or ozone, and n= 5–6 for other groups). Comparisons between air and 
ozone under each surgery condition and the comparisons between different surgeries under the 
same exposure condition are shown in graphs (* indicate p value ≤ 0.05 with respect to surgery 
or ozone exposure). A) tumor necrosis factor alpha (Tnfα), B) interleukin 6 (Il-6), C) interleukin 1 
beta (Il-1β), D) interleukin 4 (Il-4), E) interferon gamma (Ifnγ), F) interleukin 5 (Il-5) and G) 
interleukin 13 (Il-13). 
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Figure 2.4 
 
 
 
 
Figure 2.4 Inflammatory cytokine proteins in bronchoalveolar lavage fluid (BALF) of 
SHAM, DEMED and ADREX rats after exposure to air or ozone. Values represent mean±SE 
(n=4 animals for SHAMair or ozone, and n=5–6 for other groups). Comparisons between air and 
ozone under each surgery condition and the comparisons between different surgeries under the 
same exposure condition are shown in graphs (* indicates p value ≤ 0.05with respect to surgery 
or ozone exposure). A) Tumor necrosis factor alpha (TNFα), B) interleukin 6 (IL-6), C) 
interleukin 1 beta (IL-1β), D) interleukin 4 (IL-4), E) interferon gamma (IFNγ), F) interleukin 5 (IL-
5), G) interleukin 13 (IL-13) and H) IL4/IFNγ ratio. 
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2.4 Discussion 
 
We have recently shown that circulating stress hormones are increased after ozone 
exposure in rats and humans, and are linked to both systemic and pulmonary effects of ozone 
exposure (Bass et al., 2013; Miller et al., 2015, 2016a, 2016b, 2016c). In this study, a 
transcriptional Approach was used to understand the molecular underpinnings of ozone-induced 
acute lung injury and inflammation in SHAM, DEMED and ADREX rats. The goal was to 
elucidate potential mechanisms and roles of adrenergic and steroidal hormones in ozone-
induced lung injury and inflammation. Ozone-induced changes in expression of number of 
genes in the lungs of SHAM rats were markedly diminished in DEMED and ADREX rats (5-fold 
decrease from over 2300 genes). Moreover, pathways involved in ozone-induced inflammatory 
and oxidative stress responses, such as NRF2, acute phase response, PI3K/AKT and p38 
MAP-kinase were up-regulated after ozone exposure in SHAM rats but were not changed in 
DEMED or ADREX rats. Genes regulating the neutrophilic innate immune response and 
associated proteins favoring Th2 phenotype induced after ozone exposure in SHAM rats were 
diminished in DEMED and ADREX rats. When predictive pathways were examined, it was 
evident that ozone-induced transcriptional changes were similar to those induced by 
glucocorticoid-like compounds such as dexamethasone and prednisolone and to those induced 
by forskolin. Ozone exposure was associated with increases in the expression of glucocorticoid-
responsive genes in the lungs of SHAM rats but not DEMED or ADREX rats. Together, these 
findings show that adrenergic and steroidal hormones modulate ozone-induced global gene 
expression changes in the lung. Hormonal regulation of air pollution-induced injury and 
inflammation has not been well studied even though steroidal and adrenergic interventions are 
widely used in treatment of lung diseases (Barnes, 2013; Fuso et al., 2013). 
Gene expression outputs obtained by RNAseq were adequate in quantifying the 
magnitude of changes induced by ozone and were generally consistent with those reported in 
previous publications (Gohil et al., 2003; Ward et al., 2015). Eighty percent of the top ozone-
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induced changed transcripts in the lung as measured by an Affymetrix rat panel (Ward et al., 
2015) were altered in the same direction in SHAM rats. The diminution of ozone-induced lung 
transcriptome changes in the absence of circulating stress hormones in DEMED and ADREX 
rats could be characterized using RNAseq. Since we were not able to remove the cortex while 
keeping the medulla intact in these animals, it was not possible to determine if corticosterone 
plus mineralocorticoids and epinephrine played independent roles in ozone-induced changes. 
Future work with pharmacological interventions is planned to address the role of individual 
stress hormones. 
Oxidative stress responsive pathways have been shown to be upregulated in the lungs 
after ozone exposure including NRF2 (Kim et al., 2004) and acute phrase response (Bass et al., 
2013; Laskin et al., 1994) which are presumed to counter ozone-induced lung injury and 
inflammation through induction of genes involved in these pathways (Cho et al., 2013). 
Moreover, it has been shown that steroid-induced NRF2 activation is a key event induced by 
oxidant injury and enhances airway epithelial barrier integrity (Shintani et al., 2015). Adrenal-
derived stress hormones have been shown to independently increase plasma levels of acute 
phase proteins (Eastman et al., 1996; Merchant et al., 2010; Schade et al., 1987). The 
upregulation of NRF2 and acute phase pathways in ozone-exposed SHAM rats but their 
inhibition in DEMED and ADREX rats suggests that NRF2 nuclear translocation and activation 
of acute phase response in the lung cells may require the presence of circulating epinephrine 
and/or corticosterone. 
We have shown that ozone exposure induces systemic metabolic changes (Miller et al., 
2015). PI3K/AKT is an intracellular signaling pathway involved in metabolism, cell cycle control, 
and proliferation (Hassan et al., 2013). The activation of selected genes in PI3K/AKT pathway 
by ozone in SHAM rats at 1-D suggests that the transcriptional changes observed after ozone 
exposure are not only restricted to inflammatory mechanisms, but also involve other signaling 
processes including metabolic (Miller et al., 2015; Ward and Kodavanti, 2015). The activation of 
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adrenergic receptors has been shown to induce PI3K/AKT pathway (Nakaoka et al., 2015) while 
blockade of these receptors by propranolol has shown downregulation (Pan et al., 2015). Thus, 
the diminution of the pathway activation score in DEMED and ADREX rats emphasizes the 
contribution of stress hormones in interactively modulating multiple biological processes. 
Based on known glucocorticoid responsive genes (Wang et al., 2004), we identified 
gene signatures in ozone-exposed SHAM, DEMED and ADREX rats. Although ozone did not 
change the expression of the glucocorticoid receptor Nr3c1 in SHAM rats (data not shown), the 
expression of glucocorticoid target genes - Tcs22d3 (also known as Gilz), Bhlhe40, Srgn, Plk2 
and Gem - were significantly increased by ozone. These ozone-induced changes in 
glucocorticoid responsive genes have been shown previously (Thomson et al., 2016) and 
suggest that the lung is an active target for corticosterone action. The magnitude of this effect 
was greater on day 1 than on day 2, perhaps suggesting a degree of adaptation to the ozone 
exposure as has been described for lung injury and inflammation (Kirschvink et al., 2002; 
Iwasaki et al., 1998). 
Although the cellular signaling induced by epinephrine is mediated primarily by 
posttranslational events, some signature changes known to be mediated by adrenergic receptor 
activation were found. The predicted gene signature included the activation of Forskolin 
pathway in ozone-exposed SHAM but not in DEMED or ADREX rats. Forskolin raises the levels 
of cAMP which is also downstream of β adrenergic receptor activation (Wallukat, 2002). The 
diminution of ozone effects in DEMED rats supports the role of epinephrine as a modulator of 
ozone induced lung injury/inflammation. 
Ozone-induced innate immune response has been shown to be associated with 
increases in the neutrophil chemo-attractant IL6 (Gabehart et al., 2015; Johnston et al., 2003; 
Krishna et al., 1998). We noted that ILl6 mRNA and proteins were up-regulated in SHAM but not 
in ADREX and DEMED rats, suggesting that adrenergic and steroidal hormones 
transcriptionally regulate innate immune response normally activated by ozone. Increased levels 
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of epinephrine, and cortisol favors the development of the Th2 response (Spellberg and 
Edwards, 2001). Ozone exposure has also been shown to promote Th2 phenotype shift in nasal 
and airway tissues (Kumagai et al., 2016; Wu et al., 2014). Similarly, we observed that there 
was an increase in BALF IL4/IFN-γ ratio in SHAM but not in DEMED and ADREX rats exposed 
to ozone suggesting that stress hormones may be involved in preferentially mediating the Th2 
shift. 
Since stress hormones play a fundamental role in homeostatic balance, ADREX and 
DEMED surgeries likely change some of the basic physiological processes in tissues where 
stress hormone receptors are expressed. It is also likely that the lack of circulating epinephrine, 
mineralocorticoids and glucocorticoids in ADREX rats may impact lung epithelial integrity. 
ADREX increased the expression of several lung cytokines, including Il-5, Il-13, and Tnfα, as 
determined using qPCR and immunoassays, in air and ozone exposed animals. ADREX was 
associated with inhibition of many genes regulating acquired immunity even in air-exposed 
animals suggesting a key role of adrenal-derived hormones in regulation of immune response 
upon encountering injury. Surprisingly, DEMED alone, associated with depletion of only 
epinephrine (Miller et al., 2016b), did not alter the expression of these genes, suggesting that 
the lack of glucocorticoids but not epinephrine, likely contributes to immune homeostasis. 
Increased expression of beta-2 adrenergic receptors in alveolar type II cells has been shown to 
increase alveolar fluid clearance (McGraw et al., 2001), while glucocorticoids have been 
reported to improve epithelial barrier function (Kielgast et al., 2016). 
Ozone remains a potential health hazard as its levels could exceed >0.2 ppm in areas 
with hot climate and heavy industry (The Royal Society, 2008). Human clinical studies often use 
0.2–0.4 ppm concentration with intermittent exercise which is comparable to 1.0 ppm exposure 
in the rats during rest (Hatch et al., 1994, 2013). The level of ozone used in our study (1.0 ppm) 
is much higher than what is expected in the polluted air. However, our goal was to achieve 
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detectable lung injury and inflammation in SHAM rats, such that any potential protective effects 
of DEMED and ADREX could be reliably detected. 
This study did not allow assessment of contribution of individual hormones in ozone-
induced lung injury and inflammation since it is not possible to surgically remove only the cortex. 
Although, the role of stress hormones in the development and magnitude of immunological 
responses has been extensively studied (Dhabhar et al., 2012), it has not been examined in the 
context of inhaled pollutants. The temporality of sequential events after the activation of a stress 
response was not taken into account and the role of ozone-induced hormonal changes in this 
context will need to be further examined. 
In summary, ozone-induced transcriptional changes in the lung are greatly mitigated by 
both DEMED and ADREX surgeries demonstrating the key roles played by circulating 
adrenergic as well as steroidal hormones in the ozone-induced injury and inflammation. Ozone-
induced increases in innate immune genes and proteins were markedly attenuated, including an 
increase in the ratio of IL-4/IFN-γ, in DEMED and ADREX rats, suggesting immune modulation 
by stress hormones. Immune, metabolic and oxidative stress pathways were induced in the 
lungs by ozone in SHAM rats while ADREX and DEMED conferred protection against these 
changes. In addition, upstream analysis by IPA showed that global gene changes induced by 
ozone in the lungs of SHAM rats were similar to steroidal chemicals and adrenergic influence. 
From the public health perspective, glucocorticoid and adrenergic receptors are widely 
targeted to combat pulmonary chronic disease conditions such as asthma and COPD. The 
dynamic role of environmental stressors and the use of therapeutic approaches targeting 
steroidal and adrenergic mechanisms should be investigated in the treatment of lung 
inflammatory conditions. 
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CHAPTER 3: ADRENERGIC AND GLUCOCORTICOID RECEPTOR ANTAGONISTS 
REDUCE OZONE-INDUCED LUNG INJURY AND INFLAMMATION 
 
3.1 Introduction 
Ozone is a reactive secondary pollutant which oxidizes biomolecules in the respiratory 
tract upon inhalation (Bromberg, 2016). The accepted paradigm of ozone-induced lung injury 
and inflammation involves its direct interaction with lung lining components and generation of 
oxidized lipid and protein byproducts (Auerbach and Hernandez, 2012), which are responsible 
for activation of the inflammatory signaling cascade and mediating downstream effects such as 
lung function decrement, increased vascular permeability, and neutrophilic inflammation. These 
ozone-induced effects are reversible even if daily exposure continues over several days 
suggesting tolerance or adaptation (Miller et al., 2016c). The oxidatively-modified reactive 
byproducts act as signaling factors locally within the lung, stimulating the release of cytokines 
and chemokines to promote recruitment of neutrophils and activation of NRF2 and NFB 
pathways in the lung (Hollingsworth et al., 2007). However, the contribution of circulating 
biomolecules in ozone-induced lung injury and inflammation has only been recently examined 
(Kodavanti, 2016). 
Acute ozone exposure has also been shown to induce pulmonary sensory irritation and 
C-fiber activation. Upstream events that are involved in this response include neuron firing of 
the nucleus tractus solitarius (NTS) (Gackière et al., 2011), increases in circulating 
adrenocorticotropic hormone (ACTH) (Thomson et al., 2013), and cardiac changes through 
autonomic reflex mechanisms (Arjomandi et al., 2015; Gordon et al., 2014). These events 
suggest that ozone inhalation is capable of triggering a centrally-mediated neuroendocrine 
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stress response which results in increased release of stress hormones into the systemic 
circulation (Kodavanti, 2016; Snow et al., 2017). Indeed, we have recently shown that circulating 
stress hormones such as epinephrine and cortisol/corticosterone rise rapidly after acute ozone 
exposure in both rodents (Bass et al., 2013; Miller et al., 2015, 2016b) and humans (Miller et al., 
2016a). Subsequent ozone-induced lung global gene expression changes mimic those induced 
by downstream events promoted by β2 adrenergic and glucocorticoid receptor activation, further 
suggesting that circulating stress hormones play a key role as mediators of pulmonary 
responses (Henriquez et al., 2017a). The role of circulating adrenal gland-derived stress 
hormones in ozone-induced lung injury and inflammation in rats was further confirmed by the 
evidence that bilateral adrenalectomy diminished these ozone effects (Miller et al., 2016b) and 
associated global lung transcriptional changes (Henriquez et al., 2017a). 
Adrenergic receptors (AR) are widely distributed throughout the body and although 
epinephrine is a prototypical agonist for all types of AR, the selective activation of specific AR 
subtypes determines the physiological organ-specific response. β1AR are mainly expressed in 
the cardiac tissue and are central in maintaining cardiac output and contractility of cardiac 
muscle (Kurz et al., 1991), hence βAR blockers are widely used to reduce blood pressure. On 
the other hand, β2AR are primarily distributed in the smooth muscles of bronchi and blood 
vessels (Morgan and Laufgraben, 2013). Airway smooth muscle relaxation by β2AR agonists is 
a common pharmacological intervention used for bronchodilation in asthma and chronic 
obstructive pulmonary disease (Cazzola et al., 2013). Propranolol (PROP) is a non-selective 
βAR antagonist capable of blocking both β1AR and β2AR and, unlike epinephrine, it readily 
crosses the blood brain barrier (Olesen et al., 1978). 
Circulating cortisol/corticosterone binds to glucocorticoid receptors (GR) that are present 
in virtually all cells in the body. Nuclear translocation of these receptors up-regulates a variety of 
genes involved in homeostatic response(s) (Oakley and Cidlowski, 2013). Non-genomic actions 
of glucocorticoids on GR have also been identified (Duque and Munhoz, 2016). Although the 
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anti-inflammatory and immunosuppressive actions of glucocorticoids are not completely 
understood, potent GR agonists are commonly used to treat inflammatory conditions (Petta et 
al., 2016). By contrast, other studies have shown pro-inflammatory actions of GR activation 
(Cruz-Copete and Cidlowski, 2015). Mifepristone (MIFE) is a GR antagonist used to examine 
cellular effects of GR (Kakade and Kulkarni, 2014).      
The goal of this study was to use a targeted pharmacological approach to examine the 
role of βAR and GR in mediating ozone-induced lung injury and inflammation. PROP, a non-
selective βAR antagonist, was used to antagonize the activity of epinephrine while MIFE, a GR 
antagonist, was used to antagonize the activity of corticosterone.  We hypothesized that the 
blocking of βAR and/or GR would produce selective inhibition of lung injury and/or inflammation 
and associated signaling events caused by exposure to ozone in rats.  
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3.2 Materials and Methods 
3.2.1 Animals 
Male Wistar Kyoto (WKY) rats (10 weeks of age), purchased from Charles River 
Laboratory (Raleigh, NC) were housed in pairs in polycarbonate cages containing beta chip 
bedding under controlled conditions (21°C, 50-65% relative humidity and 12h light/dark cycle). 
Rats were provided with standard Purina (5001) rat chow (Brentwood, MO) and water ad 
libitum, and housed in an Association for Assessment and Accreditation of Laboratory Animal 
Care (AAALAC) approved animal facility. Animal procedures were approved by the US 
Environmental Protection Agency, National Health and Environmental Effects Research 
Laboratory Institutional Animal Care and Use Committee. Because we previously determined 
that 5-10% of male WKY rats develop spontaneous cardiac hypertrophy (Shannahan et al., 
2010), all animals were evaluated for evidence of cardiac hypertrophy relative to body weights 
at necropsy. Those with 20% or greater increases in the heart to body weight ratio were 
removed from further data analysis. 
3.2.2 Drug pretreatments and ozone exposures 
Three studies were conducted for each protocol involving PROP, MIFE, and PROP 
followed by MIFE (PROP+MIFE) pretreatments (Fig. 3.1). For each study, rats were randomized 
by body weight into four groups (vehicle/air, drug/air, vehicle/ozone, drug/ozone) and time point 
(one day, D+1; or two days, D+2) (n=8/group). In the first study, rats were injected i.p. with 
sterile saline (1 mL/kg) or propranolol hydrochloride (PROP, Sigma-Aldrich, St Louis, MO; 10 
mg/kg in saline). In the second study, rats were injected s.c. with pharmaceutical grade corn oil 
(1 mL/kg) or mifepristone (MIFE, Cayman Chemical Co., Ann Arbor, MI; 30 mg/kg in corn oil). In 
the third study, control rats were injected with saline (1 mL/kg, i.p.) followed by corn oil (1 mL/kg, 
s.c.) while the drug-treated group was injected with PROP (10 mg/kg, i.p.) followed by MIFE (30 
mg/kg, s.c.) (PROP+MIFE). For all three studies, the vehicle/drug pretreatments began seven 
days prior to the start of air or ozone exposure (from Day-7 to Day-1 in the morning) and 
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continued each day of air or ozone exposure (D+1 and D+2) (Fig. 3.1). Rats were exposed to 
either filtered air or ozone (0.8 ppm) for 4h during D+1 and/or D+2 in individual wire-mesh cages 
placed in exposure chambers.  
Ozone was generated using a silent arc discharge generator (OREC, Phoenix, AZ) and 
delivered to 1000 L Hinners-type chambers using mass flow controllers. O3 concentration was 
recorded continuously by photometric analyzers (API Model 400, Teledyne, San Diego, CA). 
Chamber temperature (average oF) and relative humidity (RH: average %) were measured 
continuously and recorded hourly. The mean ozone chamber concentration was 0.803±0.002 
ppm (Mean ± standard deviation). The RH for control chamber was 49±4 and ozone chamber 
was 46±3. The temperature of control chamber was 72.8±0.3 oF and ozone chamber was 
74.2±0.4 oF. The control chamber flow was maintained at 256±24 while ozone chamber flow at 
261±3 liters per minute). 
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Figure 3.1 
 
Figure 3.1 Schema of the experimental design. For all three studies, the timing for drug 
pretreatments and the information on air or ozone exposure, plethysmography and necropsies 
are indicated by corresponding arrows. Animals assigned to 1 day (4 hr) air or ozone exposure 
are referred as group D+1 and those assigned to 2 consecutive days of exposure are referred 
as group D+2. Animals assigned to group D+2 were subjected to plethysmography prior to the 
start of drug pretreatment, after 3 days of drug pretreatment (D-4) and immediately after each 
day of air/ozone exposure. Necropsy and tissue collection were performed immediately after 
exposure (D+1) or after exposure and plethysmography (D+2) (within 1-2 hours of exposure). 
Vehicles: SAL, saline; CO, corn oil; drugs: PROP, propranolol; MIFE, mifepristone. 
D-7 D-6 D-5 D-4 D-3 D-2 D-1 D+1 D+2
Exposure, air or 
0.8 ppm ozone, 
4 h/day, 7-11 AM
Whole body plethysmography
Drug treatments (6-7 AM)
Study 1: Propranolol (PROP), 10 mg/kg i.p. - Vehicle, Saline (SAL)
Study 2: Mifepristone (MIFE), 30 mg/kg s.c. - Vehicle, Corn Oil (CO)
Study 3: PROP+MIFE - Vehicle, (SAL+CO)
Necropsy (D+1)
-Tissue 
collection
Necropsy (D+2)
-Tissue 
collection
Group D+1 
(n=8/group)
Group D+2
(n=8/group)
Day
Experimental Design
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3.2.3 Whole body plethysmography 
In rats assigned to the D+2 group, ventilatory parameters were measured in 
unrestrained animals using whole body plethysmography (WBP) prior to drug treatments, during 
drug treatments and immediately after each day of air or ozone exposure.  Briefly, rats were 
placed in pre-calibrated WBP chambers (Model PLY3213; Buxco Electronics, Inc., Wilmington, 
NC). During the first two minutes, the rats were allowed to acclimate. Then data were averaged 
for a total time of 5 minutes using EMKA iox 2 software (SCIREQ, Montreal, Canada). 
Ventilatory parameters included breathing frequency, tidal volume (TV), minute volume (MV), 
peak inspiratory flow (PIF), peak expiratory flow (PEF), inspiratory time (IT), expiratory time 
(ET), and enhanced pause (Penh), an index of air flow limitation and surrogate measure of 
bronchoconstriction (Hammelmann et al., 1997). 
3.2.4 Cytokine protein quantification 
Immediately after exposure on day 1 (D+1), and after exposure and plethysmography on 
day 2 (D+2), rats were necropsied during the course of 1-2 hours. The rats were euthanized 
with an overdose of Fatal Plus (sodium pentobarbital, Virbac AH, Inc., Fort Worth, TX; >200 
mg/kg, i.p.). Blood samples were collected from the abdominal aorta directly in vacutainer tubes. 
EDTA containing blood samples were used to perform complete blood count on a Beckman-
Coulter AcT blood analyzer (Beckman-Coulter Inc., Fullerton, California). Additionally, blood 
smears were prepared and stained with Wright-Giemsa (Fisher Scientific) using a Hema-Tek 
2000 slide stainer (Miles, Inc., Elkhart, IN, USA). Because this hematology analyzer provided 
data for only total white blood cells and lymphocytes, additional blood smear slides were used to 
verify the number of lymphocytes and to evaluate relative numbers of monocytes and 
neutrophils for the D+1 animals based on 100 white blood cells per slide.  
The right lung was lavaged with Ca2+ and Mg2+ free PBS, pH 7.4, at 37 °C. The lavage 
volume was calculated based on 28 mL/kg body weight total lung capacity, and the right lung 
weight being 60% of total lung weight (Bass et al., 2013). Bronchoalveolar lavage fluid (BALF) 
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was used to determine total cell count (Z1 Coulter Counter, Coulter, Inc., Miami, FL) and cell 
differentials by preparing Cytospin slides (Thermo Fisher Scientific, Waltham, MA). These slides 
were stained with Diff-Quik (Thermo Fisher Scientific) and cell differentials were performed 
under light microscopy (300 cells/slide). Cell-free BALF (supernatant from whole BALF 
centrifuged at 1500xg) was used to measure total protein (Coomassie plus Protein Assay Kit, 
Pierce, Rockford, IL), albumin (DiaSorin, Stillwater, MN), and N-acetyl--D-glucosaminidase 
(NAG) activity (Roche Diagnostics, Indianapolis IN) using commercially available kits adapted 
for use on a Konelab Arena 30 clinical analyzer (Thermo Chemical Lab Systems, Espoo, 
Finland). Following lavage, the right caudal lobe was removed, frozen in liquid nitrogen, and 
stored at -80oC for RNA extraction.  
3.2.5 Lung RNA Isolation and real time-quantitative PCR  
Total RNA was isolated from a uniform portion (10-20 mg) of the right caudal lung lobe 
using RNeasy mini kit (Qiagen, Valencia, CA). RNA was quantified using a Qubit 2.0 fluorimeter 
(ThermoFisher Scientific, Waltham, MA) and reverse transcribed using Qscript cDNA Supermix 
(Quanta Biosciences, Beverly, MA). Primers were designed using sequences annotated in NCBI 
and obtained from Integrated DNA Technologies, Inc (Coralville, IA) including: β-Actin (Actb): f-
CAACTGGGACGATATGGAGAAG, r-GTTGGCCTTAGGGTTCAGAG; tumor necrosis factor 
(tnf) f-ACCTTATCTACTCCCAGGTTCT, r-GGCTGACTTTCTCCTGGTATG; Interleukin 6 (Il6) f-
CTTCACAAGTCGGAGGCTTAAT, r-GCATCATCGCTGTTCATACAATC; Chemokine (C-X-C 
motif) -ligand 2 (Cxcl2 or Mip2) f- GCCTCGCTGTCTGAGTTTATC, r- 
GAGCTGGCCAATGCATATCT; Metallothionein-2 (Mt2a) f- CAGCGATCTCTCGTTGATCTC, r- 
GGAGGTGCATTTGCATTGTT; TSC22 domain family protein 3 (Tsc22d3 or Gilz) f- 
CCGAATCATGAACACCGAAATG, r- GCAGAGAAGAGAAGAAGGAGATG. Quantitative PCR 
was performed for each gene using SYBR® Green PCR Master Mix (ThermoFisher, Waltham, 
MA) on the Applied Biosystems 7900HT Sequence Detection System (Foster City, CA). Relative 
mRNA expression was calculated using the ΔΔCt method following initial normalization to the 
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housekeeping gene (Actb) and then with the respective vehicle-air control group. The 
determination of lung mRNA expression was performed only for D+1 samples since it has been 
shown that ozone-induced increases in mRNA expression precedes the release of associated 
proteins and inflammation (Hollingsworth et al., 2007; Kodavanti et al., 2015).  
3.2.6 Cytokine quantification  
Serum and BALF cytokine concentrations were quantified using the V-PLEX 
proinflammatory panel 2 (rat) kit per manufacturer’s protocol (Mesoscale Discovery Inc., 
Rockville, MD). The electrochemiluminescence signals for each protein were detected using 
Meso Scale Discovery® platform (Mesoscale Discovery Inc., Rockville, MD). In control animals 
in which the levels of some cytokines in BALF were below the assay detection limit, the values 
were substituted with the lowest quantified value for the given cytokine in the group. 
Measurement of BALF and plasma cytokines was restricted only to D+2 samples since it has 
been noted that ozone-induced inflammation is maximal at this time point (Ward et al., 2015).  
3.2.7 Statistics  
For all endpoints, data were analyzed using a two-way analysis of variance (ANOVA). 
PROP, MIFE and MIFE+PROP studies were treated as independent experiments. D+1 and D+2 
exposure groups were also treated as independent experiments. The two independent variables 
were exposure (air or 0.8 ppm ozone) and pretreatment (vehicle or drug). The Holm-Sidak post-
hoc test was used to correct for all multiple comparisons and significant differences were 
considered when a P-value of ≤ 0.05 was achieved. All data (n=6-8 animals/group) are 
expressed as mean ± SEM and GraphPad prism 6.07 software was used for statistical analysis. 
For pulmonary gene expression analysis only, outliers were identified based on the false 
discovery rate and discarded using the ROUT method (robust regression and outlier removal 
(Motulsky and Brown, 2006). 
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3.3 Results 
3.3.1 Ozone-induced changes in ventilatory parameters are not impacted by PROP, MIFE and 
PROP+MIFE pretreatment 
In air-exposed rats, drug pretreatments did not affect any of the ventilatory parameters at 
D+1 or D+2 (Fig. 3.2). In ozone-exposed vehicle-treated rats, PEF and corresponding PenH 
values were consistently increased, both on D+1 and D+2, indicative of labored breathing. In 
ozone-exposed rats, PROP pretreatment was without effect on D+1, however, on D+2, this 
combination led to significantly reduced frequency of breathing (Fig. 3.2A). In ozone exposed 
MIFE-pretreated rats, results were similar to the ozone-only group. Finally, in the ozone-
exposed PROP+MIFE pretreated rats, MV was significantly reduced at D+2 (Fig. 3.2B). Notably, 
immediately after the second day of exposure, PenH values were further increased in all ozone-
exposed rats on D+2 (D+2>D+1), and no drug-related influences were apparent (Fig 3.2D). 
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Figure 3.2 Ventilatory parameters in vehicle- or drug-pretreated rats after each day of air 
or ozone. Ventilatory parameters determined after the first (D+1) and second (D+2) day of air or 
0.8 ppm ozone exposure are shown (pre-air or -ozone exposure data are not shown). The 
breathing parameters indicate mean ± standard error of mean (SEM) of n=6-8 animals/group. 
Significant differences between groups (P ≤ 0.05) are indicated by * for ozone effect and by † 
for drug pretreatment effect. A) Breathing frequency, B) minute volume (MV), C) peak expiratory 
flow (PEF), D) enhanced pause (PenH).   
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3.3.2 Ozone-induced pulmonary injury and inflammation are reduced by PROP, MIFE and/or 
PROP+MIFE pretreatments 
Drug pretreatment in air-exposed rats did not influence any of the measures of lung 
injury and inflammation. Pulmonary vascular leakage, as measured by protein and albumin 
content in BALF, is a key event occurring after ozone exposure. Ozone-induced BALF protein 
(Fig. 3.3A) and albumin (Fig. 3.3B) tended to increase in all vehicle-pretreated rats at D+1. On 
D+2 all vehicle-pretreated ozone-exposed rats demonstrated marked increases in BALF protein 
and albumin that were diminished with all drug pretreatments. NAG activity in BALF, a marker of 
macrophage activation, was increased after both days of ozone exposure in vehicle-pretreated 
animals (D+2>D+1) (Fig. 3.3C). Ozone-induced increases in NAG activity on D+2 were 
attenuated by MIFE and MIFE+PROP but not PROP (Fig. 3.3C).  
To determine the extent of ozone-induced inflammation in the lungs and effects of drug 
pretreatments, BALF total cells, neutrophils and lymphocytes were counted. Total cells in BALF 
were not changed by any of the drug pretreatments or ozone exposure except for a non-
significant reduction in all ozone exposed rats in the PROP study at D+1 (Fig. 3.4A). Ozone 
exposure on D+1 did not increase BALF neutrophil influx substantially in any of the vehicle or 
drug-pretreated groups except for a small but significant increase in saline-pretreated rats in the 
PROP study. The ozone-induced lung neutrophilia was significant in all vehicle-pretreated rats 
on D+2. This ozone-induced neutrophilia was prevented by PROP and PROP+MIFE but not 
MIFE alone (Fig. 3.4B). Ozone exposure resulted in reduced number of lymphocytes in BALF 
on D+1 and D+2 in all vehicle-treated rats. There was no effect of any drug pretreatment on 
ozone-induced reduction in BALF lymphocytes (Fig. 3.4C). 
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Figure 3.3 
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Figure 3.3 The influence of drug pretreatments on ozone-induced BALF protein leakage 
and N-acetyl glucosaminidase (NAG) activity. Protein (A), albumin (B), and NAG activity (C) 
were determined in BALF collected immediately following exposure to air or 0.8 ppm ozone, 4 
hr/day for 1 day (D+1) or 2 days (D+2). Values indicate mean ± SE of n=6-8 animals/group. 
Significant differences between groups (P ≤ 0.05) are indicated by * for ozone effect in matching 
pretreatment groups, and by † for drug effect in matching exposure groups.  
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Figure 3.4 
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Figure 3.4 The influence of drug pretreatments on ozone-induced changes in lung 
inflammation as determined by BALF cell count. Total cells (A), neutrophils (B) and 
lymphocytes (C) were determined in BALF collected immediately following exposure to air or 
ozone (0.8 ppm), 4 hr/day for 1 day (D+1) or 2 consecutive days (D+2). Values indicate mean ± 
SE of n=6-8 animals/group. Significant differences between groups (P ≤ 0.05) are indicated by * 
for ozone effect in matching pretreatment groups, and by † for drug effect in matching exposure 
groups.  
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3.3.3 Ozone-induced decreases in circulating white blood cells (WBC) and lymphocytes were 
reversed by MIFE pretreatment 
To determine the relationship between levels of immune cells in the lung and in the 
circulation, complete blood count and cell differentials were performed. Circulating total WBC 
were reduced to nearly half in all vehicle pretreated rats exposed to ozone (Fig. 3.5A). This 
ozone-induced decrease was prevented in rats pretreated with MIFE or PROP+MIFE but not 
PROP alone. This pattern was not replicated in circulating neutrophils as no specific exposure- 
or pretreatment-related changes were noted in the D+1 group (Fig. 3.5B). Since nearly 70-90% 
of circulating WBC (Cameron and Watson, 1949) in this strain of rats are lymphocytes, the 
changes in circulating lymphocytes reflected the changes observed in WBC after ozone 
exposure and drug-pretreatments (Fig. 3.5C). 
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Figure 3.5 
 
Figure 3.5 The effects of drug pretreatments on ozone-induced changes in circulating 
white blood cells (WBC) in rats. Circulating total white blood cells (A), neutrophils (B) and 
lymphocytes (C) were determined in rats immediately after exposure to air or 0.8 ppm ozone, 4 
hr/day for 1 day (D+1). Values indicate mean ± SE of n=6-8 animals/group. Significant 
differences between groups (P ≤ 0.05) are indicated by * for ozone effect in matching 
pretreatment groups, and by † for drug effect in matching exposure groups.  
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3.3.4 Ozone-induced increases in expression of pro-inflammatory mediators in the lung are 
diminished by PROP pretreatment 
Lung mRNA (D+1) and BALF protein levels (D+2) of IL-6 and TNF-α were assessed to 
determine if the influence of PROP and MIFE on ozone-induced inflammatory changes occur at 
the transcriptional and signaling levels. Ozone exposure was associated with increases in Il6 
lung mRNA and BALF protein in all vehicle pretreated rats. Ozone’s effect on Il6 mRNA and 
BALF protein was significantly reduced in animals pretreated with PROP but not MIFE or 
PROP+MIFE (Fig. 3.6A, 3.6C). Although no consistent ozone exposure or drug pretreatment-
related changes were apparent on Tnf mRNA expression as determined on D+1, marked 
increases in BALF TNF-α protein were noted in all ozone-exposed vehicle-pretreated rats at 
D+2 (Fig. 3.6B, 3.6D).  This ozone effect on TNF- was slightly reduced in rats pretreated with 
PROP, however, there was no significant effect of MIFE or PROP+MIFE (Fig. 3.6D).  
In addition to the above mentioned inflammatory cytokines, we also determined the 
effect of PROP and MIFE pretreatments at the D+1 time point on two lung transcripts known to 
be upregulated after ozone exposure: Cxcl2 (also known as Mip2, a neutrophil chemoattractant) 
and Mt2a (metallothionein 2a, an acute phase reactant (Henriquez et al., 2017a; Ward et al., 
2015). Ozone exposure increased expression of Cxcl2 and Mt2a in vehicle pretreated rats (Fig. 
3.7A, 3.7B). The ozone-induced up-regulation of Cxcl2 was significantly decreased only by 
PROP and PROP+MIFE pretreatments whereas MIFE alone did not have any effect (Fig. 3.7A). 
Ozone-induced upregulation of Mt2a, a free radical scavenger released in inflammatory 
conditions (Kurz et al., 1991), was significantly reduced by all drug pretreatments (Fig. 3.7B).  
The expression of the glucocorticoid responsive gene Tsc22d3 was also markedly increased 
after ozone exposure in all vehicle-pretreated rats. That ozone-induced increase was diminished 
by PROP, MIFE and PROP+MIFE (Fig. 3.7C). 
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Figure 3.6 
 
Figure 3.6 Ozone-induced changes in Tnf-α and Il6 lung mRNA and BALF proteins in rats 
pretreated with βAR and GR antagonists. Lung mRNA expression of Il6 (A) and Tnf (B) were 
determined in D+1 groups while BALF protein levels of IL-6 (C) and TNF-α (D) were assessed 
in D+2 groups.  Values indicate mean ± SE of n=6-8 animals/group. Significant differences 
between groups (P ≤ 0.05) are indicated by * for ozone effect in matching pretreatment groups, 
and by † for drug effect in matching exposure groups. 
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Figure 3.7 
 
Figure 3.7 The effect of drug pretreatments on ozone-induced increases in pulmonary 
Cxcl2, Mt2a and Tsc22d3 mRNA expression.  Relative lung mRNA expression was 
determined in D+1 groups for Cxcl2 (also known as Mip2; A), Mt2a (B) and Tsc22d3 (C). Values 
indicate mean ± SE of n=6-8 animals/group. Significant differences between groups (P ≤ 0.05) 
are indicated by * for ozone effect in matching pretreatment groups, and by † for drug effect in 
matching exposure groups. 
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3.4 Discussion 
In this study, we blocked the activity of stress hormone receptors βAR and GR, 
individually or together, to better understand and define the role of stress hormones in ozone-
induced pulmonary effects. The experimental design was developed to separately account for 
the effects likely to be mediated via epinephrine, corticosterone, or both, by pretreating rats with 
PROP, MIFE or PROP+MIFE, respectively (Fig. 3.8). We hypothesized that βAR and GR 
blockade would prevent ozone-mediated activation of downstream signaling events stimulated 
by increased circulating epinephrine and/or corticosterone and, as a result, the extent of ozone-
induced pulmonary effects. Since only PROP+MIFE but not other individual pretreatments 
reduced minute volume and PEF in ozone-exposed rats, the degree of ozone-induced lung 
edema or neutrophilic inflammation in the PROP and/or MIFE-pretreated rats were likely not 
influenced by the possibility of reduction in lung ozone dose. Nevertheless, PROP, MIFE or 
PROP+MIFE were sufficient to attenuate ozone-induced pulmonary protein leakage; however, 
only PROP and PROP+MIFE reduced ozone-induced lung neutrophilic inflammation, and pro-
inflammatory cytokine increases. On the other hand, only MIFE pretreatment reversed ozone-
induced lymphopenia and increases in BALF NAG activity which reflects macrophage activation 
(Fig. 3.8). These data suggest that PROP and MIFE have distinct roles in mediating 
inflammatory cell-specific responses induced by ozone. It is noteworthy that pretreatment of 
animals with PROP, MIFE or PROP+MIFE had very little if any pulmonary and systemic effect in 
air-exposed animals, highlighting the role of βAR and GR as specific modulators of ozone–
induced pulmonary vascular leakage and innate immune responses. Since βAR and GR have 
been widely manipulated in therapeutics, those receiving βAR and GR-related treatments might 
have altered susceptibility to high levels of ozone or other pulmonary irritants.  
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Figure 3.8 
 
 
Figure 3.8 Proposed mechanism by which βAR and GR antagonists reduce ozone-
induced pulmonary protein leakage, cytokine expression, neutrophilic inflammation and 
lymphopenia. This schematic is based on our earlier studies that ozone-induced lung injury 
and inflammation are mediated through neuroendocrine activation of stress response and 
involves the release of adrenal-derived stress hormones, epinephrine and corticosterone 
(Kodavanti, 2016). Ozone-induced effects are inhibited by pretreatment of rats with PROP 
and/or MIFE. 
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We selected PROP and MIFE to evaluate the role of βAR and GR activation in ozone-
induced pulmonary injury/inflammation since these drugs are clinically used and have been 
validated for their desired effects (Alamo et al., 2017; Kubo et al., 2004). PROP, a non-selective 
βAR antagonist, blocks activity of both β1 and β2AR. Although epinephrine is a potent agonist of 
virtually all AR (Morgan and Laufgraben, 2013), in this study we focused only on the role of βAR 
activity since these receptors are enriched in cardiopulmonary tissues and have a major role in 
autonomic regulation and innate immune homeostatic balance (Bible et al., 2015; Folwarczna et 
al., 2011; Hegstrand and Eichelman, 1983; Kolmus et al., 2015; Sato et al., 2010).  MIFE, a GR 
antagonist, has been widely used to antagonize the GR in psychiatric disorders (Howland et al., 
2013) and adrenal hyper-production of cortisol (Morgan and Laufgraben, 2013). Several 
experimental studies have validated its anti-GR activity in animal models (Navarro-Zaragoza et 
al., 2017; Sharrett-Field et al., 2013; Wang et al., 2014). 
When examining the effects of PROP and MIFE pretreatment, it is critical to determine if 
the observed ozone effects are influenced by the change in its effective lung dose. We have 
done whole body plethysmography in several of our studies to determine the likely change in 
ozone dosimetry (Dye et al., 2015b; Snow et al., 2016). It is noteworthy that no drug 
pretreatments affected ventilatory parameters in air-exposed rats. As we have observed in 
previous studies (Dye et al., 2015b), all ozone-exposed rats regardless of drug pretreatment 
demonstrated increases in PenH and PEF, measures of labored breathing, but had no effect on 
minute volume, except for a small decrease only in PROP+MIFE rats. Since the manipulation of 
both AR and GR has been shown to change breathing parameters in humans (Antonelli-Incalzi 
and Pedone, 2007; Hirst and Lee, 1998), the observed small changes in MV only in 
PROP+MIFE group may be due to the combined βAR+GR blockade. Since only this group, but 
not PROP or MIFE alone, showed a slight reduction minute volume after ozone exposure, it is 
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not likely that the lung injury and inflammation changes are impacted by the differential ozone 
dose with different pretreatments.  
There are a number of potential mechanisms by which lung vascular permeability might 
be increased by ozone. An imbalance between peripheral sympathetic influence due to 
increased epinephrine and acute dominance of parasympathetic influence on the heart can shift 
the blood flow from high resistant peripheral vasculature to low resistant pulmonary vasculature, 
leading to pulmonary microvascular leakage (Li and Pauluhn, 2017). Our previous work has 
shown that ozone increases circulating epinephrine with no change in norepinephrine (Miller et 
al., 2015, 2016b). Thus, lung permeability changes are likely influenced by epinephrine’s effect 
on 2AR, which caused dilation of pulmonary vasculature, an effect that could be prevented by 
PROP antagonism of these receptors (Pourageaud et al., 2005). Since PROP and MIFE, each 
prevented ozone-induced lung microvascular leakage, it is possible that AR and GR effects are 
inter-related and/or centrally-mediated. Both drugs are known to cross the blood brain barrier 
and regulate expression of stress responses through their effects on the hypothalamus (Check 
et al., 2014; Neil-Dwyer et al., 1981). Interestingly, GR activation can also mediate effects of 
norepinephrine to regulate blood pressure (Shi et al., 2016).  
Ozone-induced innate inflammatory responses in the lung involve neutrophil 
extravasation through enhanced trans-endothelial migration (Krishna et al., 1997). 
Catecholamines and glucocorticoids, which are increased by ozone inhalation (Bass et al., 
2013; Miller et al., 2015; Miller et al., 2016a, 2016b) play a central role in initiating a dynamic 
process of egress of innate immune cells from their site of depot to the circulation and then 
migration to the site of inflammation, in this case the lung. It has been shown that increased 
circulating epinephrine and corticosterone can induce the innate neutrophil immune response 
(Dhabhar et al., 2012). We have shown that increases in pulmonary neutrophil extravasation is 
associated with ozone-induced increases in stress hormones and that adrenal demedullation 
and/or total adrenalectomy diminishes this inflammatory effect of ozone (Miller et al., 2016b). 
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Here we observed that inhibiting βAR with PROP and both βAR+GR with PROP+MIFE, 
mimicking systemic impacts of adrenal demedullation and total adrenalectomy, respectively, 
nearly inhibited neutrophil increases in the lung in its entirety. However, inhibition of only GR 
using MIFE was ineffective in reversing lung neutrophilic inflammation, suggesting that βAR 
activation might be central in neutrophil extravasation to the lung after ozone exposure. This is 
further supported by studies demonstrating that PROP pretreatment prevents cigarette smoke-
induced lung damage (Zhou et al., 2014), and improves survival in a sepsis model (Wilson et 
al., 2013).  
The effects of AR and GR manipulation on ozone-induced responses are immune cell 
specific. The lack of ozone-induced lymphopenia in MIFE- but not PROP-pretreated rats 
highlights the role of GR in modulating the migration, redistribution and proliferation of lymphoid 
cells in the circulation (Dhabhar et al., 2012). This effect of MIFE was not recapitulated in the 
number of BALF lymphocytes, suggesting that ozone-induced changes in circulating 
lymphocytes are likely influenced by GR-mediated egress from their storage site but not 
extravasation into the lung. The acute stress response fine-tunes immune function depending 
on the timing and magnitude of the stressor by enhancing innate and adaptive immune 
responses (Dhabhar, 2014). MIFE pretreatment has been shown to reestablish lymphocyte 
mediated immune responses in immunosuppressed mice (Rearte et al., 2010). Further, a MIFE-
mediated reduction in glucocorticoid-induced lymphocyte apoptosis may also explain these 
results (Smith and Cidlowski, 2010) since glucocorticoids inhibit the release of lymphocytes into 
the circulation and induce apoptosis (Baschant and Tuckermann 2010; Laakko and Fraker 
2002; Viegas et al., 2008).  
A marked inhibition of ozone-induced increase in BALF NAG activity by MIFE might 
indicate a role for GR in modulating the macrophage response. It is possible that the initiation of 
a stress response by epinephrine might modulate the lung innate immune response and 
subsequent systemic corticosterone immune effects (Johnson et al., 2005; Vida et al., 2004; 
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Zhou et al., 2014). This assumption is supported by the observation that PROP markedly 
diminished ozone-induced inflammatory cytokine increases and neutrophilic inflammation in the 
lung, supporting a major contribution of βAR in local pulmonary modulation of the immune 
responses. Although the activation of the sympathetic arm of the stress axis (epinephrine and 
norepinephrine) has been shown to inhibit innate immune responses in humans (Kox et al., 
2014), it is known that β2AR, which are abundant in the lung, can modulate nuclear factor 
kappa-beta-mediated inflammatory processes. Previous studies have shown that PROP 
blocked the stress-induced elevation of circulating IL-6 levels (van Gool et al., 1990) and 
reduced air pollution-induced increases in IL-6 in mice (Chiarella et al., 2014).  
Mt2a, known to be upregulated by ozone (Inoue et al., 2008), was also increased in 
vehicle-pretreated rats exposed to ozone, however, this effect was markedly reduced by both 
PROP and MIFE, suggesting that the neuroendocrine response is linked to ozone-induced 
acute phase protein expression. In humans, Mt2a gene transcription is activated by GR 
activation (Sato et al., 2013) and in a murine restrained stress model, Mt2a expression 
correlated with increased corticosterone levels (Jacob et al., 1999). This observation is in 
agreement with previous work from our lab showing that the removal of adrenal glands – which 
is the source of both epinephrine and corticosterone – reduced the ozone-induced up-regulation 
of Mt2a and many other acute phase response genes (Henriquez et al., 2017a). The increased 
expression of the glucocorticoid-responsive gene Tsc22d3 after ozone exposure supports the 
corticosterone-mediated activation of GR in the lungs. 
In conclusion, by blocking βAR and GR activity using PROP and MIFE pretreatments, 
respectively, we selectively minimized ozone-induced lung protein leakage, macrophage 
activation, neutrophilic inflammation, lymphopenia, and pulmonary inflammatory cytokine 
expression in rats (Fig. 3.8). These findings increase the plausibility of a significant mechanistic 
role for circulating stress hormones and downstream effects of βAR and GR activation in most 
pulmonary effects of ozone. Moreover, since βAR and GR agonists are commonly used in the 
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treatment of chronic inflammatory conditions of the lung, including asthma and chronic 
obstructive pulmonary disease, those receiving such treatments may show differential 
susceptibility to air pollution-induced lung effects. βAR and GR antagonists, may reduce lung 
effects induced by ozone and other air pollutants. 
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CHAPTER 4: BETA-2 ADRENERGIC AND GLUCOCORTICOID RECEPTOR AGONISTS 
MODULATE OZONE-INDUCED PULMONARY PROTEIN LEAKAGE AND INFLAMMATION 
IN HEALTHY AND ADRENALECTOMIZED RATS 
 
4.1 Introduction 
Neuroendocrine stress responses involving activation of the sympathetic-adrenal-
medullary (SAM) and hypothalamus-pituitary-adrenal (HPA) axes have been linked to 
development of asthma (Douwes et al., 2011), chronic cardiovascular diseases (An et al., 
2016), obesity (Hewagalamulage et al., 2016, Hirotsu et al., 2015), and diabetes (Joseph and 
Golden, 2017). Furthermore, maternal stress during pregnancy has been postulated to increase 
risk of developing childhood asthma and later life chronic obstructive pulmonary disease 
(COPD) through reprograming of the HPA stress axis (Rosa et al., 2017). Furthermore, 
exposure to elevated levels of air pollution has been associated with increased asthma and 
COPD symptomatology, especially in individuals living in disadvantaged communities with 
additional exposure to psychosocial stressors (Clougherty and Kubzansky, 2008; Clark et al., 
2015; Shmool et al., 2014; Wright, 2011).  Relatedly, activation of these SAM- and HPA-
mediated stress responses leads to increase the systemic release of epinephrine and 
corticosterone/cortisol, respectively, from adrenal glands, which in turn, produce tissue-specific 
homeostatic changes in metabolic and immune processes associated with the fight-or-flight 
response (Gorman, 2013).  
We have previously shown that exposure to the reactive air pollutants, such as ozone or 
acrolein not only caused respiratory injury and inflammation, but exposure led to also activation 
of these neuroendocrine stress pathways in both healthy and diabetic rat models (Bass et al., 
2013; Miller et al., 2015; Snow et al., 2017) and in humans (Miller et al., 2016a). We have also 
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shown that ozone exposure increased circulating epinephrine and corticosterone and produced 
metabolic alterations similar to a fight-or-flight response (Bass et al., 2013; Miller et al., 2015, 
2016a, Snow et al., 2017). While ozone inhalation has been shown to activate sensory vagal C-
fibers in the lung (Taylor-Clark et al., 2011), stress responsive regions in the central nervous 
system (Gackière et al., 2011), autonomic reflex mechanisms (Gordon et al., 2014), and also 
the release of adrenocorticotrophic hormone (Thomson et al., 2013), the precise mechanisms 
by which ozone inhalation activates the SAM and HPA axes are not known. 
Once released to the circulation, epinephrine and corticosterone exert their tissue effects 
through adrenergic and glucocorticoid receptors. Adrenergic receptors (AR) are G-protein 
coupled receptors involved in a variety of cellular processes induced during a fight-or-flight 
stress response (Tank and Lee Wong, 2015; Ghanemi and Hu, 2015). There are two distinct 
classes of AR α and β and these subtypes are widely distributed in all organs and associated 
vessels, and αAR and βAR are activated by circulating epinephrine and nor-epinephrine with 
different affinities such that a wide array of changes are produced in tissues upon their 
activation (Daly and McGrath, 2011). Circulating corticosterone exerts its cellular effects by 
binding to glucocorticoid receptors (GR). GR are also distributed in virtually all tissues and cells 
in the body, and are involved in maintaining homeostasis of metabolic and immune processes 
(Oakley and Cidlowski, 2011). Activation of GR by glucocorticoids leads to immunosuppression 
through transcriptional repression of proinflammatory genes (De Bosscher et al., 2000). Hence, 
AR and GR are often the target of a variety of pharmacological agonists and antagonists used 
to treat functional abnormalities associated with cardiovascular and pulmonary diseases and 
associated inflammatory conditions. 
We have recently demonstrated that adrenalectomy, which diminishes circulating 
epinephrine and corticosterone in rats, diminished ozone-induced metabolic changes and also 
lung injury, protein leakage and inflammation (Miller et al., 2016b; Henriquez et al., 2017a), 
suggesting a proinflammatory role of endogenously released epinephrine and corticosterone. 
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Although glucocorticoids have been shown to suppress immune response and inhibit 
lymphocyte function in rats, the proinflammatory effect of newly released epinephrine and 
corticosterone has also been reported after an acute restraint stress (Dhabhar et al., 2012) and 
after a treatment with exogenous epinephrine and glucocorticoids (Dhabhar et al., 2014). 
However, it is not well understood whether these stress hormones are involved in altered innate 
immune responses after ozone inhalation exposure and, if so, which pathways or potential 
mechanisms are mediating their effects on the inflammation induced by ozone exposure.  
β Adrenergic receptors (βAR) are widely distributed in the lung. Of those ~70% are of β2-
type (β2AR) while 30 % are β1AR which are primarily activated by nor-epinephrine (Barns, 
2004). β 2AR are the predominantly distributed in the airway and vascular smooth muscle, and 
also the epithelial cells. These receptors are activated by epinephrine to cause vasoconstriction 
and bronchial relaxation. Increased activity of these receptors has been linked to 
bronchodilation and reduction in vascular permeability (Barnes, 2004). A variety of β 2AR 
agonists have been developed for use as therapeutic agents to achieve bronchodilation in 
asthma and COPD (Rassler, 2013). Likewise, GR are also widely distributed in the lung tissues, 
and steroid agonists are the primary therapeutic agents used for inhibition of the chronic lung 
inflammation present these pulmonary diseases (Barnes, 2017). In many instances, a 
combination of β2AR and GR agonists are used to reverse and suppress airway 
bronchoconstriction and inflammation present in asthma and COPD (Cain and Cidlowski, 2015; 
Waldeck 2002). Therefore, herein we hypothesized that combined treatment of rats with 
agonists of β2AR, clenbuterol (CLEN) plus GR, dexamethasone (DEX), would exacerbate 
resultant ozone-induced vascular leakage and inflammation in controls (previously undergone a 
sham surgical procedure; SH), and conversely, in adrenalectomized (AD) rats, these drugs 
would restore ozone effects back to that observed in ozone-exposed SH rats with intact SAM 
and HPA axes.  
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4.2 Materials and Methods 
4.2.1 Animals 
Male, 11-12 week old Wistar Kyoto (WKY) rats, purchased from Charles River 
Laboratory (Raleigh, NC), were pair-housed in polycarbonate cages with beta chip bedding 
under controlled conditions (50-65% Relative Humidity [RH], 21°C and 12 hr light/dark cycle) in 
our animal facility approved by the Association for Assessment and Accreditation of Laboratory 
Animal Care (AAALAC). Water and food (5001 Purina rat chow; Brentwood, MO) were provided 
ad libitum except where indicated. All animal procedures were approved by the US 
Environmental Protection Agency (US EPA), National Health and Environmental Effects 
Research Laboratory (NHEERL) Animal Care and Use Committee prior to the start of the 
experiment.  
4.2.2 Animal surgeries and drug treatments 
At 12-13 weeks of age, rats underwent either total bilateral adrenalectomy (AD) or 
control sham (SH) surgeries as previously described (Miller et al., 2016b).  Briefly, the rats were 
anesthetized by i.p. injection of ketamine (25-50 mg/kg/ml in saline). Once under anesthesia, 
buprenophrine was injected (0.02 mg/kg/ml in saline; s.c.) for analgesia. During the surgery, 
additional anesthesia was induced by inhalation of vaporized isoflurane (≈3%) in a nose-only 
cone as needed. Veterinarians from Charles River Laboratories Inc. performed surgeries under 
aseptic conditions. Animals were placed in sternal recumbency. Surgeries were performed 
using protocols established at Charles River Inc. Except for the removal of adrenal glands, SH 
surgeries involved similar anesthesia and surgical approaches as AD. The recovery was 
assured by the observation of animal’s movement while on heating pads.  Once awake, animals 
were treated with Meloxicam (0.2 mg/mL/kg; s.c.) for analgesia. Additional analgesia was 
provided by administering buprenorphine (0.02 mg/mL/kg, s.c.) every 8-12 hr for 2 times.  Half 
of the rats (D+2 groups as indicated below) were injected with temperature sensitive 
transponders s.c. over the dorsal abdominal surface to allow measurement of body temperature 
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(BDMS, Seaford, DE). SH rats received normal tap water for drinking while AD rats were 
provided saline (0.9% sodium chloride) after the surgery to maintain adequate fluid and 
electrolyte balance. Following surgery, the animals were pair housed with Enviro Dry 
enrichment/nesting material, provided with powdered as well as pelleted food, and allowed to 
recover for 4-6 days prior to any drug treatment related to this study. This approach was based 
on a number of adrenalectomy studies that used/recommended a 4-6 day recovery period to 
avoid secondary changes in the body occurring as a result of AD (Nicolaides et al., 2013; 
Sakakibara et al., 2014; Miller et al. 2016b). 
SH and AD rats were randomized by body weight into four treatment groups (vehicle:air, 
vehicle:ozone, CLEN+DEX:air and CLEN+DEX:ozone) over two time periods (1-day [D+1] or 2-
day [D+2] exposures).  This resulted in 8 total groups with 8 rats/group. Vehicle or drug 
treatments began one day prior to first air or 0.8 ppm ozone exposure (4 hr/day for 1 or 2 
consecutive days). Vehicle and drug treatments were administered each day just prior to 
inhalation exposures. Vehicle injections were comprised of saline (1 mL/kg, i.p.) followed by 
pharmaceutical grade corn oil (1 mL/kg, s.c.). Drug treatments included clenbuterol 
hydrochloride, a long acting β2AR agonist (CLEN; 0.2 mg/mL saline/kg, i.p.) and a GR agonist, 
dexamethasone (DEX; 2 mg/mL corn oil/kg, s.c.). Since we were attempting to restore both the 
basal levels that were completely depleted by AD procedure and provide the increased levels 
observed during ozone-exposure in non-AD rats, these relatively high doses were selected. 
Notably, however, the doses are several fold higher than that used therapeutically. 
Nevertheless, these CLEN and DEX concentrations are within the range used in other 
laboratory rodent studies for the purpose of inducing bronchodilation and immunosuppression, 
respectively. The general experimental design is showed in Fig. 4.1. 
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Figure 4.1 
 
Figure 4.1 Experimental design and time-line. The timing for surgery, drug treatments, 
exposures, whole body plethysmography (WBP), and necropsies are indicated by arrows. 
Animals assigned to 1-day or 2-day air or ozone exposure (4 hr/day) are referred to as groups 
D+1 and D+2, respectively. Animals belonging to D+2 groups were subjected to WBP 
immediately after the first and second day of exposure. Necropsy and tissue collection were 
performed immediately after exposure on D+1 groups (within 2 hours) or immediately after 
exposure and WBP for D+2 groups (within 2.5 hours). SH, sham surgery; AD, adrenalectomy; 
SAL, saline; CO, corn oil; CLEN, clenbuterol; DEX, dexamethasone. 
D-7
Surgery recovery period (4-6 Days)
D-1 D+1 D+2
Exposure, air or 0.8 
ppm ozone, 4 hr/day, 
7-11 AM
Whole body plethysmography
Surgeries (7AM-12PM) 
SHAM (SH)
Adrenalectomy (AD)
Necropsy (D+1)
-Tissue collection
Necropsy (D+2)
-Tissue collection
Group D+1 
(n=8/group)
Group D+2
(n=8/group)
Day
Drug treatment (6-7 AM)
Vehicles:(saline + corn oil, SAL+CO)
Drugs: (clenbuterol + dexamethasone, 
CLEN+DEX)
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4.2.3 Ozone exposure 
Ozone was generated using a silent arc discharge generator (OREC, Phoenix, AZ) from 
oxygen and transported to Rochester style “Hinners” chambers using mass flow controllers 
(Coastal Instruments Inc., Burgaw, NC). Ozone concentration was controlled and recorded by 
photometric analyzers (API Model 400, Teledyne, San Diego, CA). Mean chamber temperature, 
humidity and air flow were recorded hourly (control chamber: 71.05±0.32 oF, 54.08±0.67 and 
256.1±0.57 liters/min; ozone chamber: 73.10±0.14 oF, 50.40±0.44 and 261.2±0.43 liters/min, 
respectively). Rats were exposed to air or 0.8 ppm ozone, 4 hr/day for either 1 day (D+1) or 2 
consecutive days (D+2). The actual daily mean chamber concentration of ozone was 
0.800±0.04 ppm (mean ± SD). 
4.2.4 In life assessment 
Body weights were measured prior to and daily after the surgery for all rats, including 
each day post exposure. Subcutaneous temperature was assessed immediately before and 
after each ozone exposure in the D+2 groups (n=4/group). Whole body plethysmography (WBP) 
was performed immediately following each day of exposure in the D+2 groups to detect altered 
in tidal breathing patterns (n=8/group). Rats were acclimated to the WPB chambers for two days 
prior to the first ozone exposure. Immediately post-exposure to air or ozone, on a rotational 
basis, rats were placed in rat-sized WBP chambers and, after a 2 min acclimation period, 
ventilatory parameters were recorded for an additional 5 minutes. Measurements were 
averaged every 10 seconds for the 5 min period using EMKA iox 2 software (SCIREQ, 
Montreal, Canada). All traces were visually inspected to ensure that valid breath patterns were 
not excluded. Ventilatory parameters obtained included: breathing frequency, tidal volume, 
minute volume, peak inspiratory flow (PIF), peak expiratory flow (PEF), inspiratory time (Ti), 
expiratory time (Te), relaxation time (RT) and enhanced pause (PenH).  
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4.2.5 Necropsy, blood collection, complete blood counts and assessment of circulating stress 
hormones 
An overdose of fatal plus (sodium pentobarbital, Virbac AH, Inc., Fort Worth, TX; >200 
mg/kg, i.p.) was used to euthanize rats. For D+1 groups, rats were necropsied immediately 
(within 1-2 hr) after their first exposure while for D+2 groups, rats were necropsied after their 
second exposure and WBP data acquisition (within 1.5-2.5 hr). Blood samples from the 
abdominal aorta were collected in vaccutainers tubes. Complete blood counts were performed 
using EDTA blood samples on a Beckman-Coulter AcT blood analyzer (Beckman-Coulter Inc., 
Fullerton, CA), which provides a relative measure of total white blood cells (WBC) and 
lymphocytes. Blood smears were also obtained and then stained with Diff-quick to enumerate 
relative neutrophil and monocyte numbers. The remaining EDTA blood samples were 
centrifuged at 3500 × g for 10 min and resulting plasma samples were stored at -80°C until 
analysis. Serum was collected after centrifugation of blood samples collected in serum 
separator tubes at 3500 × g for 10 min and stored at −80°C until use. Epinephrine levels in 
plasma samples were quantified using a kit obtained from Rocky Mountain Diagnostics following 
the manufacturer’s protocol (Colorado Springs, CO). Corticosterone levels were quantified in 
serum employing an immunoassay kit and following manufacturer’s directions (Arbor Assays, 
Ann Arbor, MI).  
4.2.6 Bronchoalveolar lavage and cell counts 
Bronchoalveolar lavage fluid (BALF) was collected by cannulating the trachea. The left 
lung was tied and the right lung was lavaged 3 times using the same aliquot of Ca2+ and Mg2+ 
free PBS, pH 7.4, 37°C, at 28 mL/kg body weight for total lung capacity with the right lung 
weight being 60% of the total lung weight.  Whole BALF was diluted to 10 mL using isotone and 
spiked with 0.2 mL saponin to lyse cells. Nucleated cells were counted using a Z1 Coulter 
Counter (Coulter Inc., Miami, FL). Whole BALF was also used to prepare cytospin slides, which 
were stained with Diff-quick and cell differentials were determined under light microscopy (300 
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cells/slide, one slide/ animal). The remaining BALF samples were centrifuged (1500 x g for 5 
min) and cell free BALF aliquots were analyzed for lung injury markers. The lavaged caudal lobe 
from the right lung was removed, blotted, frozen in liquid nitrogen and stored at -80oC for RNA 
extraction. We have previously noted that ~10% of male WKY rats exhibit spontaneous cardiac 
hypertrophy and associated pulmonary complications (Shannahan et al., 2010). The data 
obtained from those with cardiac hypertrophy (i.e. heart weights 20% above average at 
necropsy) were removed from further analysis to minimize the occurrence of underlying cardiac 
confounders that would impact the endpoints of interest.  
4.2.7 Assessment of BALF protein leakage markers, inflammatory cytokines 
BALF total protein was assessed using Coomassie Plus Protein Reagent from Thermo 
Fisher Diagnostics (Rockford, IL) and albumin standards from Sigma-Aldrich (St. Louis, MO). 
BALF albumin levels were determined using a kit from Sekisui Diagnostics (Lexington, MA) 
while N-acetylglucosaminidase (NAG) activity was assessed using reagents and controls from 
Sigma-Aldrich Diagnostics (St. Louis, MO).  These assays were modified for use on the Konelab 
Arena 30 clinical analyzer (Thermo Chemical Lab Systems, Espoo, Finland). Cell free BALF 
samples were used to quantify cytokine proteins using the V-PLEX proinflammatory panel 2 
(rat) kit following the manufacturer’s protocol (Meso Scale Discovery, Gaithersburg, MD). The 
electrochemiluminescence signals for each protein were detected using Meso Scale Discovery® 
platform (Mesoscale Discovery Inc., Rockville, MD). For some cytokines, the BALF levels in 
control animals were below the limit of detection. Those values were imputed with the lowest 
quantified value for a given cytokine. 
4.2.8 Flow cytometry of WBC 
For flow cytometry analyses of blood samples, the general procedures were performed 
following previously published methods (DeWitt et al., 2015). Briefly, fresh aortic blood samples 
collected in EDTA blood tubes from the D+1 animals were treated with RBC lysis buffer 
(Affymetrix eBioscience, Santa Clara, CA) and then washed twice with HBSS without Ca2+ and 
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Mg2+ (Thermo Fisher, Waltham, MA). The cells were suspended in staining buffer containing 
HBSS with 1% bovine serum albumin (BSA) and 0.1% sodium azide (Sigma-Aldrich, St. Louis, 
MO). WBC concentrations were determined using a Z1 Coulter Counter (Coulter, Inc., Miami, 
FL) and adjusted to 1 x 106 cells/ml. Cells were washed once with PBS and incubated for 30 
min at room temperature with LIVE/DEADTM fixable violet dead cell stain (Thermo Fisher, 
Waltham, MA) to determine viable cells. After incubation, cells were washed three times with 
staining buffer and then incubated with mouse anti-rat CD32 (BD Pharmingen, San Jose, CA) to 
block FC receptor-mediated nonspecific antibody binding as per manufacturer’s instructions. 
Cells were then washed three times with staining buffer and labeled for 30 min with the following 
monoclonal antibodies: APC-Cy7 mouse anti-rat CD45, PE mouse anti-rat RP1, PE-Cy7 mouse 
anti-rat CD4, FITC mouse anti-rat CD8a (BD Pharmingen, San Jose, CA). Cells labeled with 
fluorochrome-conjugated isotype control antibodies (APC-Cy7 mouse anti-rat IgG,ĸ; PE mouse 
anti-rat IgG2a,ĸ; PE-Cy7 mouse anti-rat IgG2a,ĸ; FITC mouse anti-rat IgG1 (BD Pharmingen, 
San Jose, CA)) were used as negative controls. Additional cell samples, including unstained 
cells and fluorescence minus one (FMO) controls were utilized to aid in identifying and ensuring 
accurate gating of negative and positive cell populations. After staining, cells were washed three 
times with staining buffer, fixed with 0.05% formaldehyde in PBS and kept in the dark at 4oC (no 
longer than one day) until FACS analysis. Data were collected on a LSR II flow cytometer (BD 
Biosciences, Mississauga, Canada) using FACS Diva software (BD Biosciences, Mississauga, 
Canada). The quantification of the data was performed using FlowJo software (TreeStar, Inc., 
Ashland, OR). Live cells were gated based on CD45 expression for the analysis of 
subpopulations CD4-/CD8a-, CD4-/CD8a+, CD4+/CD8a-, CD4+/CD8a+, and RP1+. Due to the low 
number of leukocytes available, a minimum of 1000 events per sample were counted. 
4.2.9 Lung RNA isolation and real time-quantitative PCR  
An uniform portion of frozen caudal lung lobe was separated and weighed (20-30 mg) for 
RNA extraction using the RNeasy mini kit (Qiagen, Valencia, CA). RNA was quantified using 
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Qubit 2.0 fluorimeter (Thermo Fisher, Waltham, MA). Qscript cDNA Supermix (Quanta 
Biosciences, Beverly, MA) was used to synthesize cDNA by reverse transcription. Primers were 
designed using Rattus Norvegicus sequences annotated using NCBI and obtained from 
Integrated DNA Technologies, Inc. (Coralville, IA; Table 4.1). SYBR® Green PCR Master Mix 
(Thermo Fisher, Waltham, MA) was used to perform quantitative PCR using the Applied 
Biosystems 7900HT Sequence Detection System (Foster City, CA). mRNA expression was 
expressed in relative units employing the ΔΔCt method using β-actin as the housekeeping gene 
and the vehicle-air treated SH group as control. The determination of relative lung mRNA 
expression was restricted to D+1 groups since ozone-induced changes in RNA expression peak 
rapidly one day after ozone exposure (Kodavanti et al., 2015; Hollingsworth et al., 2007). Il6, 
Tnf, Cxcl2 and Il4 were selected as pro-inflammatory endpoints, which have shown consistent 
up-regulation after ozone exposure in previous publications (Henriquez et al., 2017a). Mt2a was 
selected as a marker of oxidative stress, which consistently increases after ozone exposure in 
the lungs (Inoue et al., 2008). Furthermore, expression of Tsc22d3, also known as Gilz a 
validated glucocorticoid responsive gene (Pepin et al., 2015) and Adrb2, the gene coding for 
β2AR, were measured to evaluate the role of our exposures and treatments on the lungs. 
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Table 4.1 
 
Table 4.1 Forward and reverse primer sequences designed for each gene used in PCR. 
 
 
 
 
 
 
 
 
          
  
Gene Forward Reverse 
  
  
β-Actin (Actb) 5'-CAACTGGGACGATATGGAGAAG-3' 5'-GTTGGCCTTAGGGTTCAGAG-3' 
  
  
Tumor necrosis factor 
 (Tnf) 
5'-ACCTTATCTACTCCCAGGTTCT-3' 5'-GGCTGACTTTCTCCTGGTATG-3' 
  
  
Interleukin 6 (Il6) 5'-CTTCACAAGTCGGAGGCTTAAT-3' 5'-GCATCATCGCTGTTCATACAATC-3' 
  
  
Interleukin 4 (Il4) 5'-GTCACCCTGTTCTGCTTTCT-3' 5'-GACCTGGTTCAAAGTGTTGATG-3' 
  
  
Chemokine (C-X-C 
motif)- 
ligand 2 (Cxcl2 or Mip2) 
5'-GCCTCGCTGTCTGAGTTTAT-3' 5'-GAGCTGGCCAATGCATATCT-3' 
  
  
Metallothionein-2 (Mt2a) 5'-CAGCGATCTCTCGTTGATCTC-3' 5'-GGAGGTGCATTTGCATTGTT-3' 
  
  
TSC22 domain family  
protein 3 (Tsc22d3 or 
Gilz)  
5'-CCGAATCATGAACACCGAAATG-3' 5'-GCAGAGAAGAGAAGAAGGAGATG-3' 
  
  
Beta-2 adrenergic  
receptor (Adrb2) 
5'-CTCCTTAACTGGTTGGGCTATG-3' 5'-CCTGGAAGGCAATCCTGAAA-3' 
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4.2.10 Statistics 
For each endpoint, data were log transformed when normal distribution and 
homoscedasticity were not satisfied using Shapiro-Wilk and Levene’s tests, respectively. Data 
were analyzed using a two-way analysis of variance (ANOVA). The effects of adrenalectomy 
were determined by analyzing vehicles and CLEN+DEX treated groups separately using 
independent two-way ANOVAs while drug treatment effects were determined by analyzing SH 
and AD groups separately as independent factors using two-way ANOVA. This strategy was 
used separately for D+1 and D+2 experiments. Tukey’s test was used to correct for multiple 
comparisons. Significant differences were considered when p≤0.05. For all bar graphs, data 
(n=6-8 animals/group) are expressed as mean ± SEM. GraphPad prism 7.03 and Statext 2.7 
software were used for statistical analysis. For gene expression analysis, outliers were identified 
and discarded using the ROUT method (robust regression and outlier removal, Motulsky and 
Brown 2006) prior to statistical analysis. 
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4.3 Results 
4.3.1 Ozone exposure, adrenalectomy and CLEN+DEX treatments change body weight and 
subcutaneous temperature. 
To examine the general physiological effects of ozone exposure, AD and CLEN+DEX 
treatment, body weights and subcutaneous temperatures were monitored after each day of 
exposure in the D+2 groups. Although the changes in body weights were relatively small, all AD 
rats had reduced body weight gain after surgery relative to SH rats (up to 12% on D+2). Slight 
reductions were also noted in ozone-exposed rats after each day of exposure (up to 10% on 
D+2) and/or in CLEN+DEX-treated SH rats, with the greatest reduction occurring in ozone-
exposed CLEN+DEX-treated AD rats (up to 22% on D+2) (Fig. 4.2A).  
Acute ozone exposure has been shown to cause hypothermia in animals as determined 
by reduction in core body temperature (Gordon et al., 2015). We noted that subcutaneous 
temperature was reduced by approximately 3°C in all ozone-exposed SH and AD rats when 
determined immediately following exposure for both days. Neither AD nor CLEN+DEX treatment 
changed subcutaneous temperature in air-exposed rats or modified the ozone-related 
reductions in body temperature (Fig. 4.2B).  
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Figure 4.2 
 
   
Figure 4.2 Body weight and temperature changes induced by ozone exposure in vehicle- 
and CLEN+DEX-treated SH and AD rats. Body weights (A) of rats were recorded before 
surgery (D-1) and immediately after each day of exposure to air or ozone in the D+2 animals 
(n=8/group). Subcutaneous temperatures (B) were measured using a receiver which acquired 
signals through subcutaneously injected transponders immediately before and after each day 
exposure to air or ozone (0.8ppm) for the D+2 groups (n=4/group). Bar graphs show mean ± 
SEM. Significant differences between groups (p value ≤ 0.05) are indicated by * for ozone effect 
when compared to matching air-exposed rats, # for AD effect when compared to matching SH 
rats, and † for CLEN+DEX effect when compared to matching vehicle-treated rats.  
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4.3.2 Circulating stress hormones are changed after ozone exposure in SH and AD rats treated 
with vehicle and CLEN+DEX 
Based on the expected variability in levels of stress hormones due to several variable 
influencing their levels (precise time of blood collection, stress levels in animals during 
euthanasia injection), we have seen variable degree of response to ozone in our past studies in 
male WKY rats (Miller et al., 2015, Miller et al., 2016b; Miller et al., 2016c). In this study, 
although not significant, ozone exposure tended to increase circulating epinephrine levels at 
D+1 and D+2 (p=0.13, each day using single group comparison) in SH rats (Fig. 4.3A and B). 
The trend for ozone-induced increase circulating corticosterone on D+1 in vehicle-treated SH 
rats was not significant either (p=0.24 using single group comparison) (Fig. 4.3C). However, as 
expected, AD essentially eliminated detectable plasma epinephrine and corticosterone levels 
D+1 and D+2 regardless of exposure and drug treatment (Fig. 4.3). CLEN+DEX treatment by 
itself markedly reduced circulating corticosterone in SH rats (Fig. 4.3C and D) whereas 
CLEN+DEX treatment had no influence on epinephrine levels regardless of the day of exposure 
(Fig. 4.3A and B).  
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Figure 4.3 
 
 
Figure 4.3 Ozone-induced changes in circulating stress hormones in vehicle- and 
CLEN+DEX-treated SH and AD rats.  Circulating stress hormones, epinephrine (A-B) and 
corticosterone (C-D), were measured in samples collected immediately after air or ozone 
(0.8ppm) exposure (4 hr/day) in D+1 and D+2 groups. Bar graphs show mean ± SEM of n=6-8 
/group. Significant differences between groups (p value ≤ 0.05) are indicated by * for ozone 
effect when compared to corresponding air-exposed rats, # for AD effect when compared to 
corresponding SH rats, and † for CLEN+DEX effect when compared to corresponding vehicle-
treated rats.  
D+1 D+2
A
C
SH / Air SH / Ozone
AD / Air AD / Ozone
D
B
107 
 
4.3.3 Ozone-induced changes in ventilatory parameters in SH and AD rats with and without 
CLEN+DEX treatment  
Examining first the ventilatory changes related to AD alone, we observed minor 
reductions (~20%) in breathing frequency (Fig. 4.4A) and corresponding increases in the 
success rate (% Sr) of acceptable breaths obtained during the 5-min. data acquisition period 
following D+1 air exposures (% Sr increased ~50%; data not shown). These changes are 
consistent with the generally sedate behavior of the AD rats in that they were less likely to 
engage in activities such as sniffing and grooming which typically reduce the relative number of 
acceptable breaths acquired. By comparison, the AD rats receiving CLEN+DEX failed to exhibit 
slowing of breathing frequency. These trends were likewise apparent following the D+2 air 
exposures. No other ventilatory changes were observed for the AD-only or AD rats treated with 
CLEN+DEX.  
Examining next the effects of ozone-exposure in SH (vehicle-treated) rats, we detected 
characteristic changes in spontaneous breathing patterns including: (1) intermittent slowing of 
the respiratory rate and (2) periods during which breaths had a shorter inspiratory time relative 
to expiratory time (e.g., reduced Ti/Te ratios). If exposure to an irritant gas like ozone results in 
development of bronchoconstriction, such alterations would allow disproportionately more time 
for exhalation of potentially trapped air within the deep lung. Limitations in airflow becomes 
increasingly problematic during expiration owing to dynamic narrowing of airway caliber as the 
lung size decreases. Other ventilatory changes observed in these rats included: (3) 
corresponding increases in peak expiratory flow rates (relative to inspiratory flow rates) (see 
PEF/PIF ratios) (Fig. 4.4G); (4) increases in pause [(Te-Rt) – 1] (Fig. 4.4I), and (5) 
corresponding increases in the product of the PEF/PIF ratio and pause, namely the so-called 
enhanced pause, or PenH parameter (Fig. 4.4K). Of note, all of these ozone-related ventilatory 
changes were further worsened in SH rats treated with CLEN-DEX (Fig. 4.4). More specifically, 
frequency and the Ti/Te ratio decreased significantly, whereas the PEF/PIF ratio, Pause and 
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PenH were significantly increased. However, as shown in the Fig. 4.4E insert of representative 
“breath traces” (i.e., WPB chamber flow rate fluctuations), we observed that in the SH ozone-
exposed rats receiving CLEN+DEX, the PEF/PIF ratios were increased in part due to higher 
PEF values, and in part due to truncated PIF values as these rats often exhibited a biphasic 
inspiration pattern, thus blunting their PIF values.  
Lastly, we compared the superimposed effects of ozone-exposure and CLEN+DEX 
treatment in the previously AD rats. These rats appeared to require higher breathing 
frequencies, longer Ti (to Te) ratios, but had equivalently increased PEF/PIF ratios, again in part 
due to a biphasic inspiration (data not shown). By D+2 of ozone and CLEN-DEX treatment, 
these rats showed significantly reduced Pause and corresponding PenH values. Results 
suggest a mixed ventilatory pattern of worsening inspiratory effects in combination with reduced 
airflow obstruction during exhalation.  
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Figure 4.4 
 
 
Figure 4.4 Ventilatory parameters in rats are modulated by ozone, AD and CLEN+DEX. 
Breathing frequency in breaths per minute (bpm; A-B), Ti/Te ratio (C-D), pause [ (Te/RT)-1] (E-
F), PEF/PIF (G-H), and PenH [(Te/RT)-1 x (PEF/PIF)] (I-J) were assessed immediately following 
air or ozone (0.8 ppm) exposure (4 hr/day) on both days for the D+2 groups. Bar graphs show 
mean ± SEM of n=6-8 /group. Significant differences between groups (p value ≤ 0.05) are 
indicated by * for ozone effect when compared to matching air-exposed rats, # for AD effect 
when compared to matching SH rats, and † for CLEN+DEX effect when compared to matching 
vehicle-treated rats.  
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4.3.4 Ozone-induced vascular leakage and macrophage activation are reduced by AD and 
exacerbated by CLEN+DEX treatment  
BALF protein and albumin were assessed to determine microvascular leakage in the 
lung. A slight increase in BALF protein was noted in air-exposed vehicle-treated AD rats on both 
days. In vehicle-treated SH rats, ozone exposure was associated with significant increases in 
BALF protein, which was progressive over two days. However, ozone-induced protein increase 
at D+2 was not evident in vehicle-treated AD rats (Fig. 4.5A and B). Regardless of the exposure 
or surgery status, CLEN+DEX treatment alone was associated with extensive protein leakage. 
Ozone exposure of CLEN+DEX-treated SH rats induced greater increases in BALF protein, at 
both D+1 and D+2. AD moderately reduced the ozone-induced increase of BALF protein in 
CLEN+DEX-treated rats at D+2 (Fig. 4.5A and B). Changes in BALF albumin generally followed 
a similar pattern of changes as BALF protein, except the increase in albumin was greatest in 
ozone-exposed AD rats treated with CLEN+DEX at D+2 (Fig. 4.5C and D). 
As we have noted in previous publications (Henriquez et al., 2017b), ozone exposure 
was also associated with BALF NAG activity increases in vehicle-treated SH rats at D+2. AD 
diminished this ozone effect at D+2 (Fig. 4.5F). Regardless of the exposure and surgery 
condition, CLEN+DEX treatment significantly increased BALF NAG activity at both time points. 
Ozone exposure further increased NAG activity in CLEN+DEX-treated rats at D+1 and D+2 
while AD blunted this ozone-induced response (Fig. 4.5E and F).     
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Figure 4.5 
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Figure 4.5 Ozone-induced pulmonary vascular leakage and macrophage activation are 
modulated by AD and CLEN+DEX. BALF protein (A-B), albumin (C-D), and NAG activity (E-F) 
were assessed in rats 1-2.5 hr following air or ozone (0.8 ppm) exposure (4 hr/day) for D+1 and 
D+2 groups. Bar graphs show mean ± SEM of n=6-8 /group. Significant differences between 
groups (p value ≤ 0.05) are indicated by * for ozone effect when compared to corresponding air-
exposed rats, # for AD effect when compared to corresponding SH rats, and † for CLEN+DEX 
effect when compared to corresponding vehicle-treated rats. 
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4.3.5 Ozone-induced pulmonary inflammation is reduced by AD and restored by CLEN+DEX 
Ozone exposure decreased BALF alveolar macrophages but AD reversed this effect in 
vehicle-treated SH rats at D+1 (Fig. 4.6A). CLEN+DEX pretreatment increased alveolar 
macrophages in ozone- but not air-exposed SH rats at both time points. This CLEN+DEX effect 
was significantly smaller in AD rats exposed to ozone relative to SH rats (Fig. 4.6A and B). 
Ozone exposure increased BALF neutrophils at D+2 in vehicle-treated SH rats. This ozone 
effect was diminished in vehicle-treated AD rats (Fig. 4.6D). Treatment with CLEN+DEX, in 
general, caused small increases in BALF neutrophils in air-exposed SH and AD rats at D+2, 
with the effect being exacerbated in ozone-exposed SH and AD rats at D+2 (AD>SH) (Fig. 4.6C 
and D). BALF lymphocytes were not impacted significantly by AD in vehicle-treated air- or 
ozone-exposed rats at any time point whereas CLEN+DEX pretreatment increased BALF 
lymphocytes in ozone-exposed SH and AD rats at D+2 (Fig. 4.6E and F).   AD increased BALF 
eosinophils in air- exposed vehicle-treated rats at both time points. Ozone led to increased 
eosinophils in vehicle-treated SH rats at D+2. CLEN+DEX treatment, in general, increased 
eosinophils in all rats; this effect was greatest in ozone-exposed SH rats at both times (Fig. 
4.6G and H).  
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Figure 4.6 
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Figure 4.6 Ozone-induced lung inflammation is modulated by AD and CLEN+DEX. BALF 
macrophages (A-B), neutrophils (C-D), lymphocytes (E-F), and eosinophils (G-H) were 
calculated based on cell differentials and total cell counts in rats 1-2.5 hr following air or ozone 
(0.8 ppm) exposure (4 hr/day) for D+1 and D+2 groups. Bar graphs show mean ± SEM of n=6-8 
/group. Significant differences between groups (p value ≤ 0.05) are indicated by * for ozone 
effect when compared to corresponding air-exposed rats, # for AD effect when compared to 
corresponding SH rats, and † for CLEN+DEX effect when compared to corresponding vehicle-
treated rats. 
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4.3.6 Ozone-induced reduction of circulating WBC and lymphocytes is modulated by AD and 
CLEN+DEX treatment  
In vehicle-treated SH rats, ozone exposure decreased circulating WBC at D+1; however, 
this ozone effect was not apparent in vehicle-treated AD rats. CLEN+DEX treatment tended to 
decrease WBC in all rats at D+1 with a maximum drop occurring in ozone-exposed AD rats (Fig. 
4.7A). This CLEN+DEX effect was not apparent on D+2 (Fig. 4.7B). A small drop in circulating 
lymphocytes was noted in air-exposed vehicle-treated AD rats at D+1. Ozone exposure in 
vehicle-treated SH rats markedly decreased circulating lymphocytes at D+1 and D+2. This 
ozone effect was not observed in vehicle-treated AD rats. CLEN+DEX treatment was 
associated with remarkable reduction of circulating lymphocytes in all animals regardless of 
surgery or exposure condition at both time points (Fig. 4.7C and D).  Circulating neutrophils 
were not affected by AD or ozone in vehicle-treated rats, however, CLEN+DEX caused 
significant increases in circulating neutrophils in all rats regardless of surgery or exposure (Fig. 
4.7E and F). 
In order to further examine the types of lymphocytes impacted by ozone and CLEN+DEX 
at the D+1 time point, subpopulations of lymphocytes were quantified as a percentage of total 
leukocytes (CD45+) and then normalized using total CD45+ leukocyte count. Generally, CD4-
CD8a- and CD4+CD8a- made up the substantial portion of WBC (60-95%, Fig. 4.8A and C). 
Ozone exposure, as noted above, decreased overall leukocyte counts (CD4-CD8a-), and tended 
to decrease all cells positive for lymphocyte markers such as CD4-CD8a+ (Fig. 4.8B), 
CD4+CD8a- (Fig. 4.8C), and CD4+CD8a+ (Fig. 4.8D) in vehicle-treated SH rats; however, this 
trend was not observed in AD rats. CLEN+DEX treatment significantly decreased all T-
lymphocyte subpopulations regardless of surgery or exposure status except for CD4-CD8- 
leukocytes (Fig. 4.8).  
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Figure 4.7 
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Figure 4.7 Ozone-induced changes in circulating WBC and lymphocytes are modulated 
by AD and CLEN+DEX. Circulating WBC (A-B), lymphocytes (C-D) and neutrophils (E-F) were 
assessed following air or ozone (0.8 ppm) exposure (4 hr/day) for D+1 and D+2 groups. Bar 
graphs show mean ± SEM of n=6-8 /group. Significant differences between groups (p value ≤ 
0.05) are indicated by * for ozone effect when compared to corresponding air-exposed rats, # 
for AD effect when compared to corresponding SH rats, and † for CLEN+DEX effect when 
compared to corresponding vehicle-treated rats. 
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Figure 4.8 
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Figure 4.8 Flow cytometry assessment of circulating leukocyte subpopulations after 
ozone exposure in SH and AD rats treated with vehicle or CLEN+DEX. Percentage of 
circulating leukocyte subpopulations CD4-CD8a- (A), CD4-CD8a+ (B), CD4+CD8a- (C), and 
CD4+CD8a+ (D) were determined following air or ozone (0.8 ppm) exposure (4 hr/day) for D+1 
groups. Cells positive for CD4-CD8a+, CD4+CD8a-, and CD4+CD8a+ were considered T-
lymphocyte subpopulations. Relative numbers were determined based on CD45+ cells (total 
leukocytes). Bar graphs show mean ± SEM of n=6-8 /group. Significant differences between 
groups (p value ≤ 0.05) are indicated by * for ozone effect when compared to corresponding air-
exposed rats, # for AD effect when compared to corresponding SH rats, and † for CLEN+DEX 
effect when compared to corresponding vehicle-treated rats. 
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4.3.7 Ozone-induced effects on BALF cytokines in SH and AD rats treated with vehicles or 
CLEN+DEX 
Proinflammatory cytokines were assessed to determine the role of AD and CLEN+DEX 
on ozone-mediated lung inflammation. BALF IL-6 levels were increased in all vehicle-treated SH 
and AD rats exposed to ozone relative to air at both time points. CLEN+DEX treatment resulted 
in highly exacerbated IL-6 increases in SH rats exposed to ozone at D+1 and D+2. This 
interactive effect of ozone and CLEN+DEX was less remarkable in AD rats (Fig. 4.9A and B). 
Ozone exposure increased BALF levels of TNF-α at D+1 in both SH and AD vehicle-treated 
rats. CLEN+DEX-treatment did not influence ozone-induced increases in BALF TNF-α at D+1.  
However, on D+2, CLEN+DEX treatment was associated with marked increases in BALF TNF-α 
in ozone-exposed rats regardless of surgery (Fig. 4.9C and D). BALF IL-4 levels were generally 
low in D+1 samples and below the detection limit in most D+2 samples with no apparent ozone 
effect in vehicle-treated rats. CLEN+DEX treatment increased IL-4 levels in ozone-exposed SH, 
but not AD rats, at D+1 (Fig. 4.9E and F). 
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Figure 4.9 
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Figure 4.9 Ozone-induced changes in BALF cytokine levels are influenced by AD and/or 
CLEN+DEX treatment.  BALF IL-6 (A-B), TNF-α (C-D) and IL-4 (E-F) proteins were quantified 
in samples collected 1-2.5 hr following air or ozone (0.8 ppm) exposure (4 hr/day) for D+1 and 
D+2 groups. Bar graphs show mean ± SEM of n=6-8 /group. Significant differences between 
groups (p value ≤ 0.05) are indicated by * for ozone effect when compared to corresponding air-
exposed rats, # for AD effect when compared to corresponding SH rats, and † for CLEN+DEX 
effect when compared to corresponding vehicle-treated rats. BLD: below the limit of detection. 
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4.3.8 Ozone-induced pulmonary cytokine mRNA changes in SH and AD rats treated with 
vehicle or CLEN+DEX  
Lung expression of genes involved in inflammatory processes, acute phase response 
and those responsive to AR and GR signaling was assessed in all samples from D+1 groups to 
determine if stress hormone receptors are involved in transcriptional regulation of genes known 
to be induced by ozone (Henriquez et al., 2017a). Changes in Il6 mRNA expression were similar 
to those observed for IL-6 BALF protein at D+1 and D+2. AD in vehicle-treated air-exposed rats 
increased lung Il6 expression. However, ozone exposure up-regulated Il6 expression only in 
vehicle-treated SH but not AD rats. CLEN+DEX treatment further exacerbated Il6 expression in 
ozone-exposed SH and AD rats (SH>AD; Fig. 4.10A). Even though BALF protein was 
increased, Tnf gene expression was not changed by ozone exposure or CLEN+DEX treatment 
in SH rats.  However, CLEN+DEX treatment down-regulated Tnf expression in both air- and 
ozone-exposed AD rats (Fig. 4.10B). Il4 expression tended to increase in vehicle-treated SH 
rats exposed to ozone but this effect was not evident in AD rats. CLEN+DEX treatment in SH 
but not AD rats increased Il4, especially in air-exposed SH rats (Fig. 4.10C). In vehicle-treated 
rats, Cxcl2 expression was up-regulated after ozone exposure and AD effectively inhibited this 
effect. CLEN+DEX treatment increased Cxcl2 expression in all rats exposed to air or ozone; 
however, these increases were smaller in AD rats relative to SH rats (Fig. 4.10D). Lung Mt2a 
(an acute phase response gene) expression in vehicle-treated rats followed a similar pattern of 
change as observed with Cxcl2 in regards to ozone and AD effects (Fig. 4.10E). CLEN+DEX in 
all animals increased Mt2a expression to approximately 50-200 fold 
(SH:ozone>SH:air>AD:ozone>AD:air). In SH vehicle-treated rats, ozone tended to increase 
Ardb2, the gene expressing the β2AR protein; however, its expression was decreased in all 
vehicle-treated AD rats. CLEN+DEX significantly induced Ardb2 expression in the air-exposed 
vehicle-treated rats while this effect was less pronounced in ozone-exposed SH rats and air- or 
ozone-exposed AD rats (Fig. 4.10F). Expression of Tsc22d3, a GR responsive gene, tended to 
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increase after ozone exposure in the lungs of vehicle-treated SH rats; however, AD effectively 
down-regulated Tsc22d3 expression in air- and ozone-exposed vehicle-treated rats. 
CLEN+DEX treatment significantly increased the expression of Tsc22d3 for all groups except 
for ozone-exposed SH rats (Fig. 4.10G). 
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Figure 4.10 
 
Figure 4.10 Ozone-induced changes in lung inflammatory gene expression, and the 
effects of AD and CLEN+DEX.  Relative lung gene expressions for Il6 (A), Tnf (B), Il4 (C), 
Cxcl2 (D), Mt2a (E), Adrb2 (F) and Tsc22d3 (G) were determined in tissues collected 1-2.5 hr 
following air or ozone (0.8 ppm) exposure (4 hr/day) for D+1 groups. Significant differences 
between groups (p value ≤ 0.05) are indicated by * for ozone effect when compared to 
corresponding air-exposed rats, # for AD effect when compared to corresponding SH rats, and † 
for CLEN+DEX effect when compared to corresponding vehicle-treated rats. 
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4.4 Discussion 
We have previously shown that neuroendocrine activation leading to increased 
circulating stress hormones was necessary for mediating ozone-induced lung injury and 
inflammation since AD rats were protected from these ozone effects (Miller et al., 2016b; 
Henriquez et al., 2017a). Because AD is invasive and also eliminates circulating 
mineralocorticoids along with stress hormones, one cannot rule out their contribution in 
diminution of ozone-induced lung effects. The goal of this study was to evaluate if agonists of 
stress hormone receptors β2AR and GR were able to restore ozone-induced lung injury, 
inflammation and innate immune cell trafficking in AD rats, and exacerbate these effects in SH 
rats. Here, we reconfirmed that the pulmonary and systemic effects of ozone inhalation, 
characterized by vascular leakage, neutrophilic inflammation, cytokine release in the lungs and 
peripheral vascular lymphopenia, were significantly diminished by AD (Miller et al. 2016b). The 
treatment with a combination of β2AR and GR agonists (CLEN+DEX) was able to restore these 
ozone effects in AD rats, and further exacerbate ozone-induced lung protein leakage, 
inflammation and lymphopenia in SH rats. It was also noted that CLEN+DEX itself caused injury 
and cytokine increases in the lung. Although a variety of β2AR and GR agonists have been 
widely used for the treatment of chronic lung diseases (Fireman, 1995; Barnes, 2011), β2AR 
agonists have been shown to exacerbate lung inflammation in asthmatics (Mcivor et al., 1998, 
Boulet et al., 2001) and epidemiological studies have indicated exacerbation of lung 
inflammation in asthmatics during increased air pollution episodes (Qian et al., 2009). Even 
though high concentrations of agonists were used, our study provides a potential causal 
mechanistic link between activation of stress hormone receptors in mediation of air pollution 
health effects, and how these effects might be exacerbated in those receiving asthma therapy.  
Hypothermia following air pollution exposure has been postulated to be a protective 
autonomic mechanism in rodents (Gordon et al., 2014), likely reducing the pollutant dosimetry 
and/or impact on the lung (Terrien et al., 2011, Gorr 2017). In this study, we too observed a 
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hypothermic response to ozone in SH rats via assessment of subcutaneous temperature, a 
measurement known to reflect ozone-induced effects on core body temperature (Gordon et al., 
2014). Interestingly, although AD reversed most ozone effects on the lung and periphery, 
hypothermia was not reversed, suggesting this autonomic response is likely regulated upstream 
and independent of neuroendocrine stress axes activation. It is also likely that this response 
might be regulated by nor-epinephrine action, especially producing local effects at sympathetic 
nerve endings, since adrenalectomy did not influence the levels of nor-epinephrine (Miller et al., 
2016b). 
2AR and GR agonists are widely used for the treatment of chronic lung diseases such 
as asthma and COPD to cause bronchodilation and inhibition of inflammation through 
immunosuppression, respectively. Since ozone-induced lung protein leakage and inflammation 
are also associated with increased levels of endogenous 2AR and GR agonists, it is likely that 
air pollution effects are exacerbated in those receiving this therapy.  A variety of agonists and 
antagonists of different formulations are available and are given to patients as a singular 
therapy or as part of a combination. CLEN, a specific 2AR agonist, although not prescribed in 
the US, is used in other counties with a recommended dose of 0.02-0.06 mg/day for 
bronchodilation, and much higher doses of up to 0.12 mg/day for inducing weight loss (Drug 
Enforcement Administration, 2013). Likewise, DEX is a widely used steroid in humans, in 
veterinary practice and employed extensively in research. At the recommended repeated adult 
dose levels of 0.75 to 9 mg every 6-12 hr for an average 70 kg person it is anti-inflammatory, 
whereas for patients with adrenal insufficiency, doses of up to 0.15 mg/kg/day every 6-12 hr are 
given (http://reference.medscape.com/drug/decadron-dexamethasone-intensol-dexamethasone-
342741- accessed 9-20-17). In this study we justify using higher levels than what is used 
therapeutically in humans to assure a sufficient coverage of expected change due to 
adrenalectomy-mediated depletion and ozone-induced increases.  
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As we previously demonstrated (Miller et al., 2016b), AD nearly completely eliminated 
stress hormones, corticosterone and epinephrine, from the circulation. Importantly, 
corticosterone, but not epinephrine, was significantly diminished by CLEN+DEX treatment.  
Since the HPA axis is regulated by a negative feedback inhibition controlled by glucocorticoids 
themselves (Keller-Wood 2015), it is likely that this is due to the known DEX-dependent 
inhibition of corticosterone synthesis and release (Kolebinov et al., 1975). The increased 
expression of the glucocorticoid responsive gene Tsc22d3, which has been shown to increase 
following ozone exposure in multiple organs (Thomson et al., 2013, 2016), upregulation of the 
adrenergic receptor β2 gene (Adrb2), together with increased trend of circulating epinephrine 
and corticosterone in SH rats following ozone exposure supports the conclusion that β2AR and 
GR are involved in mediating ozone lung effects.  
Since inhaled β2AR and GR agonists are widely used as bronchodilators and 
immunosuppressant, respectively (Cazzola et al., 2012, Brusselle and Bracke 2014, Yayan and 
Rasche 2016), we wanted to determine if ozone-induced ventilatory changes were influenced by 
systemic CLEN+DEX and AD. While CLEN+DEX treatment in air-exposed animals had some 
effect and increased pause, PEF/PIF and PenH, ozone effects in general were exacerbated by 
the drug treatment when considering these endpoints even though measurements were taken 
post-exposure. It is important to note that the biphasic inspiration trace observed in CLEN+DEX 
treated animals might have influenced ventilation and changes in Ti/Te, pause and PEF/PIF. 
Since CLEN+DEX in all air- and ozone-exposed rats was associated with lung protein leakage 
and increased NAG activity but not increases in alveolar macrophages, it is likely that ozone-
induced changes in ventilatory parameters in CLEN+DEX-treated rats were perhaps linked to 
macrophage influx and release of inflammatory cytokines as discussed below.  
As reported earlier (Miller et al., 2016b), AD prevented the ozone-induced vascular 
protein leakage in the lungs. Conversely, CLEN+DEX treatment in air-exposed animals was 
enough to induce marked vascular leakage, indicating a crucial role for β2AR and GR in this 
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response. CLEN treatment has been shown to decrease pulmonary vascular resistance (PVR) 
in horses (Dodam et al., 1993). Likewise, salbutamol, a different β2AR agonist, significantly 
decreased PVR in humans (Spiekerkoetter et al., 2002). β2AR agonist treatment is also 
associated with acute pulmonary edema in females (Eliat et al., 2002) while epinephrine-
induced pulmonary edema has been characterized in rats (Hao et al., 2001). In addition, lung 
epithelial permeability is increased by β2AR agonists (Unwalla et al., 2015, Unwalla et al., 2012). 
Collectively, this suggests that CLEN may decrease PVR, which can enhance blood flow in the 
pulmonary vasculature, and increase pulmonary edema and epithelial permeability, leading to 
increased levels of BALF protein and albumin in CLEN+DEX-treated rats. In the SH rats, these 
effects are likely mediated by the increased epinephrine released following ozone exposure. 
Conversely, increased glucocorticoid activity has been implicated in decreased permeability of 
lung epithelium (Kielgast et al., 2016, Matheson et al., 2004) and alleviation of pulmonary 
edema (Matthay 2014). However, since our protocol included both CLEN+DEX, it is not clear 
how DEX might have influenced the effects of CLEN.  
The changes in lavageable macrophages after ozone exposure are likely influenced by 
the temporality of the assessment (Kumarathasan et al., 2015; Laskin et al., 1998). Increased 
adhesion of activated alveolar macrophages might reduce the efficiency of recovery during 
lavage procedure (Gordon et al., 2016, Bhalla et al., 1996). While the decrease in alveolar 
macrophages after ozone exposure on D+1 was prevented by AD, it is noteworthy that 
CLEN+DEX treatment increased alveolar macrophages but only in ozone-exposed rats 
(SH>AD).  The duration and the degree of stress hormone increases and the dose of drugs 
might influence this disparity between ozone and CLEN+DEX.  Broug-Holub et al. (1998) 
demonstrated that physical stress in rats leads to enhanced macrophage activity that is 
reversed by parasympathetic but not sympathetic blockade while McGovern et al. (1996) found 
that ozone and β adrenergic inhibition cooperatively inhibit macrophage activity. Furthermore, 
exercise-dependent suppression of macrophage antiviral function was dependent on stress 
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hormones (catecholamines) and reversed by AD, suggesting their role in modulating 
macrophage function (Kohut et al., 1998). 
Neutrophilia is one of the hallmarks of ozone exposure (Hollingsworth et al., 2007, Alexis 
et al., 2010; Kodavanti et al., 2015) and acute stress scenarios directly modulate neutrophil 
recruitment, migration and mobilization through the action of stress hormones (Dhabhar et al., 
2012).Consistent with our previous publications (Miller et al., 2016b; Henriquez et al., 2017a), 
ozone exposure increased the accumulation of neutrophils in BALF while stress hormone 
absence (by AD) was associated with decreased BALF neutrophils in ozone-exposed rats. 
Interestingly, ozone-induced increases in BALF neutrophil numbers is 2-3-fold higher in SH 
treated with CLEN+DEX. These results suggest the combination of ozone along with 
CLEN+DEX produce exacerbated lung neutrophilic inflammation.  
Effects of ozone inhalation are not limited to the respiratory system. Our results support 
the previous observation that ozone exposure reduces circulating WBC, especially lymphocytes, 
while increasing circulating epinephrine and corticosterone in rats (Miller et al., 2016b; 
Henriquez et al., 2017b). Since CLEN+DEX also produces a substantial reduction in circulating 
lymphocytes (likely due to the immunosuppressive dose of DEX) while increasing BALF 
neutrophils, it is likely that these effects of ozone are modulated by stress hormones in a 
dynamic manner (Dhabhar et al., 2012). Although the separation between circulating T-
lymphocytes and B-lymphocytes could not be assessed since CD3, a pan marker of 
lymphocytes, was not included, it was apparent that T-lymphocyte subpopulations CD4-CD8a+ 
(cytotoxic), CD4+CD8a- (Helper) and CD4+CD8a+ were decreased by CLEN+DEX and to some 
extent by ozone.  This demonstrates that T-lymphocytes are sensitive to stress hormone levels 
and their receptor activation. It is well known that glucocorticoids induce thymic atrophy 
(Roggero et al., 2006, Pazirandeh et al., 2002) and apoptosis in circulating T-cells (Cidlowski et 
al., 1996), which is consistently observed in different models of stress (Szabo et al., 2017). The 
pattern of ozone-induced decrease and AD-mediated recovery of circulating leukocyte cell 
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subpopulations suggest that endogenous levels of stress hormones are sufficient to dynamically 
regulate the relative size of cytotoxic and helper T-cell pools.    
We have previously reported that global lung gene expression changes observed after 
ozone exposure are diminished in AD rats (Henriquez et al., 2017a), suggesting that diminution 
of circulating stress hormones reduce ozone effects at the transcriptome level. In this study, we 
sought to determine the specific influence of activating β2AR and GR in AD rats on inflammatory 
and acute phase markers. We noted that ozone exposure was associated with increases in 
proteins and mRNA for inflammatory markers, including acute phase response genes, and, as 
observed earlier (Henriquez et al., 2017a), this response was inhibited in AD rats. Moreover, we 
noted that CLEN+DEX itself was sufficient to induce inflammatory genes to much higher levels 
than ozone, such that no further increases were discernible by ozone. These changes confirm 
that activation of β2AR and GR modulates lung transcriptional changes, which likely influence 
the inflammatory response to ozone.  
The concentration of ozone used in this study (0.8 ppm) is much higher than what is 
likely encountered environmentally. However, this level in resting rats can be comparable to 
exercising humans exposed to 0.2 ppm ozone (Hatch et al., 2014), and it has been recently 
shown that ambient ozone concentrations can rise up to 0.2 ppm under certain circumstances in 
the US (EPA, 2017).  
There are a number of limitations to our study. The dynamic nature of ozone-induced 
changes was not examined to determine how the recovery or progression of injury might occur 
after ozone exposure, especially in the case of AD. Also, the CLEN+DEX doses used in this 
study, although within the range of those used by many research publications (Jonasson et al., 
2013; Sato et al., 2008; Ryan et al., 2010; Kopitar, 1969; Huang et al., 2014; Sadarani and 
Majumdar 2015; Sun et al., 2009), were much higher than human therapeutic doses, and the 
interaction of CLEN and DEX with air pollutants at therapeutic levels need to be carefully 
examined.  
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In conclusion, our results suggest that both endogenous and exogenous levels of 
epinephrine and glucocorticoids dynamically regulate ozone-induced pulmonary and extra-
pulmonary responses. Ozone-induced lung vascular protein leakage, inflammation and 
peripheral lymphopenia were diminished in AD rats, and agonists of β2AR and GR restored this 
phenotype implicating their role (Fig. 4.11). Moreover, these agonists by themselves were 
sufficient to induce lung vascular leakage and inflammation producing ozone-like lung injury and 
lymphopenia (Fig. 4.11). These data provide a potential mechanistic link for the epidemiological 
evidence that air pollution effects are exacerbated in those socioeconomically disadvantaged 
communities with high levels of psychosocial stresses and high levels of circulating stress 
hormones (Douwes et al., 2011). Furthermore, this study may suggest that the pulmonary 
effects of air pollutants might be exacerbated in asthmatics or COPD patients receiving chronic 
bronchodilator treatment with or without immunosuppressant steroids, since air pollutants 
increase levels of circulating stress hormones.   
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Figure 4.11 
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Figure 4.11 Potential mechanisms involved in ozone-induced lung injury and 
inflammation in SH and AD rats treated with CLEN+DEX. It is well established that normal 
rats (SH) when exposed to ozone (0.8 ppm, 4 hr/day) develop lung injury and inflammation 
(indicated by +++). This data summary shows that all effects of ozone are reduced or prevented 
by adrenalectomy (AD) as a result of lack of circulating stress hormones, epinephrine and 
corticosterone (indicated by +). Epinephrine and corticosterone are known to exert organ-
specific effects through adrenergic (AR) and glucocorticoid (GR) receptors, respectively. Lung 
tissue primarily expresses βAR. When SH and AD rats are treated with agonists of β2AR and 
GR (CLEN+DEX), the ozone effects are exacerbated/restored (indicated by ++++++ or +++++) 
in SH/AD rats, respectively. It is noteworthy that the CLEN+DEX treatment in air-exposed SH 
rats were sufficient to induce lung injury/inflammation while drug supplementation in ozone-
exposed sham rats exacerbated lung injury/inflammation.   
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CHAPTER 5: CONCLUSIONS AND PERSPECTIVES 
5.1 Air pollution and neuroendocrine stress response 
Air pollution is a “silent killer” and millions of people die prematurely every year as a 
consequence (Jerret et al., 2015). Epidemiological studies have shown that psychosocial 
stresses exacerbate responses triggered by air pollution exposure (Clougherty and Kubzansky, 
2009). Even maternal stress has been associated with increased offspring susceptibility to air 
pollution. Stress, a non-specific host response to an external threat produced in all living beings, 
has been linked to major human ailments. Neuroendocrine stress response is produced 
centrally after receiving sensory danger signals from external environment or internal changes 
in the body, which causes HPA and SAM activation. The processes initiated in the 
hypothalamus and other areas of CNS mediate the release of stress hormones into the 
circulation, which prepare the host to act, face or escape any threat. This neuroendocrine 
activation, also referred to as a “fight or flight response”, is widely conserved in mammals. Some 
of the hallmark changes associated with stress response include the redirection of blood flow to 
muscles, the mobilization of energy sources to the site of stress, hypothermia or hyperthermia 
(depending on the type of stress and host) and the stimulation of an immune response to 
counter stress.  Although this stress response has been linked to air pollution exposure in 
epidemiology, no earlier studies have examined the contribution of this response in mediating 
pulmonary and systemic health effects of air pollutants.  
Systemic health effects of air pollutants and the mechanisms by which peripheral organs 
are affected have been at the forefront of air pollution research since there is a great interest in 
understanding how virtually all chronic diseases of non-pulmonary and pulmonary origin are 
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associated with exposure to air pollution. It is believed that the complex milieu of circulating 
factors, often referred to as “molecular shrapnel”, is involved in mediating systemic effects; 
however, the origin and the causes of change in these circulating factors are not understood. 
The current mechanistic paradigm implicates that the release of bioactive components such as 
cytokines, oxidation by-products and vasoactive substances released from the pollutant-injured 
lung tissue into the circulation induce systemic and distant organ effects. However, our 
laboratory has recently shown an alternative mechanism involving neuroendocrine activation 
causing widespread systemic multi organ as well as pulmonary effects of inhaled pollutants, 
which challenges the current mechanism paradigm.  We have shown that ozone and acrolein-
induced extra-pulmonary effects are similar to those produced during a “fight or flight response”. 
Based on the neuroendocrine activation, and the characteristic of air pollution response, it is 
believed that sensory input from lung to brain, rather than spillover of bioactive substances into 
the circulation mediates changes in the circulating milieu and peripheral effects (Kodavanti 
2016). The activation of neuroendocrine system by air pollutants and the release of stress 
hormones in the circulation can affect peripheral organs through their action on stress hormone 
receptors.   
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5.2 Ozone exposure and stress hormones: possible mechanisms of lung CNS 
communication 
We have shown that through activation of neuroendocrine stress axes such as SAM and 
HPA, ozone exposure induces a rapid release of circulating stress hormones, epinephrine and 
corticosterone, which through their organ specific effects cause the release of hundreds of 
metabolites, acute phase proteins and more importantly stress hormones into the circulation 
(Bass et al., 2013; Miller et al., 2015, 2016a; 2016b; 2016c). More importantly, our studies led 
us to identify the two fundamental survival processes implicated in the fight-or-flight response 
(i.e energy mobilization and immune surveillance) to be induced by exposure to ozone, which 
explains how multi-organ effects are produced. Furthermore, our intervention studies 
demonstrate that circulating stress hormones are necessary for producing a vast number ozone 
effects including lung injury and innate immune response (Miller et al., 2016b).   
Ozone is an irritant which activates vagal C fibers in the airways. These afferent C fibers 
originate from jugular and nodose ganglion, and relay sensory input from the lung to the NTS 
and surrounding areas of the CNS to produce autonomic respiratory reflexes and cardiovascular 
responses (Taylor-Clark and Undem, 2010). This lung-CNS communication axis might explain 
how ozone exposure activates stress responsive regions in the brain and would explain the 
activation of neuroendocrine stress responses (Gackière et al., 2011). Neuronal firing in stress 
responsive areas in the brain mediates SAM and HPA axes activation, which upregulate the 
release of catecholamines and corticosteroids, respectively, capable of mediating metabolic and 
immune responses in the body. However, the precise mechanisms by which the lung 
communicates with the brain in inducing SAM and HPA after air pollution exposure remains to 
be examined. Based on our findings that not only systemic but also lung effects of ozone are 
diminished in adrenalectomized rats (Miller et al., 2016b), our main goal was to examine how 
stress hormones that are released from the adrenal glands in response to ozone exposure elicit 
pulmonary injury and inflammation. We hypothesized that the CNS-mediated release of stress 
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hormones, epinephrine and corticosterone, through their action on AR and GR, respectively, 
modulate ozone-induced vascular leakage and inflammation in the lungs. We sought to examine 
how immune responses are regulated under air pollutant stress through stress hormone-
mediated action on their cellular receptors. 
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5.3 AR and GR activation by stress hormones is necessary to induce pulmonary injury 
and inflammation after ozone exposure   
In the first specific aim (Henriquez et al., 2017a), we characterized the role of circulating 
stress hormones in lung transcriptional processes induced by ozone using global mRNAseq in 
rats that have undergone ADREX or DEMED. In this study, we demonstrated that lung 
transcriptional response to ozone was nearly abolished in DEMED and ADREX rats, implying 
that the effect of circulating stress hormones after ozone exposure was occurring at the 
transcriptional level in the lung. Using IPA we found that ADREX and DEMED attenuated the 
changes in genes involved in pathways classically up-regulated by ozone exposure, such as 
oxidative stress and pro-inflammatory PI3K/AKT signaling. In addition, when ozone-induced 
gene expression changes were compared against a known database from other chemicals 
using Ingenuity comparison tools, the signature of global gene expression changes in ozone-
exposed SHAM rats resembled those induced by glucocorticoids (methylprednisolone and 
dexamethasone) and cAMP-increasing substances such as forskolin (an effect induced by AR 
activation). These findings indicated that ozone-induced transcriptional changes are similar to 
those induced by drugs activating AR and GR. Further assessment of cytokine proteins and 
mRNA suggested a tendency of ozone to produce Th2 immune responses, and to up-regulate 
the expression of glucocorticoid responsive genes in lung tissue were diminished by ADREX.  
Although this study provided significant insights into the potential contribution of 
epinephrine and corticosterone in mediating ozone lung effects, both DEMED and ADREX are 
invasive procedures.  Furthermore, adrenal glands also produce mineralocorticoids and sex 
hormones in addition to corticosteroids and catecholamines, thus, one cannot rule out the 
contribution of these factors in ozone-induced lung effects.  Therefore, the goal of the second 
study was to further assess the specific roles of each stress hormone in mediating ozone-
induced lung injury and inflammation using a targeted pharmacological approach in vivo. 
Conducting this study was important in determining the role of stress hormones for two reasons: 
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1) it allowed us to avoid the side-effects of adrenalectomy surgery and suppression of 
mineralocorticoids/sex hormones, and 2) we were able to specifically isolate the role of each 
stress hormone separately by treating rats to AR and GR blocker individually or in combination. 
With DEMED and ADREX, we were able to block the effect of only epinephrine or both 
epinephrine and corticosterone together, respectively, but not corticosterone by itself. In this 
specific aim, we examined the contribution of AR and GR in mediating ozone effects by 
pretreating rats with βAR antagonist, PROP, and GR antagonist, MIFE, individually or in 
combination. We hypothesized that the epinephrine and corticosterone released into the 
circulation following exposure would bind to pulmonary βAR and GR, respectively, and 
collectively mediate ozone-induced lung injury and trafficking of immune cells to the lung.  
The results from this specific aim (Henriquez et al., 2017b) demonstrated that inhibition 
of both stress hormone receptors with PROP and MIFE led to overall decreases in all ozone-
induced lung effects and, therefore, it was concluded that the circulating stress hormones 
epinephrine and corticosterone are required for ozone to induce lung injury and inflammation. 
Ozone-induced lung vascular leakage was prevented by PROP, MIFE, and PROP+MIFE 
treatments, suggesting that corticosterone and epinephrine are contributing individually to 
ozone-induced lung vascular leakage. However, ozone-induced pulmonary neutrophilia was 
prevented primarily by PROP whereas lymphopenia was prevented primarily by MIFE, 
illustrating the specific involvement of βAR in mediating neutrophil extravasation to the lung and 
GR in mediating egress of lymphocytes in the circulation. The attenuation of ozone-induced 
increases in inflammatory mediator mRNA and proteins by PROP but not MIFE implicated the 
role of epinephrine and AR in local effects of ozone in the lung. The use of the strategy to 
isolate the ozone effects mediated by epinephrine and corticosterone emphasized the role of 
HPA and SAM axes as independent arms of neuroendocrine stress response activation, 
individually controlling each effect observed following ozone inhalation. 
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Asthma and chronic lung diseases, often linked to environmental exposures, are some 
of the leading causes of human morbidity and mortality worldwide (Soriano et al., 2017). 
Bronchodilators and immune suppressants are the two major therapeutics used in the treatment 
of these lung diseases, as well as for cardiovascular and chronic inflammatory conditions. More 
importantly, these are the therapeutics that mimic stress hormones and exert their effects 
through binding to AR and GR receptors.  This implies that normal functioning of 
neuroendocrine stress axes is critically important in diseases, and that these axes are 
therapeutically manipulated for combating chronic diseases. In addition, it has been reported 
epidemiologically that individuals receiving asthma mediation have exacerbated air pollution 
effects (Gent et al., 2003). The activation of AR and GR receptors by increased air pollution 
exposure might coincide with the use of these receptor agonists in lung disease patients to 
exacerbate pulmonary injury and inflammation.   
In the third aim, to demonstrate the direct contribution of stress hormone receptors 
activation in ozone-induced effects, we carried out a “gain of function” experiment (Henriquez et 
al., 2017c, in review). We hypothesized that the treatment of adrenalectomized rats with β2AR 
and GR agonists will reverse the protective effect of AD and restore ozone-induced lung injury 
and inflammation. The re-gain of ozone-sensitivity in AD rats, by providing drugs mimicking the 
activity of stress hormones, would unequivocally demonstrate the causal role of epinephrine and 
corticosterone as bioactive circulating factors mediating ozone-induced lung injury. Further, we 
postulated that this intervention would allow us to examine if air pollution effects are 
exacerbated in those receiving dual bronchodilator and immunosuppressant therapy. A 
combination of widely used bronchodilator (clenbuterol) and steroid (dexamethasone) was used 
(CLEN+DEX) to examine their influence on ozone-induced lung injury and innate immune 
response in  AD and SH rats. This study allowed us to reconfirm our earlier findings that ozone-
induced lung injury and inflammation, increased cytokine expression, as well as lymphopenia 
are diminished by depleting circulating stress hormones through AD. More importantly, by 
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pharmacologically activating 2AR, which are predominantly located in lung bronchial smooth 
muscle cells, and GR using CLEN+DEX, we not only restored the ozone injury phenotype in AD 
rats but further exacerbated ozone effects in healthy SH rats.  These findings support the 
conclusion that those receiving bronchodilators and combinational therapy are likely to 
experience increased air pollution adverse effects through a common mechanism.  Subsequent 
studies in our lab that used therapeutic doses of CLEN+DEX provides further support to this 
hypothesis, and raises concern for exacerbated air pollution effects in asthmatics and COPD 
patients receiving therapy.  
In these three preceding core chapters, by using different experimental strategies, we 
conclude that air pollutants activate neuroendocrine stress axes, and through the release of 
epinephrine and corticosterone into the circulation, mediate ozone-induced lung injury and 
inflammation. The contribution of circulating stress hormones in mediating pulmonary effects of 
air pollution was not investigated in previous air pollution studies. Further, using 
pharmacological and surgical interventions, we show that ozone-induced effects in the lung are 
mediated through AR and GR receptors. Since AR and GR agonists are widely used in 
treatment of chronic lung diseases, our results show a potential common mechanism where 
these drugs might exacerbate acute air pollution effects. Finally, our findings bring forth a new 
dimension to air pollution health effects research and show that ozone pulmonary injury and 
innate immune effects are mediated by circulating stress hormones.  
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5.4 Challenging a classic paradigm  
The main results of this dissertation challenge the current mechanistic paradigm 
explaining how ozone mediates pulmonary and systemic health effects. It is believed that 
spillover of bioactive substances from the lung to circulation may serve to transport signals to 
the periphery and induce effects in distant organs. We provide a new mechanism whereby 
inhaled pollutants through CNS activation of neuroendocrine stress axes contribute to not only 
effects in the peripheral organs, but also in the lung. Since neuroendocrine activation and 
resulting effects are observed rapidly after air pollution exposure, prior to induction of lung 
vascular leakage and inflammation, the systemic and pulmonary changes are a direct 
consequence of CNS activation. Using surgical and pharmacological interventions, we confirm 
the central role of AR and GR receptors, which were previously unrecognized in air pollution 
studies (Fig. 5.1).  
There is a body of evidence justifying the role of lung-CNS communication as a 
mechanism explaining how inhaled irritants trigger autonomic responses and reflex 
bronchoconstriction such as cough, sneeze or apnea, and in the case of ozone, cardiovascular 
depression or hypothermia. However, the neuroendocrine stress axes activation was not 
investigated prior to our studies.  Although we did not explore how the lung communicates with 
the brain following ozone exposure, follow-up investigations could test if cervical vagotomy or 
desensitization of C-fibers using capsaicin will prevent ozone-induced release of stress 
hormones and further downstream effects. Likewise, blockade of pain receptors with long-
lasting anesthesia could be used to examine the role of pain receptors in stimulation of 
neuroendocrine stress axes. A number of studies, including our own unpublished findings, have 
used TRPA and TRPV receptor blockers, but the results have not provided consistent findings 
delineating their role in stimulation of vagus nerves and central stress responsive regions. 
Animal models of gene knock outs lacking critical genes involved in SAM or HPA axes 
activation can also be used to explore in more detail the ozone-induced neuroendocrine stress 
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response. For instance, knock out mice deficient for corticotrophin releasing hormone gene in 
hypothalamus (Jobe and Ikegami, 1998), specific AR (Chiarella et al., 2014) and enzymes 
involved in the biosynthesis of catecholamines and glucocorticoids (Alves et al., 2016) are 
available and could serve to investigate how ozone and stress cooperatively interact to induce 
pulmonary and extra-pulmonary alterations.  
In addition, the use of humans with diseases involving altered glucocorticoid and 
catecholamine production or metabolism could serve as models for evaluation of stress 
hormone modulation of ozone-induced responses. For example, post-traumatic stress disorder 
(PTSD) or adrenal gland disorders, such as Addison’s disease or Cushing’s syndrome where 
cortisol levels are abnormally low and high, respectively, could represent human models to 
investigate the role of stress hormones on air pollution-induced health effects.  Perhaps these 
models could also be used to identify subpopulations with exaggerated or reduced ozone-
induced responses. The use of accepted clinical tests which modulate circulating glucocorticoid 
levels, such as dexamethasone suppression test or ACTH stimulation test, in conjunction with 
ozone exposures could be useful to establish the role of HPA axis activation in ozone-induced 
lung injury and inflammation in humans. Furthermore, although our results clearly support the 
role of stress hormones in ozone-induced pulmonary responses, we believe that other pathways 
might interactively influence ozone effects. For example, the role of serotonin might shed some 
light on how environmental stressors, such as ozone and psychosocial stressors, interact to 
exacerbate disease phenotype.  An interesting example is the therapeutic use of ACTH in the 
treatment of pulmonary sarcoidosis and granuloma (Baughman et al., 2016), which suggests 
potential interaction of stress axes and inflammatory processes at different levels.     
Long-acting bronchodilator monotherapy has been discouraged for treatment of asthma 
since it increases the risk of asthma-related death (Rottenkolber et al., 2015).  Gent et al. (2003) 
found that levels of ozone below the current NAAQS were significantly associated with 
exacerbation of respiratory symptoms only in asthmatic children taking maintenance medication 
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such as long-acting β-agonist (LABA). In a separate experiment, we found that CLEN by itself at 
doses higher than what was used in the third aim had no effect on lung injury and inflammation 
in air-exposed animals; however, this treatment highly exacerbated ozone-induced lung injury 
(data not shown). Interestingly, in our third specific aim, we found that the combination of β2AR 
and GR agonists (CLEN+DEX) effectively exacerbated ozone-induced responses in SH rats. 
Although the drug doses were carefully selected based on previous publications, these doses 
were higher than the therapeutic doses used for lung disease. Thus, a follow-up investigation of 
how CLEN, DEX, and/or other agonists at therapeutic doses might exacerbate air pollutant-
induced pulmonary injury and inflammation will be important in determining a causal link 
between potential drug/air pollution interactions observed in epidemiology.  
Another area of research worth further analysis is the exploration of strategies to assess 
how minimizing stress responses could alleviate or attenuate air pollution-induced adverse 
health effects. In our second publication, we found that βAR and GR antagonists significantly 
reduced acute lung injury and inflammation induced by ozone exposure. Since PTSD and other 
psychosocial stressors are associated with increased circulating stress hormones, the use of 
therapeutics that reduce circulating stress hormones or inhibit AR and GR might be considered 
for mitigation of air pollution health effects. Also, the inclusion of other compounds known to 
modulate stress responses, such as oxytocin which plays a key role as a suppressor of HPA 
axis activation (Crockford et al., 2017), could be used to evaluate interventions aimed to reduce 
the health effects of air pollution inhalation and stress.      
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Figure 5.1 
 
 
Figure 5.1 Proposed mechanism of hormonal stress mediated pulmonary effects of 
ozone inhalation. Hypo: Hypothalamus, HPA Hypothalamic-Pituitary-Adrenal: SAM: 
Sympathetic-Adrenal-Medullary, NE: Norepinephrine, PVN: Paraventricular Nucleus, NTS: 
Nucleus Tractus Solitarius. Adapted from Kodavanti, 2016. 
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5.5 Additional hypotheses 
In this study, we also highlight the role of adrenal glands as a modulator of ozone-
induced responses in the lung. Recently, the role of “inter-organ communication” (Droujinine 
and Perrimon, 2013) has gained attention. Although our paradigm involving stress hormones as 
important mediators of ozone-induced responses were limited to the lungs and circulation, 
results not included in this dissertation showed wide-spread, drug intervention-dependent 
metabolic modulation of ozone-induced changes. We will follow-up these studies by analyzing 
other relevant metabolic markers in achieved tissues such as the liver, muscle, adipose, and 
pancreas. Remarkably, the lung-liver axis and lung-kidney axis has been researched in the 
context of pulmonary infection, thus indicating that pulmonary responses are influencing or 
being influenced by changes occurring in other organs (Hilliard et al., 2015; Kaczmarczyk, 
1994).  
Finally, although we propose neuroendocrine stress response as a controlling 
mechanism governing pulmonary and extra-pulmonary effects induced by ozone, we cannot 
rule out the contribution of other novel mediators. For example, Fei et al. (2017) and Huffman et 
al. (2006) demonstrated that progesterone and thyroid hormone act as modulators of ozone-
induced responses. Ozone-induced changes in circulating metabolites and acute phase 
response proteins are extensive, and the research in our laboratory includes examination of 
other pathways (i.e. metabolic). Undoubtedly, the extension of these findings to evaluate the 
action of other air pollutants seems promising. For example, acrolein, another gaseous airway 
irritant, has been shown to induce similar activation of this neuroendocrine stress response 
(Snow et al., 2017).  
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5.6 Significance and Impact 
Despite significant air quality improvement during the past few decades, the associations 
between relatively low levels of air pollutants and detrimental health effects are still apparent 
(Pinault et al., 2016; Shi et al., 2016). Ozone, one of the six criteria air pollutants, is ubiquitously 
distributed in the atmosphere and expected to increase as a result of climate change. While this 
homeostatic neuroendocrine stress response can be induced by a variety of physical and 
psychosocial stresses, this project provides mechanistic insights on how environmental 
stressors can contribute to a variety of diseases through impairment of the dynamic 
orchestration of stress hormone-mediated immune and metabolic processes in multiple organs. 
Accordingly, the recognition of interactive effects between ozone exposure and non-chemical 
stressors will help to elucidate the mechanisms of disease susceptibility and the role of 
neuroendocrine stress pathways.  
The impairment of the neuroendocrine system has been linked to a variety of stress-
related chronic disease conditions including cardiovascular, metabolic, neurological and 
developmental. The contribution of environmental pollutants and psychosocial stressors as 
independent activators of neuroendocrine stress response opens the field for the 
characterization and evaluation of how shared mechanisms can cooperatively contribute to 
exacerbate air pollution health effects in socially disadvantaged and psychologically vulnerable 
populations. Thus, the assessment of psychosocial stress as an aggravating factor worsening 
population’s responses to environmental pollutants might be an important area of future 
research effort. It will also be critical to understand how SAM and HPA axes interact with the 
serotonergic system and lead to changes in circulating steroidal and adrenergic hormones that 
mediate downstream immune and metabolic changes. Furthermore, since developmental 
programming of the HPA axis has been implicated in susceptibility of children to chronic 
diseases, it will be important to understand how environmental or psychosocial stressors during 
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critical windows of development in pregnancy might impair children’s HPA programming and 
predispose them to exacerbated air pollution health effects.  
The understanding of how endogenous stress hormones, exogenous drugs, and stress 
hormone receptors, which are widely targeted in the treatment of chronic pulmonary conditions 
such as asthma and COPD, modulate pollutant-induced lung responses will have important 
translational impacts, and will provide insights into the questioned effectiveness of current 
therapeutic approaches for pulmonary inflammatory conditions. The role of the neurohormonal 
stress response has not been fully integrated into the environmental toxicology field, nor in 
currently available adverse outcome pathways (AOP). Since stress response is a common 
outcome of a variety of environmental and social risk factors, this project has major implications 
in harmonizing the risk assessment strategy for different stressors, and it can serve as a 
common AOP for many environmental exposures to improve in vitro screening strategies for 
better in vivo predictions. Currently, efforts are under way at the EPA to incorporate 
neuroendocrine SAM and HPA axes activation in future AOP paradigms. Thus, the research 
findings from this dissertation will serve to alter the direction of the current environmental 
toxicology field to emphasize the consideration of a systems biology approach when examining 
air pollution adverse health effects.  
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APPENDIX 
 
Supplementary Table 2.1A 
 
 
Supplementary Table 2.1A: Relative fold change (ozone/air) for the forty most up-regulated 
genes after ozone exposure in SHAM rats and their relative expression changes in DEMED and 
ADREX rats (1-day time point). 
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Supplementary Table 2.1B 
 
 
 
Supplementary Table 2.1B: Relative fold change (ozone/air) for the forty most down-regulated 
genes after ozone exposure in SHAM rats and their relative expression changes in DEMED and 
ADREX rats (1-day time point). 
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Supplementary Table 2.2 
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Supplementary Table 2.2: Significantly changed genes by ozone in DEMED and ADREX rats 
that were shared or unique at day 1 (1-D; A and B, respectively) and at day 2 (2-D; C and D, 
respectively). Values indicate the number of genes changed by ozone with their respective 
direction (up ↑ or down ↓ regulation, also genes which changed the direction of regulation are 
indicated as ↑↓ or ↓↑). Each group of genes was assessed for the determination of 
overrepresented biological processes. Both fold enrichment (FE) and p-values are listed. 
Shared and unique groups of genes in the figure 1 Venn diagram were analyzed to determine 
likely link to specific function or pathway. A Panther overrepresentation test was performed for 
each group of genes and the outcome and significance are provided in the supplementary 
materials table 2 A, B, C, and D. Gene names were upload to the webpage of Panther 
classification system (http://www.pantherdb.org/). The annotation database used was GO 
Ontology (released 2017-02-28) with Rattus Novergicus database reference list. The annotation 
used was "GO biological process complete". Significantly overrepresented pathways (p<0.05) 
were calculated using Bonferroni correction for multiple testing. Fold enrichment (FE) was 
calculated as the ratio between the expected number genes and the actual number of genes 
belonging to any particular biological process. The six pathways with the higher FE values for 
each group of genes were included in the table. If no processes were over-represented in a 
given gene group, the respective cell in the table was left empty. 
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Supplementary Table 2.3 
 
 
Supplementary Table 2.3. Canonical pathways that were up/down regulated by ozone in 
SHAM but not changed or reversed in DEMED or ADREX rats (1-day time point).  
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Supplementary Table 2.4 
 
 
Supplementary Table 2.4. Activation score for canonical pathways upregulated (>0) by ozone 
in SHAM rats but reduced or unchanged by ozone in ADREX rats (1-day time point). 
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Supplementary Figure 2.1 
 
 
Supplementary Figure 2.1: Correlation between qPCR (Ct) and RNAseq. (Normalized counts) 
for selected genes. 
 
159 
 
REFERENCES 
 
7 million premature deaths annually linked to air pollution (2017, July). Retrieved from 
http://www.who.int/mediacentre/news/releases/2014/air-pollution/en/ 
 
8-Hour Ozone (2008) Nonattainment Area Summary. (2017, July). Retrieved from 
https://www3.epa.gov/airquality/greenbook/hnsum.html 
 
Air Pollution Standards May Save Thousands of Lives, Greatly Improve Public Health.  (2016). 
Retrieved from https://www.thoracic.org/advocacy/clean-air/ats-marron-institute-report.php 
 
Air Quality – National Summary (2017, July). Retrieved from https://www.epa.gov/air-trends/air-
quality-national-summary 
 
Air Quality Standards. (2017, July). Retrieved from 
http://ec.europa.eu/environment/air/quality/standards.htm 
 
Akcılar, R., Akçer, S., Şimşek, H., Akcılar, A., Bayat, Z., Genç, O., 2015. The effect of ozone on 
blood pressure in DOCA-salt-induced hypertensive rats. Int. J. Clin. Exp. Med. 8,12783–12791. 
 
Alamo, I.G., Kannan, .K.B., Bible, L.E., Loftus, T.J., Ramos, H., Efron, P.A., Mohr, A.M. 2017. 
Daily propranolol administration reduces persistent injury-associated anemia after severe 
trauma and chronic stress. J. Trauma. Acute. Care. Surg. 82(4), 714–721. 
 
Alexis, N., Urch, B., Tarlo, S., Corey, P., Pengelly, D., O'Byrne, P., Silverman, F. 2000. 
Cyclooxygenase metabolites play a different role in ozone-induced pulmonary function decline 
in asthmatics compared to normals. Inhal. Toxicol. 12(12), 1205-24. 
 
Alexis, N.E., Becker, S., Bromberg, P.A., Devlin, R., Peden, D.B. 2004. Circulating CD11b 
expression correlates with the neutrophil response and airway mCD14 expression is enhanced 
following ozone exposure in humans. Clin Immunol. 111(1), 126-31. 
 
Alexis, N.E., Lay, J.C., Hazucha, M., Harris, B., Hernandez, M.L., Bromberg, P.A., Kehrl, H., 
Diaz-Sanchez, D., Kim, C., Devlin, R.B., et al. 2010. Low-level ozone exposure induces airways 
inflammation and modifies cell surface phenotypes in healthy humans. Inhal. Toxicol.  22(7), 
593-600. 
 
Alexis, N.E., Zhou, H., Lay, J.C., Harris, B., Hernandez, M.L., Lu, T.S., Bromberg, P.A., Diaz-
Sanchez, D., Devlin, R.B., Kleeberger, S.R., Peden, D.B. 2009. The glutathione-S-transferase 
Mu 1 null genotype modulates ozone-induced airway inflammation in human subjects. J Allergy 
Clin Immunol. 124(6), 1222-1228.e5.  
 
Alfaro, M.F., Putney, L., Tarkington, B.K., Hatch, G.E., Hyde, D.M., Schelegle, E.S. 2004. Effect 
of rapid shallow breathing on the distribution of 18O-labeled ozone reaction product in the 
respiratory tract of the rat. Inhal. Toxicol. 16(2), 77-85. 
 
Alfaro, M.F., Walby, W.F., Adams, W.C., Schelegle, E.S.  2007. Breath condensate levels of 8-
isoprostane and leukotriene B4 after ozone inhalation are greater in sensitive versus 
nonsensitive subjects. Exp. Lung. Res. 33(3-4), 115-33. 
160 
 
 
Alfaro-Rodríguez, A., González-Piña, R. 2005. Ozone-induced paradoxical sleep decrease is 
related to diminished acetylcholine levels in the medial preoptic area in rats. Chem. Biol. 
Interact. 151(3), 151-8. 
 
Alves, E., Lukoyanov, N., Serrão, P., Moura, D., Moreira-Rodrigues, M. 2016. Epinephrine 
increases contextual learning through activation of peripheral β2-adrenoceptors. 
Psychopharmacology (Berl). 233(11):2099-108.  
 
An, K., Salyer, J., Brown, R.E., Kao, H.F., Starkweather, A., and Shim, I. 2016. Salivary 
Biomarkers of Chronic Psychosocial Stress and CVD Risks: A Systematic Review. Biol Res 
Nurs. 18(3), 241-63. 
 
Anderson, G.B., Bell, M.L. 2010. Does one size fit all? The suitability of standard ozone 
exposure metric conversion ratios and implications for epidemiology. J. Expo. Sci. Environ. 
Epidemiol. 20(1), 2-11. 
 
Antonelli-Incalzi, R., Pedone, C. 2007. Respiratory effects of beta-adrenergic receptor blockers. 
Curr. Med. Chem. 14(10), 1121–8. 
are diminished in adrenalectomized rats. Toxicol. Sci. 150 (2), 312–322. 
 
Arito, H., Uchiyama, I., Arakawa, H., Yokoyama, E. 1990. Ozone-induced bradycardia and 
arrhythmia and their relation to sleep-wakefulness in rats. Toxicol. Lett. 52(2), 169-78. 
 
Arito, H., Uchiyama, I., Yokoyama, E. 1992. Acute effects of ozone on EEG activity, sleep-
wakefulness and heart rate in rats. Ind. Health. 30(1), 23-34. 
 
Arjomandi, M., Wong, H., Donde, A., Frelinger, J., Dalton, S., Ching, W., Power, K., Balmes, 
J.R. 2015. Exposure to medium and high ambient levels of ozone causes adverse systemic 
inflammatory and cardiac autonomic effects. Am. J. Physiol. Heart Circ. Physiol. 308(12), 
H1499-509. 
 
Atkinson, R.W., Butland, B.K., Dimitroulopoulou, C., Heal, M.R., Stedman, J.R., Carslaw, N., 
Jarvis, D., Heaviside, C., Vardoulakis, S., Walton, H., Anderson, H.R. 2016. Long-term 
exposure to ambient ozone and mortality: a quantitative systematic review and meta-analysis of 
evidence from cohort studies. BMJ Open. 6(2), e009493. 
 
Auerbach, A., Hernandez, M.L. 2012. The effect of environmental oxidative stress on airway 
inflammation. Curr. Opin. Allergy Clin. Immunol. 12(2), 133-9.  
 
Bachmann, J. 2007. Will the circle be unbroken: a history of the U.S. National Ambient Air 
Quality Standards. J. Air. Waste. Manag. Assoc. 57(6), 652-97. 
 
Banks, M.A., Porter, D.W., Martin, W.G., Castranova, V. 1990. Effects of in vitro ozone 
exposure on peroxidative damage, membrane leakage, and taurine content of rat alveolar 
macrophages. Toxicol Appl Pharmacol. 105(1), 55-65. 
 
Barker, J.S., Wu, Z., Hunter, D.D., Dey, R.D. 2015. Ozone exposure initiates a sequential 
signaling cascade in airways involving interleukin-1beta release, nerve growth factor secretion, 
and substance P upregulation. J. Toxicol. Environ. Health A. 78(6), 397-407. 
 
161 
 
Barnes, P.J. 1995. Inhaled glucocorticoids for asthma. N Engl. J. Med. 332(13), 868-75. 
 
Barnes, P.J. 2004. Small airways in COPD. N Engl J Med. 350(26), 2635-7. 
 
Barnes, P.J. 2011. Glucocorticosteroids: current and future directions. Br J Pharmacol. 163(1), 
29-43.  
 
Barnes, P.J., 2013. Corticosteroid resistance in patients with asthma and chronic obstructive 
pulmonary disease. J. Allergy Clin. Immunol. 131, 636–645.  
 
Barnes, P.J. 2017. Glucocorticosteroids. Handb Exp Pharmacol. 237, 93-115. 
 
Barnes, P.J., Adcock, I.M. 2009. Glucocorticoid resistance in inflammatory diseases. Lancet. 
373(9678), 1905-17. 
 
Baschant, U., Tuckermann, J. 2010. The role of the glucocorticoid receptor in inflammation and 
immunity. J. Steroid. Biochem. Mol. Biol. 120(2-3), 69–75.   
 
Bass, V., Gordon, C.J., Jarema, K.A., MacPhail, R.C., Cascio, W.E., Phillips, P.M., Ledbetter, 
A.D., Schladweiler, M.C., Andrews, D., Miller, D., et al., 2013. Ozone induces glucose 
intolerance and systemic metabolic effects in young and aged Brown Norway rats. Toxicol. 
Appl. Pharmacol. 273, 551–560. 
 
Baughman, R.P., Barney, J.B., O'Hare, L., Lower, E.E. 2016. A retrospective pilot study 
examining the use of Acthar gel in sarcoidosis patients. Respir. Med. 110, 66-72.  
 
Bell, M.L., McDermott, A., Zeger, S.L., Samet, J.M., Dominici, F. 2004. Ozone and short-term 
mortality in 95 US urban communities, 1987-2000. JAMA. 292(19), 2372-8. 
 
Bell, M.L., Zanobetti, A., Dominici, F. 2013. Evidence on vulnerability and susceptibility to health 
risks associated with short-term exposure to particulate matter: a systematic review and meta-
analysis. Am. J. Epidemiol. 178(6), 865-76. 
 
Bennett, W.D., Ivins, S., Alexis, N.E., Wu, J., Bromberg, P.A., Brar, S.S., Travlos, G., London, 
S.J. 2016. Effect of Obesity on Acute Ozone-Induced Changes in Airway Function, Reactivity, 
and Inflammation in Adult Females. PLoS One. 11(8), e0160030. 
 
Berger, A., 2000. Th1 and Th2 responses: what are they? BMJ 321, 424. 
 
Berlin, S.R., Langford, A.O., Estes, M., Dong, M., Parrish, D.D. 2013. Magnitude, decadal 
changes, and impact of regional background ozone transported into the greater Houston, 
Texas, area. Environ. Sci. Technol. 47(24), 13985-92.  
 
Bhalla, D.K. 1999. Ozone-induced lung inflammation and mucosal barrier disruption: toxicology, 
mechanisms, and implications. J Toxicol Environ Health B Crit Rev. 2(1), 31-86. 
 
Bhalla, D.K., Hoffman, L.A., and Pearson, A.C. 1996. Modification of macrophage adhesion by 
ozone: role of cytokines and cell adhesion molecules. Ann N Y Acad Sci. 796, 38-46. 
 
Bhalla, D.K., Reinhart, P.G., Bai, C., Gupta, S.K. 2002. Amelioration of ozone-induced lung 
injury by anti-tumor necrosis factor-alpha. Toxicol Sci. 69(2), 400-8. 
162 
 
 
Bible, L.E., Pasupuleti, L.V., Gore, A.V., Sifri, Z.C., Kannan, K.B., Mohr, A.M. 2015. Daily 
propranolol prevents prolonged mobilization of hematopoietic progenitor cells in a rat model of 
lung contusion, hemorrhagic shock, and chronic stress. Surgery 158(3), 595–601. 
 
Biermann, T., Stilianakis, N., Bleich, S., Thürauf, N., Kornhuber, J., Reulbach, U. 2009. The 
hypothesis of an impact of ozone on the occurrence of completed and attempted suicides. Med 
Hypotheses. 72(3), 338-41. 
 
Blomberg, A., Mudway, I., Svensson, M., Hagenbjörk-Gustafsson, A., Thomasson, L., Helleday, 
R., Dumont, X., Forsberg, B., Nordberg, G., Bernard, A. 2003. Clara cell protein as a biomarker 
for ozone-induced lung injury in humans. Eur. Respir. J. 22(6), 883-8. 
 
Bobb, G.A., and Fairchild, E.J. 1967. Neutrophil-to-lymphocyte ratio as indicator of ozone 
exposure. Toxicol Appl Pharmacol. 11(3), 558-64. 
 
Booster, G.D., Oland, A.A., Bender, B.G. 2016. Psychosocial Factors in Severe Pediatric 
Asthma. Immunol. Allergy. Clin. North. Am. 36(3), 449-60.  
 
Bosson, J.A., Blomberg, A., Stenfors, N., Helleday, R., Kelly, F.J., Behndig, A.F., Mudway, I.S. 
2013. Peripheral blood neutrophilia as a biomarker of ozone-induced pulmonary inflammation. 
PLoS One. 8(12), e81816.  
 
Boulet, L.P., Chakir, J., Milot, J., Boutet, M., and Laviolette, M. 2001. Effect of salmeterol on 
allergen-induced airway inflammation in mild allergic asthma. Clin Exp Allergy. 31(3), 430-7. 
 
Broeckaert, F., Clippe, A., Knoops, B., Hermans, C., Bernard, A. 2000. Clara cell secretory 
protein (CC16): features as a peripheral lung biomarker. Ann. N Y Acad. Sci. 923, 68-77. 
 
Bromberg, P.A. 2016. Mechanisms of the acute effects of inhaled ozone in humans. Biochim 
Biophys Acta. 1860(12), 2771-81.  
 
Bromberg, P.A., Koren, H.S., 1995. Ozone-induced human respiratory dysfunction and disease. 
Toxicol. Lett. 82, 307–316.  
 
Broug-Holub, E., Persoons, J.H., Schornagel, K., Mastbergen, S.C., and Kraal, G. 1998. Effects 
of stress on alveolar macrophages: a role for the sympathetic nervous system. Am J Respir Cell 
Mol Biol. 19(5), 842-8. 
 
Brown Norway rats: acute and delayed effect on heart rate, core temperature and motor activity. 
Inhal. Toxicol. 26, 380–390. 
 
Brusselle, G., and Bracke, K. 2014. Targeting immune pathways for therapy in asthma and 
chronic obstructive pulmonary disease. Ann Am Thorac Soc. 11 Suppl 5, S322-8.  
 
Burden of disease from ambient and household air pollution (2017, July). Retrieved from 
http://www.who.int/phe/health_topics/outdoorair/databases/en/ 
 
Bush, M.L., Asplund, P.T., Miles, K.A., Ben-Jebria, A., Ultman, J.S. 1996. Longitudinal 
distribution of O3 absorption in the lung: gender differences and intersubject variability. J. Appl. 
Physiol. (1985). 81(4), 1651-7. 
163 
 
 
Byers, N., Ritchey, M., Vaidyanathan, A., Brandt, A.J., Yip, F. 2016. Short-term effects of 
ambient air pollutants on asthma-related emergency department visits in Indianapolis, Indiana, 
2007-2011. J. Asthma. 53(3), 245-52. 
 
Cabello, N., Mishra, V., Sinha, U., DiAngelo, S.L., Chroneos, Z.C., Ekpa, N.A., Cooper, T.K., 
Caruso, C.R., Silveyra, P., 2015. Sex differences in the expression of lung inflammatory 
mediators in response to ozone. Am. J. Phys. Lung Cell. Mol. Phys. 309, L1150–L1163. 
 
Cain, D.W., and Cidlowski, J.A. 2015. Specificity and sensitivity of glucocorticoid signaling in 
health and disease. Best Pract Res Clin Endocrinol Metab. 29(4), 545-56. 
 
Cameron, D.G., Watson, G.M. 1949.The blood counts of the adult albino rat. Blood. 4, 816–818.  
 
Catania, A., Gatti, S., Colombo, G., Lipton, J.M. 2004. Targeting melanocortin receptors as a 
novel strategy to control inflammation. Pharmacol. Rev. 56(1), 1-29. 
 
Cazzola, M., Page, C.P., Calzetta, L., Matera, M.G. 2012. Pharmacology and therapeutics of 
bronchodilators. Pharmacol. Rev.  64(3), 450-504. 
 
Cazzola, M., Page, C.P., Rogliani, P., Matera, M.G. 2013. β2-agonist therapy in lung disease. 
Am. J. Respir. Crit. Care. Med. 187(7), 690–6. 
 
Check, J.H., Wilson, C., Cohen, R., Sarumi, M. 2014. Evidence that Mifepristone, a 
progesterone receptor antagonist, can cross the blood brain barrier and provide palliative 
benefits for glioblastoma multiforme grade IV. Anticancer Res. 34(5), 2385–8. 
 
Chen, C., Arjomandi, M., Balmes, J., Tager, I., Holland, N., 2007. Effects of chronic and acute 
ozone exposure on lipid peroxidation and antioxidant capacity in healthy young adults. Environ. 
Health Perspect. 115, 1732–1737. 
 
Chen, C.Y., Bonham, A.C., Plopper, C.G., Joad, J.P. 2003. Neuroplasticity in nucleus tractus 
solitarius neurons after episodic ozone exposure in infant primates. J. Appl. Physiol. (1985). 
94(2), 819-27. 
 
Chen, J.C., Schwartz, J. 2009. Neurobehavioral effects of ambient air pollution on cognitive 
performance in US adults. Neurotoxicology. 30(2), 231-9. 
 
Chiarella, S.E., Soberanes, S., Urich, D., Morales-Nebreda, L., Nigdelioglu, R., Green, D., 
Young, J.B., Gonzalez, A., Rosario, C., Misharin, A.V, et al. 2014. β₂-Adrenergic agonists 
augment air pollution-induced IL-6 release and thrombosis. J. Clin. Invest. 124(7), 2935-46.  
 
Chiu, H.F., Weng, Y.H., Chiu, Y.W., Yang, C.Y. 2017. Short-term effects of ozone air pollution 
on hospital admissions for myocardial infarction: A time-stratified case-crossover study in 
Taipei. J. Toxicol. Environ. Health A. 80(5), 251-257. 
 
Cho, H.-Y., Gladwell,W., Yamamoto, M., Kleeberger, S.R., 2013. Exacerbated airway toxicity of 
environmental oxidant ozone in mice deficient in Nrf2. Oxidative Med. Cell. Longev. 2013, 
254069. 
 
164 
 
Chounlamountry, K., Boyer, B., Penalba, V., François-Bellan, A.M., Bosler, O., Kessler, J.P., 
Strube, C. 2015. Remodeling of glial coverage of glutamatergic synapses in the rat nucleus 
tractus solitarii after ozone inhalation. J Neurochem. 134(5), 857-64.  
 
Chuang, G.C., Yang, Z., Westbrook, D.G., Pompilius, M., Ballinger, C.A., White, C.R., 
Krzywanski, D.M., Postlethwait, E.M., Ballinger, S.W. 2009. Pulmonary ozone exposure induces 
vascular dysfunction, mitochondrial damage, and atherogenesis. Am. J. Physiol. Lung Cell. Mol. 
Physiol. 297(2), L209-16. 
 
Cidlowski, J.A., King, K.L., Evans-Storms, R.B., Montague, J.W., Bortner, C.D., and Hughes, 
F.M. Jr. 1996. The biochemistry and molecular biology of glucocorticoid-induced apoptosis in 
the immune system. Recent Prog Horm Res. 51, 457-90. 
 
Clark, A.J., Strandberg-Larsen, K., Masters Pedersen, J.L., Lange, P., Prescott, E., and Rod, 
N.H. 2015. Psychosocial risk factors for hospitalisation and death from chronic obstructive 
pulmonary disease: a prospective cohort study. COPD. 12(2), 190-8. 
 
Clougherty, J.E., Kubzansky, L.D. 2008. Traffic-related air pollution and stress: effects on 
asthma.Environ Health Perspect. 116(9), A376-7. 
 
Clougherty, J.E., Kubzansky, L.D. 2009. A framework for examining social stress and 
susceptibility to air pollution in respiratory health. Environ. Health Perspect. 117(9), 1351-8.  
 
Clougherty, J.E., Rossi, C.A., Lawrence, J., Long, M.S., Diaz, E.A., Lim, R.H., McEwen, B., 
Koutrakis, P., Godleski, J.J. 2010. Chronic social stress and susceptibility to concentrated 
ambient fine particles in rats. Environ Health Perspect. 118(6), 769-75.  
 
Cockburn, A., Barraco, R.A., Reyman, T.A., Peck, W.H. 1975. Autopsy of an Egyptian mummy. 
Science. 187(4182), 1155-60. 
 
Cohen, A.J., Brauer, M., Burnett, R., Anderson, H.R., Frostad, J., Estep, K., Balakrishnan, K., 
Brunekreef, B., Dandona, L., Dandona, R., et al. 2017. Estimates and 25-year trends of the 
global burden of disease attributable to ambient air pollution: an analysis of data from the Global 
Burden of Diseases Study 2015. Lancet.  389(10082), 1907-1918.  
 
Coleridge, J.C., Coleridge, H.M., Schelegle, E.S., Green, J.F. 1993. Acute inhalation of ozone 
stimulates bronchial C-fibers and rapidly adapting receptors in dogs. J. Appl. Physiol. (1985). 
74(5), 2345-52. 
 
Connor, A.J., Laskin, J.D., Laskin, D.L. 2012. Ozone-induced lung injury and sterile 
inflammation. Role of toll-like receptor 4. Exp. Mol. Pathol. 92(2), 229-35.  
 
Coogan, P.F., White, L.F., Yu, J., Brook, R.D., Burnett, R.T., Marshall, J.D., Bethea, T.N., 
Rosenberg, L., Jerrett, M. 2017. Long-Term Exposure to NO2 and Ozone and Hypertension 
Incidence in the Black Women's Health Study. Am. J. Hypertens. 30(4), 367-372. 
 
Cooper, O.R., Parrish, D.D., Ziemke, J., Balashov, N.V., Cupeiro, M., Galbally, I.E., Gilge, S., 
Horowitz, L., Jensen, N.R., Lamarque, J.-F., et al., 2014. Global distribution and trends of 
tropospheric ozone: an observation-based review. Elem. Sci. Anthr. 2, 29. 
 
 
165 
 
Correia, A.W., Pope, C.A.3rd., Dockery, D.W., Wang, Y., Ezzati, M., Dominici, F. 2013. Effect of 
air pollution control on life expectancy in the United States: an analysis of 545 U.S. counties for 
the period from 2000 to 2007. Epidemiology. 24(1), 23-31. 
 
Cottet-Emard, J.M., Dalmaz, Y., Pequignot, J., Peyrin, L., Pequignot, J.M. 1997. Long-term 
exposure to ozone alters peripheral and central catecholamine activity in rats. Pflugers. Arch. 
433(6), 744-9. 
 
Couzo, E., Jeffries, H.E., Vizuete, W. 2013. Houston's rapid ozone increases: preconditions and 
geographic origins. Environ. Chem. 10(3), 260-268. 
 
Crockford, C., Deschner, T., Wittig, R.M. 2017. The Role of Oxytocin in Social Buffering: What 
Do Primate Studies Add?. Curr. Top. Behav. Neurosci. [Epub ahead of print]. 
 
Cruz-Topete, D., Cidlowski, J.A. 2015. One hormone, two actions: anti- and pro-inflammatory 
effects of glucocorticoids. Neuroimmunomodulation. 22(1-2): 20–32. 
 
Daly, C.J., McGrath, J.C. 2011. Previously unsuspected widespread cellular and tissue 
distribution of β-adrenoceptors and its relevance to drug action. Trends Pharmacol Sci. 32(4), 
219-26. 
 
Day, D.B., Xiang, J., Mo, J., Li, F., Chung, M., Gong, J., Weschler, C.J., Ohman-Strickland, 
P.A., Sundell, J., Weng, W., Zhang, Y., Zhang, J.J. 2017. Association of Ozone Exposure With 
Cardiorespiratory Pathophysiologic Mechanisms in Healthy Adults. JAMA Intern. Med. [Epub 
ahead of print] 
 
De Bosscher, K., Vanden Berghe, W., Haegeman, G. 2000. Mechanisms of anti-inflammatory 
action and of immunosuppression by glucocorticoids: negative interference of activated 
glucocorticoid receptor with transcription factors. J Neuroimmunol. 109(1), 16-22. 
 
Delaunois, A., Segura, P., Dessy-Doizé, C., Ansay, M., Montaño, L.M., Vargas, M.H., Gustin, P. 
1997. Ozone-induced stimulation of pulmonary sympathetic fibers: a protective mechanism 
against edema. Toxicol. Appl. Pharmacol. 147(1), 71-82. 
 
Devlin, R.B., Duncan, K.E., Jardim, M., Schmitt, M.T., Rappold, A.G., Diaz-Sanchez, D. 2012. 
Controlled exposure of healthy young volunteers to ozone causes cardiovascular effects. 
Circulation. 126(1), 104-11.  
 
DeWitt, J.C., Williams, W.C., Creech, N.J., and Luebke, R.W. 2016. Suppression of antigen-
specific antibody responses in mice exposed to perfluorooctanoic acid: Role of PPARα and T- 
and B-cell targeting. J Immunotoxicol. 13(1), 38-45.  
 
Dhabhar, F.S. 2014. Effects of stress on immune function: the good, the bad, and the beautiful. 
Immunol Res. 58(2-3), 193-210.  
 
Dhabhar, F.S., Malarkey, W.B., Neri, E., McEwen, B.S.  2012. Stress-induced redistribution of 
immune cells--from barracks to boulevards to battlefields: a tale of three hormones--Curt Richter 
Award winner. Psychoneuroendocrinology. 37(9), 1345-68. 
 
166 
 
Di, Q., Wang, Y., Zanobetti, A., Wang, Y., Koutrakis, P., Choirat, C., Dominici, F., Schwartz, J.D. 
2017. Air Pollution and Mortality in the Medicare Population. N. Engl. J. Med. 376(26), 2513-
2522. 
 
Dodam, J.R., Moon, R.E., Olson, N.C., Exposito, A.J., Fawcett, T.A., Huang, Y.C., Theil, D.R., 
Camporesi, E., and Swanson, C.R. 1993. Effects of clenbuterol hydrochloride on pulmonary gas 
exchange and hemodynamics in anesthetized horses. Am J Vet Res. 54(5), 776-82. 
 
Dormans, J.A., van Bree, L., Boere, A.J., Marra, M., Rombout, P.J. 1999. Interspecies 
differences in time course of pulmonary toxicity following repeated exposure to ozone. Inhal. 
Toxicol. 11(4), 309-29. 
 
Douwes, J., Brooks, C., and Pearce, N. 2011. Asthma nervosa: old concept, new insights. Eur 
Respir J. 37(5), 986-90.  
 
Droujinine, I.A., Perrimon, N. 2013. Defining the interorgan communication network: systemic 
coordination of organismal cellular processes under homeostasis and localized stress. Front.  
 
Duque, E.A., Munhoz, C.D. 2016. The Pro-inflammatory Effects of Glucocorticoids in the Brain. 
Front. Endocrinol. (Lausanne). 7, 78. 
 
Dye, J.A., Costa, D.L., Kodavanti, U.P. 2015a. Executive Summary: variation in susceptibility to  
ozone-induced health effects in rodent models of cardiometabolic disease. Inhal Toxicol.27 
Suppl 1, 105-15. 
 
Dye, J.A., Ledbetter, A.D., Schladweiler, M.C., Costa, D.L., Kodavanti, U.P. 2015b. Whole body 
plethysmography reveals differential ventilatory responses to ozone in rat models of 
cardiovascular disease. Inhal. Toxicol. 27 Suppl 1, 14–25. 
 
Dziedzic, D., White, H.J. 1986. Thymus and pulmonary lymph node response to acute and 
subchronic ozone inhalation in the mouse. Environ Res. 41(2), 598-609. 
 
Eastman, H.B., Fawcett, T.W., Udelsman, R., Holbrook, N.J., 1996. Effects of perturbations of 
the hypothalamic-pituitary-adrenal axis on the acute phase response: altered C/EBP and acute 
phase response gene expression in lipopolysaccharide-treated rats. Shock Augusta Ga 6, 286–
92. 
 
Eliat, C., Lassel, L., Guillou, Y.M., and Le Bouar, G. 2002. Intravenous beta-2-adrenergic 
agonists for tocolytic therapy in pre-eclampsia: two cases of acute pulmonary edema. Ann Fr 
Anesth Reanim. 21(9), 737-40. 
 
EPA, 2007. Airnow.gov (2017. September 7). Retrieved from 
https://airnow.gov/index.cfm?action=airnow.mapsarchivedetail&domainid=29&mapdate=201708
31&tab=2 
 
Erickson, M.A., Jude, J., Zhao, H., Rhea, E.M., Salameh, T.S., Jester, W., Pu, S., Harrowitz, J., 
Nguyen, N., Banks, W.A. 2017. Serum amyloid A: an ozone-induced circulating factor with 
potentially important functions in the lung-brain axis. FASEB J. 31(9):3950-3965. 
 
Everly, G.S., Lating, J.M. 2012. The Anatomy and Physiology of the Human Stress Response. A 
Clinical Guide to the Treatment of the Human Stress Response, 17-51. 
167 
 
 
Farraj, A.K., Hazari, M.S., Winsett, D.W., Kulukulualani, A., Carll, A.P., Haykal-Coates, N., 
Lamb, C.M., Lappi, E., Terrell, D., Cascio, W.E., Costa, D.L. 2012. Overt and latent cardiac 
effects of ozone inhalation in rats: evidence for autonomic modulation and increased myocardial 
vulnerability. Environ. Health Perspect. 120(3), 348-54. 
 
Fei, X., Bao, W., Zhang, P., Zhang, X., Zhang, G., Zhang, Y., Zhou, X., Zhang, M. 2017. 
Inhalation of progesterone inhibits chronic airway inflammation of mice exposed to ozone. Mol 
Immunol. 85, 174-184.  
 
Fink, G. 2010. Stress Science Neuroendocrinology (pp. 3-37). San Diego, CA. Academic Press.  
 
Fireman, P. 1995. B2 agonists and their safety in the treatment of asthma. Allergy Proc. 16(5), 
235-9. 
 
Folwarczna, J., Pytlik, M., Sliwiński, L., Cegieła, U., Nowińska, B., Rajda, M. 2011.Effects of 
propranolol on the development of glucocorticoid-induced osteoporosis in male rats. Pharmacol. 
Rep. 63(4), 1040–9. 
 
Frampton, M.W. 2011. Ozone air pollution: how low can you go?. Am. J. Respir. Crit. Care. 
Med. 184(2), 150-1. 
 
Francis, M., Sun, R., Cervelli, J.A., Choi, H., Mandal, M., Abramova, E.V., Gow, A.J., Laskin, 
J.D., Laskin, D.L. 2017. Editor's Highlight: Role of Spleen-Derived Macrophages in Ozone-
Induced Lung Inflammationand Injury. Toxicol. Sci. 155(1), 182-195.  
 
Freed, A.N., Chou, C.L., Fuller, S.D., Croxton, T.L. 1996. Ozone-induced vagal reflex modulates 
airways reactivity in rabbits. Respir. Physiol. 105(1-2), 95-102. 
 
Friedrich, M.J. 2016. Air Pollution Highest in World’s Poorest Cities. JAMA. 316(3), 259.  
Fuller, C.H., Feeser, K.R., Sarnat, J.A., O'Neill, M.S. 2017. Air pollution, cardiovascular 
endpoints and susceptibility by stress and material resources: a systematic review of the 
evidence. Environ Health. 16(1), 58.  
 
Fuso, L., Mores, N., Valente, S., Malerba, M.,Montuschi, P., 2013. Long-acting beta-agonists 
and their association with inhaled corticosteroids in COPD. Curr. Med. Chem. 20, 1477–1495. 
 
Gabehart, K., Correll, K.A., Loader, J.E.,White, C.W., Dakhama, A., 2015. The lung response to 
ozone is determined by age and is partially dependent on toll-like receptor 4. Respir. Res. 16, 
117. 
 
Gackière, F., Saliba, L., Baude, A., Bosler, O., Strube, C. 2011. Ozone inhalation activates 
stress-responsive regions of the CNS. J. Neurochem. 117(6), 961-72. 
 
Gent, J.F., Triche, E.W., Holford, T.R., Belanger, K., Bracken, M.B., Beckett, W.S., Leaderer, 
B.P. 2003. Association of low-level ozone and fine particles with respiratory symptoms in 
children with asthma. JAMA. 290(14), 1859-67. 
 
George, G., Hook, G.E. 1984. The pulmonary extracellular lining. Environ. Health. Perspect. 55, 
227-37. 
 
168 
 
Gerrity, T., Wiester, M. 1987. Experimental Measurements of the Uptake of Ozone in Rats and 
Human Subjects. U.S. Environmental Protection Agency, Washington, D.C., EPA/600/D-87/319 
(NTIS PB88125422),  
 
Ghanemi, A., Hu, X. 2015. Elements toward novel therapeutic targeting of the adrenergic 
system. Neuropeptides. 49, 25-35. 
 
Giannadaki, D., Lelieveld, J., Pozzer, A. 2016. Implementing the US air quality standard for 
PM2.5 worldwide can prevent millions of premature deaths per year. Environ. Health. 15(1), 88.  
 
Gohil, K., Cross, C.E., Last, J.A., 2003. Ozone-induced disruptions of lung transcriptomes. 
Biochem. Biophys. Res. Commun. 305, 719–728. 
 
Goldstein, B.D. 1978. The pulmonary and extrapulmonary effects of ozone. Ciba. Found. Symp. 
(65), 295-319. 
 
Gomez-Crisostomo, N.P., Rodriguez Martinez, E., Rivas-Arancibia, S. 2014. Oxidative stress 
activates the transcription factors FoxO 1a and FoxO 3a in the hippocampus of rats exposed to 
low doses of ozone. Oxid. Med. Cell. Longev. 805764. 
 
González-Guevara, E., Martínez-Lazcano, J.C., Custodio, V., Hernández-Cerón, M., Rubio, C., 
Paz, C. 2014. Exposure to ozone induces a systemic inflammatory response: possible source of 
the neurological alterations induced by this gas. Inhal. Toxicol. 26(8), 485-91. 
 
Goodman, J.W., Peter-Fizaine, F.E., Shinpock, S.G., Hall, E.A., Fahmie, D.J. 1989. 
Immunologic and hematologic consequences in mice of exposure to ozone. J. Environ. Pathol. 
Toxicol. Oncol. 9(3), 243-52. 
 
Gordon, C.J., Jarema, K.A., Lehmann, J.R., Ledbetter, A.D., Schladweiler, M.C., Schmid, J.E., 
Ward, W.O., Kodavanti, U.P., Nyska, A., MacPhail, R.C. 2013. Susceptibility of adult and 
senescent Brown Norway rats to repeated ozone exposure: an assessment of behavior, serum 
biochemistry and cardiopulmonary function. Inhal. Toxicol. 25(3), 141-59.  
 
Gordon, C.J., Johnstone, A.F., Aydin, C., Phillips, P.M., MacPhail, R.C., Kodavanti, U.P., 
Ledbetter, A.D., Jarema, K.A. 2014. Episodic ozone exposure in adult and senescent Brown 
Norway rats: acute and delayed effect on heart rate, core temperature and motor activity. Inhal. 
Toxicol. 26(7), 380-90. 
 
Gordon, C.J., Phillips, P.M., Johnstone, A.F., Beasley, T.E., Ledbetter, A.D., Schladweiler, M.C., 
Snow, S.J., Kodavanti, U.P. 2016. Effect of high-fructose and high-fat diets on pulmonary 
sensitivity, motor activity, and body composition of brown Norway rats exposed to ozone. Inhal 
Toxicol. 28(5), 203-15. 
 
Gorman, L.S. 2013.The adrenal gland: common disease states and suspected new 
applications. Clin Lab Sci. 26(2), 118-25. 
 
Gorr, TA. 2017. Hypometabolism as the ultimate defence in stress response: how the 
comparative approach helps understanding of medically relevant questions. Acta Physiol (Oxf). 
219(2), 409-440. 
 
169 
 
Gotschi, T., Heinrich, J., Sunyer, J., Künzli, N. 2008. Long-term effects of ambient air pollution 
on lung function: a review. Epidemiology. 19(5), 690-701. 
 
Graham, R.M., Friedman, M., Hoyle, G.W. 2001. Sensory nerves promote ozone-induced lung 
inflammation in mice. Am. J. Respir. Crit. Care. Med. 164(2), 307-13. 
 
Gunnison, A.F., Bowers, A., Nadziejko, C., Adler, R.A. 1997. Modulation of the inflammatory 
effects of inhaled ozone in rats by subcutaneous prolactin-secreting, pituitary-derived tumors. 
Fundam. Appl. Toxicol. 37(1), 88-94. 
 
Gupta, 2014. Biomarkers in Toxicology (pp. 217-239). San Diego, CA. Academic Press. 
 
Haagen-Smit, A.J., 1952. Chemistry and physiology of Los Angeles smog. Ind. Eng. Chem. 44, 
1342–1346. 
 
Haagen-Smit, A.J. 1963. Photochemistry and Smog. J. Air Pollut. Control Assoc. 13, 444-6. 
 
Haagen-Smit, A.J. 1970. A lesson from the smog capital of the world. Proc. Natl. Acad. Sci. U S 
A. 67(2), 887-97. 
 
Hamelmann, E., Schwarze, J., Takeda, K., Oshiba, A., Larsen, G.L., Irvin, C.G., Gelfand, E.W. 
1997.Noninvasive measurement of airway responsiveness in allergic mice using barometric 
plethysmography. Am. J. Respir. Crit. Care. Med. 156(3), 766–75. 
 
Hamilton, R.F. Jr., Hazbun, M.E., Jumper, C.A., Eschenbacher, W.L., Holian, A. 1996. 4-
Hydroxynonenal mimics ozone-induced modulation of macrophage function ex vivo. Am. J. 
Respir. Cell. Mol. Biol. 15(2), 275-82. 
 
Hamilton, R.F.Jr., Li, L., Eschenbacher, W.L., Szweda, L., Holian, A. 1998. Potential 
involvement of 4-hydroxynonenal in the response of human lung cells to ozone. Am. J. Physiol. 
274(1 Pt 1), L8-16. 
 
Hampel, R., Breitner, S., Zareba, W., Kraus, U., Pitz, M., Geruschkat, U., Belcredi, P., Peters, 
A., Schneider, A., et al. 2012. Immediate ozone effects on heart rate and repolarisation 
parameters in potentially susceptible individuals. Occup. Environ. Med. 69(6), 428-36. 
 
Han, S., Mallampalli, R.K. 2015. The Role of Surfactant in Lung Disease and Host Defense 
against Pulmonary Infections. Ann. Am. Thorac. Soc. 12(5), 765-74.  
 
Hao, Y., Okamura, S., Wang, L.M., and Mineshita, S. 2001. The involvement of bradykinin in 
adrenaline-induced pulmonary edema in rats. J Med Dent Sci. 48(3), 79-85. 
 
Haque, R., Umstead, T.M., Freeman, W.M., Floros, J., Phelps, D.S. 2009. The impact of 
surfactant protein-A on ozone-induced changes in the mousebronchoalveolar lavage proteome. 
Proteome Sci. 7, 12.  
 
Hassan, B., Akcakanat, A., Holder, A.M., Meric-Bernstam, F., 2013. Targeting the PI3- 
Kinase/Akt/mTOR signaling pathway. Surg. Oncol. Clin. N. Am. 22, 641–664. 
 
Hassett, C., Mustafa, M.G., Coulson, W.F., Elashoff, R.M.  1985. Splenomegaly in mice 
following exposure to ambient levels of ozone. Toxicol. Lett. 26(2-3), 139-44. 
170 
 
 
Hatch, G.E., McKee, J., Brown, J., McDonnell, W., Seal, E., Soukup, J., Slade, R., Crissman, K., 
Devlin, R. 2013. Biomarkers of Dose and Effect of Inhaled Ozone in Resting versus Exercising 
Human Subjects: Comparison with Resting Rats. Biomark. Insights. 8, 53-67. 
 
Hatch, G.E., Slade, R., Harris, L.P., McDonnell, W.F., Devlin, R.B., Koren, H.S., Costa, D.L., 
McKee, J. 1994. Ozone dose and effect in humans and rats. A comparison using oxygen-18 
labeling and bronchoalveolar lavage. Am. J. Respir. Crit. Care. Med. 150(3), 676-83. 
 
Hazbun, M.E., Hamilton, R., Holian, A., Eschenbacher, W.L. 1993. Ozone-induced increases in 
substance P and 8-epi-prostaglandin F2 alpha in the airways of human subjects. Am. J. Respir. 
Cell. Mol. Biol. 9(5), 568-72. 
 
Hegstrand, L.R., Eichelman, B. 1983.Increased shock-induced fighting with supersensitive β-
adrenergic receptors. Pharmacol. Biochem. Behav. 19(2), 313–20. 
 
Hemming, J.M., Hughes, B.R., Rennie, A.R., Tomas, S., Campbell, R.A., Hughes, A.V., Arnold, 
T., Botchway, S.W., Thompson, K.C. 2015. Environmental Pollutant Ozone Causes Damage to 
Lung Surfactant Protein B (SP-B). Biochemistry. 54(33), 5185-97.  
 
Henriquez, A., House, J., Miller, D.B., Snow, S.J., Fisher, A., Ren, H., Schladweiler, M.C., 
Ledbetter, A.D., Wright, F., and Kodavanti, U.P. 2017a. Adrenal-derived stress hormones 
modulate ozone-induced lung injury and inflammation. Toxicol Appl Pharmacol. 329, 249-258.  
 
Henriquez, A.R., Snow, S.J., Schladweiler, M.C., Miller, C.N., Dye, J.A., Ledbetter, A.D., 
Richards, J.E., Mauge-Lewis, K., McGee, M.A., and Kodavanti, U.P. 2017b. Adrenergic and 
glucocorticoid receptor antagonists reduce ozone-induced lung injury and inflammation. Toxicol 
Appl Pharmacol. (Forthcoming). 
 
Henriquez, A.R., Snow, SJ., Schladweiler, MC., Miller, CN., Dye, JA.,Ledbetter, AD., Richards, 
JE., Hargrove, MM., Kodavant, UP. 2017c. Beta-2 adrenergic and glucocorticoid receptor 
agonists modulate ozone-induced lung vascular leakage and inflammation in healthy and 
adrenalectomized rats. (Forthcoming). 
 
Hernandez-Zimbrón, L.F., Rivas-Arancibia, S. 2015. Oxidative stress caused by ozone 
exposure induces β-amyloid 1-42 overproduction and mitochondrial accumulation by activating 
the amyloidogenic pathway. Neuroscience. 304, 340-8. 
 
Hewagalamulage, S.D., Lee, T.K., Clarke, I.J., and Henry, B.A. 2016. Stress, cortisol, and 
obesity: a role for cortisol responsiveness in identifying individuals prone to obesity. Domest 
Anim Endocrinol. 56 Suppl, S112-20.  
 
Hilliard, K.L., Allen, E., Traber, K.E., Yamamoto, K., Stauffer, N.M., Wasserman, G.A., Jones, 
M.R., Mizgerd, J.P., Quinton, L.J. 2015.  The Lung-Liver Axis: A Requirement for Maximal 
Innate Immunity and Hepatoprotection during Pneumonia. Am. J. Respir. Cell. Mol. Biol. 53(3), 
378-90. 
 
Hirotsu, C., Tufik, S., and Andersen, M.L. 2015. Interactions between sleep, stress, and 
metabolism: From physiological to pathological conditions. Sleep Sci. 8(3), 143-52. 
 
171 
 
Hirst, S.J., Lee, T.H. 1998.Airway smooth muscle as a target of glucocorticoid action in the 
treatment of asthma. Am. J. Respir. Crit. Care. Med. 158(5 Pt 3), S201–6. 
 
Hjemdahl, P., Larsson, K., Johansson, M.C., Zetterlund, A., and Eklund A. 1990. Beta-
adrenoceptors in human alveolar macrophages isolated by elutriation. Br J Clin Pharmacol. 
30(5), 673-82. 
 
Ho, C.Y., Lee, L.Y. 1998. Ozone enhances excitabilities of pulmonary C fibers to chemical and 
mechanical stimuli in anesthetized rats. J. Appl. Physiol. (1985). 85(4), 1509-15. 
 
Hoag, Hannah. 2014. Air Quality to Suffer with Global Warming. Nature. 
http://www.nature.com/doifinder/10.1038/nature. 2014.15442, accessed February 9, 2016. 
 
Hoffmann, B., Luttmann-Gibson, H., Cohen, A., Zanobetti, A., de Souza, C., Foley, C., Suh, 
H.H., Coull, B.A., Schwartz, J., Mittleman, et al. 2012. Opposing effects of particle pollution, 
ozone, and ambient temperature on arterial blood pressure. Environ. Health. Perspect. 120(2), 
241-6.  
 
Holgate, S.T., Samet, J.M., Koren, H.S., Maynard, R.L. 1999. Air Pollution and Health (pp.5-20). 
London, England. Academic Press. 
 
Hollingsworth, J.W., Kleeberger, S.R., Foster, W.M. 2007. Ozone and pulmonary innate 
immunity. Proc. Am. Thorac. Soc. 4(3), 240–6. 
 
Holz, O., Khalilieh, S., Ludwig-Sengpiel, A., Watz, H., Stryszak, P., Soni, P., Tsai, M., Sadeh, J., 
Magnussen, H. 2010. SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced 
neutrophilia in healthy subjects. Eur. Respir. J. 35(3), 564-70. 
 
Hoppe, P., Praml, G., Lindner, J., Rabe, G., Fruhmann, G. 1995. Lung function and prevalence 
of irritation of eyes and respiratory airways on days with elevated ozone concentrations. Immun. 
Infekt. 23(5), 161-5. 
 
Horton, D.E., Skinner, C.B., Singh, D., Diffenbaugh, N.S. 2014. Occurrence and Persistence of 
Future Atmospheric Stagnation Events. Nature Climate Change 4(8), 698–703. 
 
Howland, R.H. 2013. Mifepristone as a therapeutic agent in psychiatry. J. Psychosoc. Nurs. 
Ment. Health. Serv. 51(6), 11–4. 
 
Hu, S.C., Ben-Jebria, A., Ultman, J.S. 1992. Longitudinal distribution of ozone absorption in the 
lung: quiet respiration in healthy subjects. J. Appl. Physiol. (1985). 73(4), 1655-61. 
 
Huang, B., Wang, D.X., Deng, W. 2014. Protective effects of dexamethasone on early acute 
lung injury induced by oleic acid in rats. Int J Clin Exp Med. 7(12), 4698-709.  
 
Huffman, L.J., Beighley, C.M., Frazer, D.G., McKinney, W.G., Porter, D.W. 2006. Increased 
susceptibility of the lungs of hyperthyroid rats to oxidant injury: specificity of effects. Toxicology. 
225(2-3), 119-27.  
 
Hwang, S.H., Choi, Y.H., Paik, H.J., Wee, W.R., Kim, M.K., Kim, D.H. 2016. Potential 
Importance of Ozone in the Association Between Outdoor Air Pollution and Dry Eye Disease in 
South Korea. JAMA Ophthalmol. [Epub ahead of print]. 
172 
 
 
Inoue, K., Takano, H., Kaewamatawong, T., Shimada, A., Suzuki, J., Yanagisawa, R., Tasaka, 
S., Ishizaka, A., Satoh, M. 2008. Role of metallothionein in lung inflammation induced by ozone 
exposure in mice. Free. Radic. Biol. Med. 45(12), 1714–22. 
 
Iwasaki, T., Takahashi, M., Saito, H., Arito, H., 1998. Adaptation of extrapulmonary responses 
to ozone exposure in conscious rats. Ind. Health 36, 57–60. 
 
Jerrett, M. 2015. Atmospheric science: The death toll from air-pollution sources. Nature. 
525(7569), 330-1. The Lancet. 2016. Air pollution--crossing borders. 388(10040), 103. 
 
Jacob, S.T., Ghoshal, K., Sheridan, J.F. 1999.Induction of metallothionein by stress and its 
molecular mechanisms. Gene. Expr. 7(4-6), 301–10. 
 
Jerrett, M., Burnett, R.T., Pope, C.A.3rd., Ito, K., Thurston, G., Krewski, D., Shi, Y., Calle, E., 
Thun, M. 2009. Long-term ozone exposure and mortality. N. Engl. J. Med. 360(11), 1085-95.  
 
Jia, X., Song, X., Shima, M., Tamura, K., Deng, F., Guo, X. 2011. Acute effect of ambient ozone 
on heart rate variability in healthy elderly subjects. J. Expo. Sci. Environ. Epidemiol. 21(5), 541-
7. 
 
Jimba, M., Skornik, W.A., Killingsworth, C.R., Long, N.C., Brain, J.D., Shore, S.A. 1995. Role of 
C fibers in physiological responses to ozone in rats. J. Appl. Physiol. (1985). 78(5), 1757-63. 
 
Joad, J.P., Kott, K.S., Bric, J.M. 1996. The local C-fiber contribution to ozone-induced effects on 
the isolated guinea pig lung. Toxicol Appl Pharmacol. 141(2), 561-7. 
 
Jobe, A.H., Ikegami, M. 1998. Surfactant homeostasis in corticotropin-releasing hormone 
deficiency in adult mice. Am. J. Respir. Crit. Care Med. 158(3), 995-7. 
 
Johnson, J.D., Campisi, J., Sharkey, C.M., Kennedy, S.L., Nickerson, M., Greenwood, B.N., 
Fleshner, M. 2005. Catecholamines mediate stress-induced increases in peripheral and central 
inflammatory cytokines. Neuroscience 135(4), 1295–307. 
 
Johnston, R.A., Schwartzman, I.N., Shore, S.A., 2003. Macrophage inflammatory protein-2 
levels are associated with changes in serum leptin concentrations following ozone induced 
airway inflammation. Chest 123, 369S–370S. 
 
Johnston, R.A., Schwartzman, I.N., Flynt, L., Shore, S.A. 2005. Role of interleukin-6 in murine 
airway responses to ozone. Am J Physiol Lung Cell Mol Physiol. 288(2), L390-7.  
 
Jonasson, S., Wigenstam, E., Koch, B., and Bucht, A. 2013. Early treatment of chlorine-induced 
airway hyperresponsiveness and inflammation with corticosteroids. Toxicol Appl Pharmacol. 
271(2), 168-74. 
 
Jones, G.L., Lane, C.G., Manning, P.J., O'Byrne, P.M. 1987. Role of the parasympathetic 
nervous system in airway hyperresponsiveness after ozone inhalation. J. Appl. Physiol. (1985). 
63(3), 1174-9. 
 
Joseph, J.J., and Golden, S.H. 2017. Cortisol dysregulation: the bidirectional link between 
stress, depression, and type 2 diabetes mellitus. Ann N Y Acad Sci. 1391(1),20-34.  
173 
 
 
Jung, C.R., Lin, Y.T., Hwang, B.F. 2015. Ozone, particulate matter, and newly diagnosed 
Alzheimer's disease: a population-based cohort study in Taiwan. J. Alzheimers Dis. 44(2), 573-
84. 
 
Kabel, J.R., Ben-Jebria, A., Ultman, J.S. 1994. Longitudinal distribution of ozone absorption in 
the lung: comparison of nasal and oral quiet breathing. J. Appl. Physiol. (1985). 77(6), 2584-92. 
Kaczmarczyk, G. 1994. Pulmonary-renal axis during positive-pressure ventilation. New Horiz. 
2(4),512-7.  
 
Kadiiska, M.B., Basu, S., Brot, N., Cooper, C., Saari Csallany, A., Davies, M.J., George, M.M., 
Murray, D.M., Jackson Roberts 2nd, L., Shigenaga, M.K., et al., 2013. Biomarkers of oxidative 
stress study V: ozone exposure of rats and its effect on lipids, proteins, and DNA in plasma and 
urine. Free Radic. Biol. Med. 61C, 408–415. 
 
Kadiiska, M.B., Hatch, G.E., Nyska, A,, Jones, D.P., Hensley, K., Stocker, R., George, M.M., 
Van Thiel, D.H., Stadler, K., Barrett, J.C., Mason, R.P. 2011. Biomarkers of Oxidative Stress 
Study IV: ozone exposure of rats and its effect on antioxidants in plasma and bronchoalveolar 
lavage fluid. Free Radic Biol Med. 51(9), 1636-42.  
 
Kafoury, R.M., Pryor, W.A., Squadrito, G.L., Salgo, M.G., Zou, X., Friedman, M. 1998. Lipid 
ozonation products activate phospholipases A2, C, and D. Toxicol. Appl. Pharmacol. 150(2), 
338-49. 
 
Kakade, A.S., Kulkarni, Y.S. 2014.Mifepristone: current knowledge and emerging prospects. J. 
Indian. Med. Assoc. 112(1), 36–40. 
 
Keller-Wood, M. 2015. Hypothalamic-Pituitary--Adrenal Axis-Feedback Control. Compr Physiol. 
5(3), 1161-82. 
 
Kenyon, N.J., Last, M.S., Eiserich, J.P., Morrissey, B.M., Temple, L.M., Last, J.A. 2006. 
Differentiation of the roles of NO from airway epithelium and inflammatory cells in ozone-
induced lung inflammation. Toxicol. Appl. Pharmacol. 215(3):250-9. 
 
Kielgast, F., Schmidt, H., Braubach, P., Winkelmann, V.E., Thompson, K.E., Frick, M., Dietl, P., 
Wittekindt, O.H., 2016. Glucocorticoids regulate tight junction permeability of lung epithelia by 
modulating Claudin 8. Am. J. Respir. Cell Mol. Biol. 54, 707–717. 
 
Kim, C.S., Alexis, N.E., Rappold, A.G., Kehrl, H., Hazucha, M.J., Lay, J.C., Schmitt, M.T., Case, 
M., Devlin, R.B., Peden, D.B., et al. 2011. Lung function and inflammatory responses in healthy 
young adults exposed to 0.06 ppm ozone for 6.6 hours. Am. J. Respir. Crit. Care. Med. 183(9), 
1215-21. 
 
Kim, H.I., Kim, H., Shin, Y.S., Beegle, L.W., Jang, S.S., Neidholdt, E.L., Goddard, W.A., Heath, 
J.R., Kanik, I., Beauchamp, J.L., 2010. Interfacial reactions of ozone with surfactant protein B in 
a model lung surfactant system. J. Am. Chem. Soc. 132, 2254–2263. 
 
Kim, M.Y., Song, K.S., Park, G.H., Chang, S.H., Kim, H.W., Park, J.H., Jin, H., Eu, K.J., Cho, 
H.S., Kang, G., et al., 2004. B6C3F1 mice exposed to ozone with 4-(N-methyl-Nnitrosamino)- 1-
3-pyridyl)-1-butanone and/or dibutyl phthalate showed toxicities through alterations of NF- 
KappaB, AP-1, Nrf2, and osteopontin. J. Vet. Sci. 5, 131–137. 
174 
 
 
Kirichenko, A., Li, L., Morandi, M.T., Holian, A. 1996. 4-hydroxy-2-nonenal-protein adducts and 
apoptosis in murine lung cells after acute ozone exposure. Toxicol. Appl. Pharmacol. 141(2), 
416-24. 
 
Kirrane, E.F., Bowman, C., Davis, J.A., Hoppin, J.A., Blair, A., Chen, H., Patel, M.M., Sandler, 
D.P., Tanner, C.M., Vinikoor-Imler, L., et al. 2015. Associations of Ozone and PM2.5 
Concentrations With Parkinson's Disease Among Participants in the Agricultural Health Study. 
J. Occup. Environ. Med. 57(5), 509-17. 
 
Kirschvink, N., Fiévez, L., Bureau, F., Degand, G., Maghuin-Rogister, G., Smith, N., Art, T., 
Lekeux, P., 2002. Adaptation to multiday ozone exposure is associated with a sustained 
increase of bronchoalveolar uric acid. Free Radic. Res. 36, 23–32. 
 
Kirsten, A., Watz, H., Pedersen, F., Holz, O., Smith, R., Bruin, G., Koehne-Voss, S., 
Magnussen, H., Waltz, D.A., 2013. The anti-IL-17A antibody secukinumab does not attenuate 
ozone-induced airway neutrophilia in healthy volunteers. Eur. Respir. J. 41, 239–241.  
 
Kleeberger, S.R., Longphre, M., Tankersley, C.G. 1999. Mechanisms of response to ozone 
exposure: the role of mast cells in mice. Res. Rep. Health. Eff. Inst. (85), 1-30, discussion 31-6. 
 
Kleeberger, S.R., Reddy, S.P., Zhang, L.Y., Cho, H.Y., Jedlicka, A.E. 2001. Toll-like receptor 4 
mediates ozone-induced murine lung hyperpermeability via inducible nitric oxide synthase. Am. 
J. Physiol. Lung. Cell. Mol. Physiol. 280(2), L326-33. 
 
Kleeberger, S.R., Seiden, J.E., Levitt, R.C., Zhang, L.Y. 1993. Mast cells modulate acute ozone-
induced inflammation of the murine lung. Am. Rev. Respir. Dis. 148(5), 1284-91. 
 
Kodavanti, U.P. 2016. Stretching the stress boundary: Linking air pollution health effects to a 
neurohormonal stress response. Biochim. Biophys. Acta. 1860(12), 2880-90.  
 
Kodavanti, U.P., Ledbetter, A.D., Thomas, R.F., Richards, J.E., Ward, W.O., Schladweiler, 
M.C., Costa, D.L. 2015. Variability in ozone-induced pulmonary injury and inflammation in 
healthy and cardiovascular-compromised rat models. Inhal Toxicol. 27 Suppl 1, 39-53. 
 
Kohut, M.L., Davis, J.M., Jackson, D.A., Colbert, L.H., Strasner, A., Essig, D.A., Pate, R.R., 
Ghaffar, A., and Mayer, E.P. 1998. The role of stress hormones in exercise-induced 
suppression of alveolar macrophage antiviral function. J Neuroimmunol. 81(1-2), 193-200. 
 
Kolebinov, NKh., Ankov, V.K., and Belovezhdov, N.I. 1975. Depression of cortisol secretion with 
dexamethasone in healthy persons. Vutr Boles. 14(1), 89-93. 
 
Kolmus, K., Tavernier, J., Gerlo, S. 2015. β2-Adrenergic receptors in immunity and 
inflammation: stressing NF-κB. Brain. Behav. Immun. 45, 297–310. 
 
Kopitar, Z. 1969. Autoradiographic investigations on the distribution of [14C]-N-AB 365 CL in 
rats and pregnant mice (ADME 1 B). Unpublished report No. U69-0108. Submitted to WHO by 
Boehringer Ingelheim Vetmedica GmbH, Ingelheim am Rhein, Germany. 
 
175 
 
Koren, H.S., Devlin, R.B., Graham, D.E., Mann, R., McGee, M.P., Horstman, D.H., Kozumbo, 
W.J., Becker, S., House, D.E., McDonnell, W.F., et al. 1989. Ozone-induced inflammation in the 
lower airways of human subjects. Am Rev Respir Dis.139(2), 407-15. 
 
Koren, L., Whiteside, D., Fahlman, Å., Ruckstul, K., Kutz, S., Checkley, S., Dumond, M., 
Wynne-Edwards, K. 2012. Cortisol and corticosterone independence in cortisol-dominant 
wildlife. Gen. Comp. Endocrinol. 177, 113–119. 
 
Kornei, K. (2017). Here are some of the world’s worst cities for air quality. Science. 
10.1126/science.aal0942. Retrieved from http://www.sciencemag.org/news/2017/03/here-are-
some-world-s-worst-cities-air-quality 
 
Kox, M., van Eijk, L.T., Zwaag, J., van den Wildenberg, J., Sweep, F.C., van der Hoeven, J.G., 
Pickkers, P. 2014. Voluntary activation of the sympathetic nervous system and attenuation of 
the innate immune response in humans. Proc. Natl. Acad. Sci. U S A. 111(20), 7379–84. 
 
Krämer, A., Green, J., Pollard, J., Tugendreich, S., 2014. Causal analysis approaches in 
ingenuity pathway analysis. Bioinforma. Oxf. Engl. 30, 523–530. 
 
Krishna, M.T., Blomberg, A., Biscione, G.L., Kelly, F., Sandstrom, T., Frew, A., Holgate, S. 
1997. Short-term ozone exposure upregulates P-selectin in normal human airways. Am. J. 
Respir. Crit. Care. Med. 155(5), 1798–803.  
 
Krishna, M.T., Chauhan, A.J., Frew, A.J., Holgate, S.T., 1998. Toxicological mechanisms 
underlying oxidant pollutant-induced airway injury. Rev. Environ. Health 13, 59–71.  
 
Krishna, M.T., Springall, D., Meng, Q.H., Withers, N., Macleod, D., Biscione, G., Frew, A., 
Polak, J., Holgate, S. 1997. Effects of ozone on epithelium and sensory nerves in the bronchial 
mucosa of healthy humans. Am. J. Respir. Crit. Care. Med. 156(3 Pt 1), 943-50. 
 
Krishnamoorthy, V., Hiller, D.B., Ripper, R., Lin, B., Vogel, S.M., Feinstein, D.L., Oswald, S., 
Rothschild, L., Hensel, P., Rubinstein, I., et al. 2012. Epinephrine induces rapid deterioration in 
pulmonary oxygen exchange in intact, anesthetized rats: a flow and pulmonary capillary 
pressure-dependent phenomenon. Anesthesiology. 117(4), 745-54. 
 
Kubo, K., Kita, T., Tsujimura, T., Nakashima, T. Effect of nicotine-induced corticosterone 
elevation on nitric oxide production in the passive skin arthus reaction in rats. 2004. J. 
Pharmacol. Sci. 94(1), 31–8.  
 
Kulle, T.J., Cooper, G.P. 1975. Effects of formaldehyde and ozone on the trigeminal nasal 
sensory system. Arch. Environ. Health. 30(5), 237-43. 
 
Kumagai, K., Lewandowski, R., Jackson-Humbles, D.N., Li, N., Van Dyken, S.J.,Wagner, J.G., 
Harkema, J.R., 2016. Ozone-induced nasal type 2 immunity in mice is dependent on innate 
lymphoid cells. Am. J. Respir. Cell Mol. Biol. Online 54, 782–791.  
 
Kumarathasan, P., Blais, E., Saravanamuthu, A., Bielecki, A., Mukherjee, B., Bjarnason, S., 
Guénette, J., Goegan, P., and Vincent, R. 2015. Nitrative stress, oxidative stress and plasma 
endothelin levels after inhalation of particulate matter and ozone. Part Fibre Toxicol. 12:28. 
 
176 
 
Kurhanewicz, N., McIntosh-Kastrinsky, R., Tong, H., Ledbetter, A., Walsh, L., Farraj, A., Hazari, 
M. 2017. TRPA1 mediates changes in heart rate variability and cardiac mechanical function in 
mice exposed to acrolein. Toxicol Appl Pharmacol. 324, 51-60.  
 
Kurz, T., Yamada, K.A., DaTorre, S.D., Corr, P.B. 1991.Alpha 1-adrenergic system and 
arrhythmias in ischaemic heart disease. Eur. Heart. J. 12 Suppl F, 88–98. 
 
Laakko, T., Fraker, P. Rapid changes in the lymphopoietic and granulopoietic compartments of 
the marrow caused by stress levels of corticosterone. 2002. Immunology, 105(1): 111–9. 
 
Lam, H.C., Li, A.M., Chan, E.Y., Goggins, W.B. 2016. The short-term association between 
asthma hospitalisations, ambient temperature, other meteorological factors and air pollutants in 
Hong Kong: a time-series study. Thorax. 71(12), 1097-1109.  
 
Lang, G., Dernoncourt, V., Bisson, J.F. 2015. Negative effect of clenbuterol on physical 
capacities and neuromuscular control of muscle atrophy in adult rats. Muscle Nerve. 52(6), 
1078-87.  
 
Langford, S.D., Bidani, A., Postlethwait, E.M. 1995. Ozone-reactive absorption by pulmonary 
epithelial lining fluid constituents. Toxicol. Appl. Pharmacol. 132(1), 122-30. 
 
Laskin, D.L., Heck, D.E., and Laskin, J.D. 1998. Role of inflammatory cytokines and nitric oxide 
in hepatic and pulmonary toxicity. Toxicol Lett. 102-103, 289-93. 
 
Laskin, D.L., Pendino, K.J., Punjabi, C.J., Rodriguez del Valle, M., Laskin, J.D. 1994. Pulmonary 
and hepatic effects of inhaled ozone in rats. Environ. Health Perspect. 102 Suppl 10, 61-4. 
 
Lee, L.Y., Dumont, C., Djokic, T.D., Menzel, T.E., Nadel, J.A. 1979. Mechanism of rapid, 
shallow breathing after ozone exposure in conscious dogs. J. Appl. Physiol. Respir. Environ. 
Exerc. Physiol. 46(6), 1108-14. 
 
Leroy, P., Tham, A., Wong, H., Tenney, R., Chen, C., Stiner, R., Balmes, J.R., Paquet, A.C., 
Arjomandi, M. 2015. Inflammatory and repair pathways induced in human bronchoalveolar 
lavage cells with ozone inhalation. PLoS One. 10(6):e0127283. 
 
Li, A.F., Richters, A. 1991. Ambient level ozone effects on subpopulations of thymocytes and 
spleen T lymphocytes. Arch Environ Health. 46(1), 57-63. 
 
Li, B., Duan, X., Xu, C., Wu, J., Liu, B., Du, Y., Luo, Q., Jin, H., Gong, W., Dong, J. 2014. Icariin 
attenuates glucocorticoid insensitivity mediated by repeated psychosocial stress on an 
ovalbumin-induced murine model of asthma. Int. Immunopharmacol. 19(2), 381-90.  
 
Li, W., Dorans, K.S., Wilker, E.H., Rice, M.B., Ljungman, P.L., Schwartz, J.D., Coull, B.A., 
Koutrakis, P., Gold, D.R., Keaney, J.F.Jr., et al. 2017. Short-Term Exposure to Ambient Air 
Pollution and Biomarkers of Systemic Inflammation: The Framingham Heart Study. Arterioscler. 
Thromb. Vasc. Biol. [Epub ahead of print]. 
 
Li, W., Pauluhn, J. 2017. Phosgene-induced acute lung injury (ALI): differences from chlorine-
induced ALI and attempts to translate toxicology to clinical medicine. Clin. Transl. Med. 6(1), 19. 
 
177 
 
Lippmann, M. 1993. Health effects of tropospheric ozone: review of recent research findings 
and their implications to ambient air quality standards. J Expo Anal Environ Epidemiol. 3(1), 
103-29. 
 
Lippmann, M. 2010. Targeting the components most responsible for airborne particulate matter 
health risks. J. Expo. Sci. Environ. Epidemiol. 20(2), 117-8. 
 
Love, M.I., Huber, W., Anders, S., 2014. Moderated estimation of fold change and dispersion for 
RNA-seq data with DESeq2. Genome Biol. 15, 550. 
 
Malig, B.J., Pearson, D.L., Chang, Y.B., Broadwin, R., Basu, R., Green, R.S., Ostro, B. 2016. A 
Time-Stratified Case-Crossover Study of Ambient Ozone Exposure and Emergency Department 
Visits for Specific Respiratory Diagnoses in California (2005-2008). Environ Health Perspect. 
124(6), 745-53.  
 
Martínez-Lazcano, J.C., González-Guevara, E., del Carmen Rubio, M., Franco-Pérez, J., 
Custodio, V., Hernández-Cerón, M., Livera, C., Paz, C. 2013. The effects of ozone exposure 
and associated injury mechanisms on the central nervous system. Rev. Neurosci. 24(3), 337-
52. 
 
Martrette, J.M., Thornton, S.N., Trabalon, M.  2011. Prolonged ozone exposure effects 
behaviour, hormones and respiratory muscles in young female rats. Physiol. Behav. 103(3-4), 
302-7. 
 
Matheson, M., McClean, M., Rynell, A.C., and Berend, N. 2004. Methylprednisolone reduces 
airway microvascular permeability but not airway resistance induced by N-formylmethionine 
leucyl-phenylalanine in the rabbit. Respirology. 9(2), 211-4. 
 
Mathews, J.A., Kasahara, D.I., Cho, Y., Bell, L.N., Gunst, P.R., Karoly, E.D., Shore, S.A. 2017. 
Effect of acute ozone exposure on the lung metabolomes of obese and lean mice. PLoS One. 
12(7), e0181017.  
 
Matthay, M.A. 2014. Resolution of pulmonary edema. Thirty years of progress. Am J Respir Crit 
Care Med. 189(11), 1301-8. 
 
Mautz, W.J., Bufalino, C. 1989. Breathing pattern and metabolic rate responses of rats exposed  
to ozone. Respir. Physiol. 76(1), 69-77. 
 
Mautz, W.J., Dohm, M.R. 2004. Respiratory and behavioral effects of ozone on a lizard and a 
frog. Comp Biochem Physiol A Mol Integr Physiol. 139(3), 371-7. 
 
McCant, D., Lange, S., Haney, J., Honeycutt, M. 2017. The perpetuation of the misconception 
that rats receive a 3-5 times lower lung tissue dose than humans at the same ozone 
concentration. Inhal. Toxicol. 29(5), 187-196. 
 
McDonnell, W.F., Horstman, D.H., Hazucha, M.J., Seal, E. Jr., Haak, E.D., Salaam, S.A., 
House, D.E. 1983. Pulmonary effects of ozone exposure during exercise: dose-response 
characteristics. J. Appl. Physiol. Respir. Environ. Exerc. Physiol. 54(5), 1345-52. 
 
178 
 
McGovern, T.J., el-Fawal, H.A., Chen, L.C., and Schlesinger, R.B. 1996. Ozone-induced 
alteration in beta-adrenergic pharmacological modulation of pulmonary macrophages. Toxicol 
Appl Pharmacol. 137(1), 51-6. 
 
McGraw, D.W., Forbes, S.L., Mak, J.C., Witte, D.P., Carrigan, P.E., Leikauf, G.D., Liggett, S.B. 
2000. Transgenic overexpression of beta(2)-adrenergic receptors in airway epithelial cells 
decreases bronchoconstriction. Am. J. Physiol. Lung. Cell. Mol. Physiol. 279(2), L379-89. 
 
McGraw, D.W., Fukuda, N., James, P.F., Forbes, S.L., Woo, A.L., Lingrel, J.B., Witte, D.P., 
Matthay, M.A., Liggett, S.B., 2001. Targeted transgenic expression of beta(2)-adrenergic 
receptors to type II cells increases alveolar fluid clearance. Am. J. Phys. Lung Cell. Mol. Phys. 
281, L895–L903. 
 
Mcivor, R.A., Pizzichini, E., Turner, M.O., Hussack, P., Hargreave, F.E., and Sears, M.R. 1998. 
Potential masking effects of salmeterol on airway inflammation in asthma. Am J Respir Crit Care 
Med. 158(3), 924-30. 
 
Merchant, S., Huang, N., Korbelik,M., 2010. Expression of complement and pentraxin proteins 
in acute phase response elicited by tumor photodynamic therapy: the engagement of adrenal 
hormones. Int. Immunopharmacol. 10, 1595–1601. 
 
Mervis, J. 2015. Behind the Numbers. GOP legislators choke on ozone standards. Science. 
349(6254), 1268. 
 
Miller, D.B., Karoly, E.D., Jones, J.C., Ward, W.O., Vallanat, B.D., Andrews, D.L., Schladweiler, 
M.C., Snow, S.J., Bass, V.L., Richards, et al. 2015. Inhaled ozone (O3)-induces changes in 
serum metabolomic and liver transcriptomic profiles in rats. Toxicol. Appl. Pharmacol. 286(2), 
65-79. 
 
Miller, D.B., Ghio, A.J., Karoly, E.D., Bell, L.N., Snow, S.J., Madden, M.C., Soukup, J., Cascio, 
W.E., Gilmour, M.I., Kodavanti, U.P. 2016a. Ozone Exposure Increases Circulating Stress 
Hormones and Lipid Metabolites in Humans. Am. J. Respir. Crit. Care. Med. 193(12), 1382-91. 
 
Miller, D.B., Snow, S.J., Schladweiler, M.C., Richards, J.E., Ghio, A.J., Ledbetter, A.D., 
Kodavanti, U.P. 2016.b Acute Ozone-Induced Pulmonary and Systemic Metabolic Effects Are 
Diminished in Adrenalectomized Rats. Toxicol. Sci. 150(2), 312-22. 
 
Miller, D.B., Snow, S.J., Henriquez, A., Schladweiler, M.C., Ledbetter, A.D., Richards, J.E., 
Andrews, D.L., Kodavanti, U.P. 2016c. Systemic metabolic derangement, pulmonary effects, 
and insulin insufficiency following subchronic ozone exposure in rats. Toxicol. Appl. Pharmacol. 
306, 47-57. 
 
Miller, F.J. 1995. Uptake and fate of ozone in the respiratory tract. Toxicol. Lett. 82-83, 277-85. 
 
Molinoff, P.B. 1984.Alpha- and beta-adrenergic receptor subtypes properties, distribution and 
regulation. Drugs. 28 Suppl 2, 1–15.  
 
Montuschi, P., Nightingale, J.A., Kharitonov, S.A., Barnes, P.J., 2002. Ozone-induced increase 
in exhaled 8-isoprostane in healthy subjects is resistant to inhaled budesonide. Free Radic. Biol. 
Med. 33, 1403–1408. 
 
179 
 
Morgan, F.H., Laufgraben, M.J. 2013. Mifepristone for management of Cushing's syndrome. 
Pharmacotherapy. 33(3), 319–29. 
 
Morrison, S.F., Nakamura, K. 2011. Central neural pathways for thermoregulation. Front. Biosci. 
(Landmark Ed). 16, 74-104. 
 
Motulsky, H.J., Brown, R.E. 2006. Detecting outliers when fitting data with nonlinear regression 
– a new method based on robust nonlinear regression and the false discovery rate. BMC 
Bioinformatics. 7, 123.  
 
Mudway, I.S., Kelly, F.J. 2000. Ozone and the lung: a sensitive issue. Mol. Aspects. Med. 21(1-
2), 1-48. 
 
Mumaw, C.L., Levesque, S., McGraw, C., Robertson, S., Lucas, S., Stafflinger, J.E., Campen, 
M.J., Hall, P., Norenberg, J.P., Anderson, T., et al. 2016. Microglial priming through the lung-
brain axis: the role of air pollution-induced circulating factors. FASEB J. 30(5), 1880-91.  
 
Murray, C.J., Atkinson, C., Bhalla, K., Birbeck, G., Burstein, R., Chou, D., Dellavalle, R., Danaei, 
G., Ezzati, M., Fahimi, A., et al. 2013. The state of US health, 1990-2010: burden of diseases, 
injuries, and risk factors. JAMA. 310(6), 591-608. 
 
Nakaoka, M., Iwai-Kanai, E., Katamura, M., Okawa, Y., Mita, Y.,Matoba, S., 2015. An alpha 
adrenergic agonist protects hearts by inducing Akt1-mediated autophagy. Biochem. Biophys. 
Res. Commun. 456, 250–256. 
 
Navarro-Zaragoza, J., Laorden, M.L, Milanés, M.V. 2017. Glucocorticoid receptor but not 
mineralocorticoid receptor mediates the activation of ERK pathway and CREB during morphine 
withdrawal. Addict. Biol. 22(2), 342-353. 
 
Neil-Dwyer, G., Bartlett, J., McAinsh, J., Cruickshank, J.M. 1981. Beta-adrenoceptor blockers 
and the blood-brian barrier. Br. J. Clin. Pharmacol. 11(6), 549–553. 
 
Nicolaides, N.C., Chrousos, and Charmandari. 2013. Adrenal Insufficiency. Endotext [Internet]. 
South Dartmouth (MA): MDText.com, Inc.; 2000-2013 Nov 18. 
 
Nishiyama, H., Ikeda, H., Kaneko, T., Fu, L., Kudo, M., Ito, T., Okubo, T. 1998. Neuropeptides 
mediate the ozone-induced increase in the permeability of the tracheal mucosa in guinea pigs. 
Am. J. Physiol.  275(2 Pt 1), L231-8. 
 
Oakley, R.H., Cidlowski, J.A. 2013. The biology of the glucocorticoid receptor: new signaling 
mechanisms in health and disease. J. Allergy. Clin. Immunol. 132(5), 1033–44.  
 
Olesen, J., Hougård, K., Hertz, M. 1978. Isoproterenol and propranolol: ability to cross the 
blood-brain barrier and effects on cerebral circulation in man. Stroke. 9(4), 344–9. 
 
Oslund, K.L., Hyde, D.M., Putney, L.F., Alfaro, M.F., Walby, W.F., Tyler, N.K., Schelegle, E.S. 
2008. Activation of neurokinin-1 receptors during ozone inhalation contributes to epithelial injury 
and repair. Am. J. Respir. Cell. Mol. Biol. 39(3), 279-88.  
 
180 
 
Oslund, K.L., Hyde, D.M., Putney, L.F., Alfaro, M.F., Walby, W.F., Tyler, N.K., Schelegle, E.S. 
2009. Activation of calcitonin gene-related peptide receptor during ozone inhalation contributes 
to airway epithelial injury and repair. Toxicol. Pathol. 37(6), 805-13. 
 
Owens, E.O., Patel, M.M., Kirrane, E., Long, T.C., Brown, J., Cote, I., Ross, M.A., Dutton, S.J. 
2017. Framework for assessing causality of air pollution-related health effects for reviews of the 
National Ambient Air Quality Standards. Regul. Toxicol. Pharmacol. [Epub ahead of print]. 
 
Ozone Designation and Classification Information. (July, 2017). Retrieved from 
https://www.epa.gov/green-book/ozone-designation-and-classification-information 
 
Ozone National Ambient Air Quality Standards, 2017 (2017, NAAQS). Retrieved from 
https://www.uschamber.com/issue-brief/ozone-national-ambient-air-quality-standards 
 
Ozone trends. (July, 2017). Retrieved from https://www.epa.gov/air-trends/ozone-trends 
 
Palli, D., Sera, F., Giovannelli, L., Masala, G., Grechi, D., Bendinelli, B., Caini, S., Dolara, P., 
and Saieva, C. 2009. Environmental ozone exposure and oxidative DNA damage in adult 
residents of Florence, Italy. Environ Pollut. 157(5), 1521-5. 
 
Pan, W.-K., Li, P., Guo, Z.-T., Huang, Q., Gao, Y., 2015. Propranolol induces regression of 
hemangioma cells via the down-regulation of the PI3K/Akt/eNOS/VEGF pathway. Pediatr. Blood 
Cancer 62, 1414–1420. 
 
Parent., R.A. 2015. Comparative Biology of the Normal Lung. London, England. CRC Press. 
 
Pazirandeh, A., Xue, Y., Prestegaard, T., Jondal, M., and Okret, S. 2002. Effects of altered 
glucocorticoid sensitivity in the T cell lineage on thymocyte and T cell homeostasis. FASEB J. 
16(7), 727-9. 
 
Pendino, K.J., Meidhof, T.M., Heck, D.E., Laskin, J.D., Laskin, D.L. 1995. Inhibition of 
macrophages with gadolinium chloride abrogates ozone-induced pulmonary injury and 
inflammatory mediator production. Am. J. Respir. Cell. Mol. Biol. 13(2), 125-32. 
 
Pepin, A., Biola-Vidamment, A., Latré de Laté, P., Espinasse, M.A., Godot, V., Pallardy, M. 
2015. TSC-22D proteins: new regulators of cell homeostasis?. Med Sci (Paris). 31(1), 75-83. 
 
Petta, I., Dejager, L., Ballegeer, M., Lievens, S., Tavernier, J., De Bosscher, K., Libert, C. 2016. 
The Interactome of the Glucocorticoid Receptor and Its Influence on the Actions of 
Glucocorticoids in Combatting Inflammatory and Infectious Diseases. Microbiol. Mol. Biol. Rev. 
80(2), 495–522. 
 
Pinault, L., Tjepkema, M., Crouse, D.L., Weichenthal, S., van Donkelaar, A., Martin, R.V., 
Brauer, M., Chen, H., Burnett, R.T. 2016. Risk estimates of mortality attributed to low 
concentrations of ambient fine particulate matter in the Canadian community health survey 
cohort. Environ Health. 15:18. 
 
Pope, C.A.3rd., Dockery, D.W. 2006. Health effects of fine particulate air pollution: lines that 
connect. J. Air. Waste Manag. Assoc. 56(6), 709-42. 
 
181 
 
Pourageaud, F., Leblais, V., Bellance, N., Marthan, R., Muller, B. 2005. Role of beta2-
adrenoceptors (beta-AR), but not beta1-, beta3-AR and endothelial nitric oxide, in beta-AR-
mediated relaxation of rat intrapulmonary artery. Naunyn. Schmiedebergs. Arch. Pharmacol. 
372(1), 14–23. 
 
Prueitt, R.L., Goodman, J.E. 2016. Evaluation of neural reflex activation as a mode of action for 
the acute respiratory effects of ozone. Inhal. Toxicol. 28(11), 484-99. 
 
Prueitt, R.L., Lynch, H.N., Zu, K., Sax, S.N., Venditti, F.J., Goodman, J.E.  2014. Weight-of-
evidence evaluation of long-term ozone exposure and cardiovascular effects. Crit. Rev. Toxicol. 
44(9), 791-822.  
 
Pryor, W.A. 1992. How far does ozone penetrate into the pulmonary air/tissue boundary before 
it reacts? Free Radic. Biol. Med. 12(1), 83-8. 
 
Pryor, W.A., Squadrito, G.L., Friedman, M. 1995. A new mechanism for the toxicity of ozone. 
Toxicol. Lett. 82-83, 287-93. 
 
Qian., Z., Lin, H.M., Chinchilli, V.M., Lehman, E.B., Duan, Y., Craig, T.J., Wilson, W.E., Liao, D., 
Lazarus, S.C., and Bascom, R. 2009. Interaction of ambient air pollution with asthma medication 
on exhaled nitric oxide among asthmatics. Arch Environ Occup Health. 4(3), 168-76.  
 
Qiao, L., Ge, A., Liang, Y., Ye, S. 2015. Oxidative Degradation of the Monolayer of 1-Palmitoyl-
2-Oleoyl-sn-Glycero-3-Phosphocholine (POPC) in Low-Level Ozone. J Phys Chem B. 119(44), 
14188-99.  
 
Ranabir, S., Reetu, K. 2011. Stress and hormones. Indian. J. Endocrinol. Metab. 15(1), 18–22. 
 
Rassler, B. 2013. Role of α- and β-adrenergic mechanisms in the pathogenesis of pulmonary 
injuries characterized by edema, inflammation and fibrosis. Cardiovasc Hematol Disord Drug 
Targets. 13(3), 197-207. 
 
Rearte, B., Maglioco, A., Balboa, L., Bruzzo, J., Landoni, V.I., Laborde, E.A., Chiarella, P.,  
Ruggiero, R.A., Fernández, G.C., Isturiz, M.A. 2010. Mifepristone (RU486) restores humoral 
and T cell-mediated immune response in endotoxin immunosuppressed mice. Clin. Exp. 
Immunol. 162(3), 568–77.  
 
Reinhart, P.G., Bassett, D.J., Bhalla, D.K. 1998. The influence of polymorphonuclear leukocytes 
on altered pulmonary epithelial permeabilityduring ozone exposure. Toxicology. 127(1-3), 17-28. 
 
Rivas-Arancibia, S., Dorado-Martínez, C., Colin-Barenque, L., Kendrick, K.M., de la Riva, C., 
Guevara-Guzmán, R. 2003. Effect of acute ozone exposure on locomotor behavior and striatal 
function. Pharmacol Biochem Behav. 74(4), 891-900. 
 
Rivas-Arancibia, S., Guevara-Guzmán, R., López-Vidal, Y., Rodríguez-Martínez, E., Zanardo-
Gomes, M., Angoa-Pérez, M., Raisman-Vozari, R. 2010. Oxidative stress caused by ozone 
exposure induces loss of brain repair in the hippocampus of adult rats. Toxicol. Sci. 113(1), 187-
97.  
 
182 
 
Rivas-Arancibia, S., Zimbrón, L.F., Rodríguez-Martínez, E., Maldonado, P.D., Borgonio Pérez, 
G., Sepúlveda-Parada, M. 2015. Oxidative stress-dependent changes in immune responses 
and cell death in the substantia nigra after ozone exposure in rat. Front. Aging. Neurosci. 7, 65. 
 
Roggero, E., Pérez, A.R., Tamae-Kakazu, M., Piazzon, I., Nepomnaschy, I., Besedovsky, H.O., 
Bottasso, O.A., and del Rey, A. 2006. Endogenous glucocorticoids cause thymus atrophy but 
are protective during acute Trypanosoma cruzi infection. J Endocrinol. 190(2), 495-503. 
 
Rohleder, N. 2014. Stimulation of systemic low-grade inflammation by psychosocial stress. 
Psychosom. Med. 76(3), 181-9. 
 
Rosa, M.J., Just, A.C., Kloog, I., Pantic, I., Schnaas, L., Lee, A., Bose, S., Chiu, Y.M., Hsu, H.L., 
Coull, B., Schwartz, J., Cohen, S., Téllez Rojo, M.M., Wright, R.O., Wright, R.J. 2017. Prenatal 
particulate matter exposure and wheeze in Mexican children: Effect modification by prenatal 
psychosocial stress. Ann Allergy Asthma Immunol. 119(3), 232-237. 
 
Rottenkolber, M., Fischer, R., Ibáñez, L., Fortuny, J., Reynolds, R., Amelio, J., Gerlach, R., 
Tauscher, M., Thürmann, P., Hasford, J., Schmiedl, S. 2015. Prescribing of long-acting beta-2-
agonists/inhaled corticosteroids after the SMART trial. BMC Pulm. Med. 15,55.  
 
Roum, J.H., Murlas, C. 1984. Ozone-induced changes in muscarinic bronchial reactivity by 
different testing methods. J. Appl. Physiol. Respir. Environ. Exerc. Physiol.  57(6), 1783-9. 
 
Ryan, K.J., Griffin, E.W., Connor, T.J. 2011. Complementary anti-inflammatory actions of the β₂-
adrenoceptor agonist clenbuterol and the glucocorticoid dexamethasone in rat brain. J 
Neuroimmunol. 232(1-2), 209-16.  
 
Sadarani, B.N., Majumdar, A.S. 2015. Resveratrol potentiates the effect of dexamethasone in 
rat model of acute lung inflammation. Int Immunopharmacol. 28(1), 773-9.  
 
Sakakibara, Y., Katoh, M., Suzuki, M., Kawabe, R., Iwase, K., and Nadai, M. 2014. Effect of 
adrenalectomy on expression and induction of UDP-glucuronosyltransferase 1A6 and 1A7 in 
rats. Biol Pharm Bull. 37(4), 618-24. 
 
Sato, S., Nomura, S., Kawano, F., Tanihata, J., Tachiyashiki, K., and Imaizumi, K. 2008. Effects 
of the beta2-agonist clenbuterol on beta1- and beta2-adrenoceptor mRNA expressions of rat 
skeletal and left ventricle muscles. J Pharmacol Sci. 107(4), 393-400.  
 
Sato, S., Shirakawa, H., Tomita, S., Tohkin, M., Gonzalez, F.J., Komai, M. 2013. The aryl 
hydrocarbon receptor and glucocorticoid receptor interact to activate human metallothionein 2A. 
Toxicol. Appl. Pharmacol. 273(1), 90–9. 
 
Sato, T., Arai, M., Goto, S., Togari, A. 2010. Effects of propranolol on bone metabolism in 
spontaneously hypertensive rats. J. Pharmacol. Exp. Ther. 334(1), 99–105. 
 
Schade, R., Göhler, K., Bürger, W., Hirschelmann, R., 1987. Modulation of rat C-reactive protein 
serum level by dexamethasone and adrenaline—comparison with the response of alpha 2-acute 
phase globulin. Agents Actions 22, 280–287. 
 
183 
 
Schelegle, E.S., Carl, M.L., Coleridge, H.M., Coleridge, J.C., Green, J.F.  1993. Contribution of 
vagal afferents to respiratory reflexes evoked by acute inhalation of ozone in dogs. J. Appl. 
Physiol. (1985). 74(5), 2338-44. 
 
Schelegle, E.S., Morales, C.A., Walby, W.F., Marion, S., Allen, R.P. 2009. 6.6-hour inhalation of 
ozone concentrations from 60 to 87 parts per billion in healthy humans. Am. J. Respir. Crit. Care 
Med. 180(3), 265-72.  
 
Schierhorn, K., Hanf, G., Fischer, A., Umland, B., Olze, H., Kunkel, G. 2002. Ozone-induced 
release of neuropeptides from human nasal mucosa cells. Int. Arch. Allergy Immunol. 129(2), 
145-51. 
 
Schlosser, P.M., Asgharian, B.A., Medinsky, M. 2010. Inhalation Exposure and absorption of 
toxicants. Comprehensive Toxicology , 2nd Edition, (1) 75-109. 
 
Schnell, J.L., Prather, M.J. 2017. Co-occurrence of extremes in surface ozone, particulate 
matter, and temperature over eastern North America. Proc. Natl. Acad. Sci. U S A. 114(11), 
2854-2859. 
 
Schultheis, A.H., Bassett, D.J., Fryer, A.D. 1994. Ozone-induced airway hyperresponsiveness 
and loss of neuronal M2 muscarinic receptor function. J. Appl. Physiol. (1985). 76(3), 1088-97. 
 
Schulz, S., Ninke, S., Watzer, B., Nüsing, R.M. 2012. Ozone induces synthesis of systemic 
prostacyclin by cyclooxygenase-2 dependent mechanism in vivo. Biochem. Pharmacol. 83(4), 
506-13.  
 
Šedý, J., Kuneš, J., Zicha, J. 2015. Pathogenetic Mechanisms of Neurogenic Pulmonary 
Edema. J Neurotrauma. 32(15), 1135-45.  
 
Seinfeld, J.H., Pandis, S.N. 2006. Atmospheric Chemistry and Physics, From Air Pollution to 
Climate Change, 2nd edition. New Jersey, USA. John Wiley & Sons.  
 
Serrano, D., Ghiotto, F., Roncella, S., Airoldi, I., Cutrona, G., Truini, M., Burgio, V.L., Baroni, 
C.D., Ferrarini, M., Pistoia, V., 1997. The patterns of IL2, IFN-gamma, IL4 and IL5 gene 
expression in Hodgkin's disease and reactive lymph nodes are similar. Haematologica 82, 542–
549. 
 
Shannahan, J.H., Schladweiler, M.C., Richards, J.H., Ledbetter, A.D., Ghio, A.J., Kodavanti, 
U.P. 2010. Pulmonary oxidative stress, inflammation, and dysregulated iron homeostasis in rat 
models of cardiovascular disease. J. Toxicol. Environ. Health A. 73(10), 641–56. 
 
Sharrett-Field, L., Butler, T.R., Berry, J.N., Reynolds, A.R., Prendergast, M.A. 2013. 
Mifepristone Pretreatment Reduces Ethanol Withdrawal Severity In Vivo. Alcohol Clin. Exp. 
Res. 37(8), 1417–23.  
 
Shi, L., Zanobetti, A., Kloog, I., Coull, B.A., Koutrakis, P., Melly, S.J., Schwartz, J.D. 2016. Low-
Concentration PM2.5 and Mortality: Estimating Acute and Chronic Effects in a Population-Based 
Study. Environ Health Perspect. 124(1), 46-52. 
 
184 
 
Shi, W.L., Zhang, T., Zhou, J.R., Huang, Y.H., Jiang, C.L. 2016. Rapid permissive action of 
dexamethasone on the regulation of blood pressure in a rat model of septic shock. Biomed. 
Pharmacother. 84, 1119–1125. 
 
Shintani, Y., Maruoka, S., Gon, Y., Koyama, D., Yoshida, A., Kozu, Y., Kuroda, K., Takeshita, I., 
Tsuboi, E., Soda, K., et al., 2015. Nuclear factor erythroid 2-related factor 2 (Nrf2) regulates 
airway epithelial barrier integrity. Allergol. Int. Off. J. Jpn. Soc. Allergol. 64 (Suppl), S54–S63. 
 
Shmool, J.L., Kubzansky, L.D., Newman, O.D., Spengler, J., Shepard, P., Clougherty, J.E. 
2014. Social stressors and air pollution across New York City communities: a spatial approach 
for assessing correlations among multiple exposures. Environ Health.13, 91. 
 
Shusterman, D. 2007. Trigeminally-mediated health effects of air pollutants: sources of inter-
individual variability. Hum. Exp. Toxicol. 26(3), 149-57. 
 
Simon, H., Reff, A., Wells, B., Xing, Jia., Frank, N. 2015. Ozone Trends Across the United 
States over a Period of Decreasing NOx and VOC Emissions. Environ. Sci. Technol. 49, 
186−195. 
 
Smith, L.K., Cidlowski, J.A. 2010. Glucocorticoid-induced apoptosis of healthy and malignant 
lymphocytes. Prog. Brain Res. 182, 1-30. 
 
Snow, S.J., Gordon, C.J., Bass, V.L., Schladweiler, M.C., Ledbetter, A.D., Jarema, K.A., 
Phillips, P.M., Johnstone, A.F., Kodavanti, U.P. 2016. Age-related differences in pulmonary 
effects of acute and subchronic episodic ozone exposures in Brown Norway rats. Inhal. Toxicol. 
28(7), 313–23. 
 
Snow, S.J., McGee, M.A., Henriquez, A., Richards, J.E., Schladweiler, M.C., Ledbetter, A.D., 
Kodavanti, U.P. 2017. Respiratory Effects and Systemic Stress Response Following Acute 
Acrolein Inhalation in Rats. Toxicol. Sci. [Epub ahead of print] 
 
Solleiro-Villavicencio, H., Rivas-Arancibia, S. 2017. Systemic Th17/IL-17A response appears 
prior to hippocampal neurodegeneration in rats exposed to low doses of ozone. Neurologia. pii: 
S0213-4853(17), 30194-9. 
 
Sorace, A., de Acetis, L., Alleva, E., Santucci, D.  2001. Prolonged exposure to low doses of 
ozone: short- and long-term changes in behavioral performance in mice. Environ. Res. 85(2), 
122-34. 
 
Soriano, J.B., Abajobir, A.A., Abate, K.H., Abera, S.F., Agrawal, A., Ahmed, M.B., Aichour, A.N., 
Aichour, I., Aichour, M.T.E., Alam, K., et al. 2017. Global, regional, and national deaths, 
prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive 
pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of 
Disease Study 2015. Lancet Respir. Med. 5(9), 691-706. 
 
Soulage, C., Perrin, D., Cottet-Emard, J.M., Pequignot, J., Dalmaz, Y., Pequignot, J.M. 2004. 
Central and peripheral changes in catecholamine biosynthesis and turnover in rats after a short 
period of ozone exposure. Neurochem. Int. 45(7), 979-86. 
 
Sozansky, J., Houser, S.M. 2014. The physiological mechanism for sensing nasal airflow: a 
literature review. Int. Forum Allergy Rhinol. 4(10), 834-8. 
185 
 
 
Speen, A.M., Kim, H.H., Bauer, R.N., Meyer, M., Gowdy, K.M., Fessler, M.B., Duncan, K.E., Liu, 
W., Porter, N.A., Jaspers, I. 2016. Ozone-derived Oxysterols Affect Liver X Receptor (LXR) 
Signaling: A Potential role for lipid-protein adducts. J Biol Chem. 291(48), 25192-25206.  
 
Spellberg, B., Edwards, J.E., 2001. Type 1/type 2 immunity in infectious diseases. Clin. Infect. 
Dis. Off. Publ. Infect. Dis. Soc. Am. 32, 76–102. 
 
Spiekerkoetter, E., Fabel, H., and Hoeper, M.M. 2002. Effects of inhaled salbutamol in primary 
pulmonary hypertension. Eur Respir J. 20(3), 524-8. 
 
Steerenberg, P.A., Garssen, J., van Bree, L., van Loveren, H., 1996. Ozone alters T-helper cell 
mediated bronchial hyperreactivity and resistance to bacterial infection. Exp. Toxicol. Pathol. 48, 
497–499. 
 
Stevens, W.H., Vanderheyden, C., Wattie, J., Lane, C.G., Smith, W., O'Byrne, P.M. 1995. Effect 
of a leukotriene B4 receptor antagonist SC-53228 on ozone-induced airway 
hyperresponsiveness and inflammation in dogs. Am J Respir Crit Care Med. 152(5 Pt 1), 1443-
8. 
 
Stiegel, M.A., Pleil, J.D., Sobus, J.R., and Madden, M.C. 2016. Inflammatory Cytokines and 
White Blood Cell Counts Response to Environmental Levels of Diesel Exhaust and Ozone 
Inhalation Exposures. PLoS One. 11(4), e0152458.  
 
Sun, J., Yang, D., Li, S., Xu, Z., Wang, X., Bai, C. 2009. Effects of curcumin or dexamethasone 
on lung ischaemia-reperfusion injury in rats. Eur Respir J. 33(2), 398-404.  
 
Sundell, J. 2004. On the history of indoor air quality and health. Indoor Air. 14 Suppl 7, 51-8. 
 
Szabo, S., Yoshida, M., Filakovszky, J., Juhasz, G. 2017. "Stress" is 80 years old: From Hans  
Selye original paper in 1936 to recent advances in GI ulceration. Curr. Pharm. Des.  [Epub 
ahead of print] 
 
Table of Historical Ozone National Ambient Air Quality Standards (NAAQS). (2017, July). 
Retrieved from https://www.epa.gov/ozone-pollution/table-historical-ozone-national-ambient-air-
quality-standards-naaqs 
 
Takebayashi, T., Abraham, J., Murthy, G.G., Lilly, C., Rodger, I., Shore, S.A. 1998. Role of 
tachykinins in airway responses to ozone in rats. J. Appl. Physiol. (1985). 85(2), 442-50. 
 
Tank, J., Biller, H., Heusser, K., Holz, O., Diedrich, A., Framke, T., Koch, A., Grosshennig, A., 
Koch, W., Krug, N., Jordan, J., Hohlfeld, J.M. 2011. Effect of acute ozone induced airway 
inflammation on human sympathetic nerve traffic: a randomized, placebo controlled, crossover 
study. PLoS One. 6(4), e18737. 
 
Tank, A.W., Lee Wong, D. 2015. Peripheral and central effects of circulating catecholamines. 
Compr Physiol. 5(1), 1-15. 
 
Taylor-Clark, T.E., Undem, B.J. 2010. Ozone activates airway nerves via the selective 
stimulation of TRPA1 ion channels. J. Physiol. 588(Pt 3), 423-33. 
 
186 
 
Taylor-Clark, T.E., Undem, B.J., 2011. Sensing pulmonary oxidative stress by lung vagal 
afferents. Respir. Physiol. Neurobiol. 178, 406–413. 
 
Tepper, J.S., Wood, R.W. 1985. Behavioral evaluation of the irritating properties of ozone. 
Toxicol. Appl. Pharmacol. 78(3), 404-11. 
 
Terrien, J. Perret, M., and Aujard, F. 2011. Behavioral thermoregulation in mammals: a review. 
Front Biosci (Landmark Ed). 16, 1428-44. 
 
Thai, P., Loukoianov, A., Wachi, S., Wu, R.  2008. Regulation of airway mucin gene expression. 
Annu. Rev. Physiol. 70, 405-29. 
 
Tham, A., Lullo, D., Dalton, S., Zeng, S., van Koeverden, I., Arjomandi, M. 2017. Modeling 
vascular inflammation and atherogenicity after inhalation of ambient levels of ozone: exploratory 
lessons from transcriptomics. Inhal. Toxicol. 29(3), 96-105. 
 
The Royal Society, 2008. Ground-level ozone in the 21st century: future trends, impacts and 
policy implications. Science Policy Report 15/08. 
 
Theis, W.S., Andringa, K.K., Millender-Swain, T., Dickinson, D.A., Postlethwait, E.M., Bailey, 
S.M. 2014. Ozone inhalation modifies the rat liver proteome. Redox Biol. 2, 52-60.  
 
Thompson, K.C., Jones, S.H., Rennie, A.R., King, M.D., Ward, A.D., Hughes, B.R., Lucas, 
C.O.M., Campbell, R.A., Hughes, A.V., 2013. Degradation and rearrangement of a lung  
surfactant lipid at the air-water interface during exposure to the pollutant gas ozone. Langmuir 
ACS J. Surf. Colloids 29, 4594–4602. 
 
Thomson, E.M., Pal, S., Guénette, J., Wade, M.G., Atlas, E., Holloway, A.C., Williams, A., 
Vincent, R., 2016. Ozone inhalation provokes glucocorticoid-dependent and independent effects 
on inflammatory and metabolic pathways. Toxicol. Sci. 152 (1), 17–28. 
 
Thomson, E.M., Vladisavljevic, D., Mohottalage, S., Kumarathasan, P., Vincent, R. 2013. 
Mapping acute systemic effects of inhaled particulate matter and ozone: multiorgan gene 
expression and glucocorticoid activity. Toxicol. Sci.135(1), 169-81.  
 
Uchiyama, I., Simomura, Y., Yokoyama, E. 1986. Effects of acute exposure to ozone on heart 
rate and blood pressure of the conscious rat. Environ Res. 41(2), 529-37. 
 
Uchiyama, I., Yokoyama, E., 1989. Effects of short- and long-term exposure to ozone on heart 
rate and blood pressure of emphysematous rats. Environ. Res. 48, 76–86. 
 
Ultman, J.S., Ben-Jebria, A., Hu, S.C. 1994. Noninvasive determination of respiratory ozone 
absorption: the bolus-response method. Res. Rep. Health. Eff. Inst. (69), 1-27; discussion 29-
42. 
 
Unwalla, H.J., Horvath, G., Roth, F.D., Conner, G.E., Salathe, M. 2012. Albuterol modulates its 
own transepithelial flux via changes in paracellular permeability. Am J Respir Cell Mol Biol. 
46(4), 551-8. 
 
187 
 
Unwalla, H.J., Ivonnet, P., Dennis, J.S., Conner, G.E., and Salathe, M. 2015. Transforming 
growth factor-β1 and cigarette smoke inhibit the ability of β2-agonists to enhance epithelial 
permeability. Am J Respir Cell Mol Biol. 52(1), 65-74. 
 
Urch, B., Speck, M., Corey, P., Wasserstein, D., Manno, M., Lukic, K.Z., Brook, J.R., Liu, L., 
Coull, B., Schwartz, J., et al. 2010. Concentrated ambient fine particles and not ozone induce a 
systemic interleukin-6 response in humans. Inhal. Toxicol. 22(3), 210-8.  
 
Valavanidis, A., Vlachogianni, T., Fiotakis, K., Loridas, S. 2013. Pulmonary oxidative stress, 
inflammation and cancer: respirable particulate matter, fibrous dusts and ozone as major 
causes of lung carcinogenesis through reactive oxygen species mechanisms. Int J Environ Res 
Public Health. 10(9), 3886-907.  
 
van Gool, J., van Vugt, H., Helle, M., Aarden, L.A. 1990. The relation among stress, adrenalin, 
interleukin 6 and acute phase proteins in the rat. Clin. Immunol. Immunopathol. 57(2), 200–10.  
 
Verhein, K.C., Hazari, M.S., Moulton, B.C., Jacoby, I.W., Jacoby, D.B., Fryer, A.D. 2011. Three 
days after a single exposure to ozone, the mechanism of airway hyperreactivity is dependent on 
substance P and nerve growth factor. Am. J. Physiol. Lung. Cell. Mol. Physiol. 300(2), L176-84.  
 
Vesely, K.R., Hyde, D.M., Stovall, M.Y., Harkema, J.R., Green, J.F., Schelegle, E.S. 1999. 
Capsaicin-sensitive C-fiber-mediated protective responses in ozone inhalation in rats. J. Appl. 
Physiol. (1985). 86(3), 951-62. 
 
Vida, G., Peña, G., Kanashiro, A., Thompson-Bonilla, M. del R., Palange, D., Deitch, E.A., 
Ulloa, L. 2011. β2-Adrenoreceptors of regulatory lymphocytes are essential for vagal 
neuromodulation of the innate immune system. FASEB J. (12), 4476–85. 
 
Viegas, L.R., Hoijman, E., Beato, M., Pecci, A. 2008. Mechanisms involved in tissue-specific 
apoptosis regulated by glucocorticoids. J. Steroid. Biochem. Mol. Biol. 109(3-5), 273–8.  
 
Wagner, J.G., Allen, K., Yang, H.Y., Nan, B., Morishita, M., Mukherjee, B., Dvonch, J.T., Spino, 
C., Fink, G.D., Rajagopalan, S., et al. 2014. Cardiovascular depression in rats exposed to 
inhaled particulate matter and ozone: effects of diet-induced metabolic syndrome. Environ. 
Health Perspect. 122(1), 27-33. 
 
Waldeck, B. 2002. Beta-adrenoceptor agonists and asthma--100 years of development. Eur J 
Pharmacol. 445(1-2), 1-12. 
 
Wallukat, G., 2002. The beta-adrenergic receptors. Herz 27, 683–690. 
 
Wang, J., Zhang, H., Su, C., Chen, J., Zhu, B., Zhang, H., Xiao, H., Zhang, J. 2014. 
Dexamethasone ameliorates H2S-induced acute lung injury by alleviating matrix 
metalloproteinase-2 and -9 expression. PLoS One. 9(4), e94701.  
 
Wang, J.-C., Derynck, M.K., Nonaka, D.F., Khodabakhsh, D.B., Haqq, C., Yamamoto, K.R., 
2004. Chromatin immunoprecipitation (ChIP) scanning identifies primary glucocorticoid receptor 
target genes. Proc. Natl. Acad. Sci. U. S. A. 101, 15603–15608. 
 
188 
 
Wang, W.N., Cheng, T.H., Gu, X.F., Chen, H., Guo, H. Wang, Y., Bao, F.W., Shi, S.Y., Xu, B.R., 
Zuo, X., et al. 2017. Assessing Spatial and Temporal Patterns of Observed Ground-level Ozone 
in China. Sci. Rep. 7(1), 3651. 
 
Ward, W.O., Kodavanti, U.P., 2015. Pulmonary transcriptional response to ozone in healthy and 
cardiovascular compromised rat models. Inhal. Toxicol. 27 (Suppl. 1), 93–104. 
 
Ward,W.O., Ledbetter, A.D., Schladweiler,M.C., Kodavanti, U.P., 2015. Lung transcriptional 
profiling: insights into the mechanisms of ozone-induced pulmonary injury in Wistar Kyoto rats. 
Inhal. Toxicol. 27 (Suppl. 1), 80–92. 
 
Warnes, G.R., Bolker, B., Bonebakker, L., Gentleman, R., Huber, W., Liaw, A., Lumley, T., 
Maechler, M., Magnusson, A., Moeller, S., et al., 2015. gplots: Various R Programming Tools for 
Plotting Data. 
 
Watkinson, W.P., Campen, M.J., Nolan, J.P., Costa, D.L., 2001. Cardiovascular and systemic 
responses to inhaled pollutants in rodents: effects of ozone and particulate matter. Environ. 
Health Perspect. 109 (Suppl. 4), 539–546. 
 
Watkinson, W.P., Gordon, C.J. 1993. Caveats regarding the use of the laboratory rat as a model 
for acute toxicological studies: modulation of the toxic response via physiological and behavioral 
mechanisms. Toxicology. 81(1), 15-31. 
 
Watkinson, W.P., Highfill, J.W., Slade, R., Hatch, G.E., 1996. Ozone toxicity in the mouse: 
comparison and modeling of responses in susceptible and resistant strains. J. Appl. Physiol. 
Bethesda Md 1985 80, 2134–2142. 
 
Weiss, B., Ferin, J., Merigan, W., Stern, S., Cox, C. 1981. Modification of rat operant behavior 
by ozone exposure. Toxicol. Appl. Pharmacol. 58(2), 244-51. 
 
WHO Global Urban Ambient Air Pollution Database (2017, July). Retrieved from 
http://www.who.int/phe/health_topics/outdoorair/databases/cities/en/ 
 
WHO. 2005. Air quality guidelines for particulate matter, ozone, nitrogen, dioxide and sulfur 
dioxide, Global update 2005 Summary of risk assessment. Retrieved from 
http://apps.who.int/iris/bitstream/10665/69477/1/WHO_SDE_PHE_OEH_06.02_eng.pdf 
 
WHO. 2013. Health effects of particulate matter. Retrieved from 
http://www.euro.who.int/__data/assets/pdf_file/0006/189051/Health-effects-of-particulate-
matter-final-Eng.pdf 
 
Wicher, S.A., Jacoby, D.B., Fryer, A.D. 2017. Newly divided eosinophils limit ozone-induced 
airway hyperreactivity in nonsensitized guinea pigs. Am. J. Physiol. Lung. Cell. Mol. Physiol. 
312(6), L969-L982. 
 
Wiegman, C.H., Li, F., Clarke, C.J., Jazrawi, E., Kirkham, P., Barnes, P.J., Adcock, I.M., Chung, 
K.F., 2014. A comprehensive analysis of oxidative stress in the ozone-induced lung 
inflammation mouse model. Clin. Sci. Lond. Engl. 1979 (126), 425–440. 
 
Wiester, M.J., Williams, T.B., King, M.E., Ménache, M.G., Miller, F.J. 1987. Ozone uptake in 
awake Sprague-Dawley rats. Toxicol. Appl. Pharmacol. 89(3), 429-37. 
189 
 
 
Williams, A.S., Leung, S.Y., Nath, P., Khorasani, N.M., Bhavsar, P., Issa, R., Mitchell, J.A., 
Adcock, I.M., Chung, K.F. 2007. Role of TLR2, TLR4, and MyD88 in murine ozone-induced 
airway hyperresponsiveness and neutrophilia. J Appl Physiol (1985). 103(4), 1189-95.  
 
Wilson, J., Higgins, D., Hutting, H., Serkova, N., Baird, C., Khailova, L., Queensland, K., Vu 
Tran, Z., Weitzel, L., Wischmeyer, P.E. 2013. Early propranolol treatment induces lung heme-
oxygenase-1, attenuates metabolic dysfunction, and improves survival following experimental 
sepsis. Crit. Care. 17(5), R195. 
 
Wright, R.J. 2011. Epidemiology of stress and asthma: from constricting communities and 
fragile families to epigenetics. Immunol Allergy Clin North Am. 31(1), 19-39.  
 
Wu, D., Tan, W., Zhang, Q., Zhang, X., Song, H., 2014. Effects of ozone exposure mediated by 
BEAS-2B cells on T cells activation: a possible link between environment and asthma. Asian 
Pac. J. Allergy Immunol. Launched Allergy Immunol. Soc. Thail. 32, 25–33. 
 
Wu, H., Guan, C., Qin, X., Xiang, Y. Qi, M., Luo, Z., Zhang, C. 2007. Upregulation of substance 
P receptor expression by calcitonin gene-related peptide, a possible cooperative action of two 
neuropeptides involved in airway inflammation. Pulm. Pharmacol. Ther. 20(5), 513-24. 
 
Wu, W., Wages, P.A., Devlin, R.B., Diaz-Sanchez, D., Peden, D.B., Samet, J.M. 2015. SRC-
mediated EGF receptor activation regulates ozone-induced interleukin 8 expression in human 
bronchial epithelial cells. Environ Health Perspect. 123(3), 231-6.  
 
Wu, Y.C., Lin, Y.C., Yu, H.L., Chen, J.H, Chen, T.F., Sun, Y., Wen, L.L., Yip, P.K., Chu, Y.M., 
Chen, Y.C. 2015. Association between air pollutants and dementia risk in the elderly. 
Alzheimers Dement. (Amst). 1(2), 220-8.  
 
Yan, Z., Jin, Y., An, Z., Liu, Y., Samet, J.M.,Wu,W., 2016. Inflammatory cell signaling following 
exposures to particulate matter and ozone. Biochim. Biophys. Acta 1860 (12), 2826–2834. 
 
Yayan, J., and Rasche, K. 2016. Asthma and COPD: Similarities and Differences in the 
Pathophysiology, Diagnosis and Therapy. Adv Exp Med Biol. 910, 31-8. 
 
Yonas, M.A., Lange, N.E., Celedón, J.C. 2012. Psychosocial stress and asthma morbidity. Curr. 
Opin. Allergy. Clin. Immunol. 12(2), 202-10. 
 
Yost, B.L., Gleich, G.J., Fryer, A.D. 1999. Ozone-induced hyperresponsiveness and blockade of 
M2 muscarinic receptors by eosinophil major basic protein. J. Appl. Physiol. (1985). 87(4), 
1272-8. 
 
Zhang, Y., Wang, Y. 2016. Climate-driven ground-level ozone extreme in the fall over the 
Southeast United States. Proc Natl Acad Sci U S A. 113(36), 10025-30.  
 
Zhou, J., Yan, J., Liang, H., Jiang, J. 2014. Epinephrine enhances the response of 
macrophages under LPS stimulation. Biomed. Res. Int. 2014, 254686.  
 
Zhou, Y., Xu, M., Zhang, Y., Guo, Y., Zhang, Y., He, B. 2014. Effects of long-term application of 
metoprolol and propranolol in a rat model of smoking. Clin. Exp. Pharmacol. Physiol. 41(9), 
708–15. 
